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Abstract 
Polyhydroxyalkanoates (PHA) are biopolymer molecules that have shown increasing 
evidence of suitability for use as biomaterials. Many different cell types from a range of 
species have been shown to adhere and develop on PHA scaffolds, with some preliminary 
in vivo studies having been performed and showing promising results. 
Several cell types have shown potential for use in tendon tissue engineering. Primary 
tendon cells (tenocytes) isolated from a rat Achilles tendon (RaT), human Mesenchymal 
Stem Cells (hMSCs) and human Embryonic Stem Cells (hESCs) have all been utilised 
throughout this investigation in many different experimental models. To date, research has 
focused on scaffold design and manufacture, suitability of the polymer for cell culture, in 
vitro testing in both static and dynamic environments and a pilot in vivo study. The aims of 
this study were to find if the PHA molecule Poly (hydroxybutyrate-co-hydroxyhexanoate) 
(PHBHHx) is able to support tendon cell culture, to design a scaffold using the polymer 
that could replicate tendon in vitro and in vivo, to mechanically stimulate cells seeded in 
scaffolds to encourage extracellular matrix remodelling into tendon like structures and to 
monitor the construct when placed in situ in a pilot in vivo model.  
Results have shown that PHBHHx can support RaT, hMSC and hESC development. 
Mechanical testing revealed a design with similar properties to those of a rat Achilles 
tendon. Bioreactor studies have demonstrated how hMSCs, hESCs and rat tenocytes can 
remodel collagen gels incorporated into the scaffold towards morphologies resembling 
tendon.  Preliminary in vivo studies have found that a PHBHHx and PHBHHx/collagen 
hybrid scaffold show little immune response when placed in situ.  
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In conclusion, this study has demonstrated the effectiveness of PHBHHx and 
PHBHHx/collagen hybrid scaffolds for use in tendon tissue engineering, providing scope 
for future breakthrough products and innovations in both scientific and clinical arenas.   
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1.1. Introduction. 
1.1.1. Regenerative Medicine. 
The field of research referred to as regenerative medicine (RM) aims to replace or 
regenerate human cells, tissues or organs to restore or establish natural function (1). Many 
different research approaches can be classified within the RM bracket; biomaterials, small 
pharmaceutical molecules and complex biological molecules, such as proteins, cell based 
therapies and tissue engineering (2). The development and successful implantation in 
human of both a functioning tissue engineered trachea (3) and bladder (4) demonstrate the 
advances made in the field over recent years. Further investigations into the tissue 
engineering of complete liver (5), kidney (6) organs are also showing promise, although 
further research is required before human testing can be carried out (7). Skin tissue 
engineering is currently at a more advanced stage of development and is in wide clinical 
use (8). 
 
Tendon injury and repair presents a major burden to healthcare systems around the world 
due to increased life expectancies and a more active lifestyle being adopted by older people 
(9). Tendons are characterised as slow healing following injury for many reasons including 
poor vasculature, low cell numbers and long term immobilisation leading to further 
degeneration (10). New treatment methods and materials are therefore required to improve 
on current gold standards, such as autografts (11), with polymer based tissue engineered 
constructs showing great promise in this area (12). 
 
This project aims to apply the principles of tissue engineering in the development of an 
artificial tendon for use as either a model for treatment assessment or as a treatment itself. 
During this project novel biopolymers, natural polymers and a range of cells that have 
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shown promise in other areas of musculoskeletal research will be examined, along with 
mechanical stimulation bioreactors and hypoxic culture conditions to determine the 
optimal environment for artificial tendon construct development.   
 
1.2. Tendon. 
 
Tendons form the bridge between muscle and bone. Each muscle has at least two tendons, 
one at the distal end, the other at the proximal end. Without tendons, the force exerted by 
the muscle would not be transferred to the skeletal system, meaning movement would not 
be possible. A secondary function of tendon is in supporting the skeleton during 
movement. The high loads applied to tendons on a regular basis mean that a highly 
specialised tissue is required to allow for correct function. 
 
1.2.1. Tendon Structure. 
 
Healthy tendon is brilliant white in colour and can vary in thickness according to its 
location, from thin cylindrical tendons (like those that control finger movement) to thick 
ribbon like structures (e.g. connecting the humorous and the bicep). The structure of these 
tendons does not vary greatly between these different types. 
 
The tendon is surrounded by a network of structures that aid in the lubrication and 
efficiency of glide along the path of force transmission. These include the retinacula 
(fibrous sheaths), reflection pulleys, synovial sheaths, paratenon and tendon bursae (13). 
These structures tend only to be found in areas where very large forces are exerted, (e.g. 
the Achilles tendon) and most are not present for the majority of tendons throughout the 
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body. Paratenon is a loose sheath of tissue consisting mainly of collagens I and III, with an 
inner layer of synovial cells surrounding most tendons acting as a guide for tendon glide. 
The epitenon is the outer layer of the tendon. Composed primarily of densely aligned cross 
linked collagen I and III fibrils, these act as a binding tissue for the tendon’s internal fibre 
bundles. Collagen I fibrils are the basic unit of the tendon that create its load bearing 
capacity by aligning with the direction in which the force acts. These collagen fibrils are 
organised into structures referred to as tertiary, secondary and primary bundles. Primary 
fibre bundles (or sub fascicles) consist of a collection of collagen I fibrils (14). Secondary 
fibre bundles (fascicle) group together the sub fascicles into larger units, which are then 
grouped into tertiary fibre bundles (15). Endotenon divides the bundles of collagen fibrils 
into areas that can be supplied with blood and other nutrients.  As well as acting as a 
binding mechanism, endotenon, made up of a “crisscross” pattern of types I and III 
collagen and high concentrations of glycosaminoglycan molecules, which trap water in the 
overall structure lubricating the system, allowing the tendon fascicles to glide over each 
other, and creating a greater range of possible movement and a higher overall tolerance of 
stress (13). 
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Fig. 1.1 The structure of tendon with approximate diameters of each section. Tendon structure is 
hierarchical, with many small units coming together to form larger and larger structural units, with 
connective tissue sheaths (endotenon) aiding in fibril glide.  Numerical diameter values from 
Richardson et al 2007 (16). 
 
1.2.2. Tendon Composition. 
 
Tendons are made up of collagens, proteoglycans, glycoproteins, water and cells(15). 
Collagen accounts for the majority of a tendon’s mass, with type I collagen being by far 
the most abundant, making up around 70% of total dry mass(17) and around 95% of the 
total mass of collagen(18). The remaining 5% is made up of types III and V collagen. In 
healthy tendons, type III collagen is found mainly in the endotenon and epitenon but is 
found throughout the tendon structure in aged or damaged tissue. Type V collagen is found 
at the centre of the collagen fibrils acting to establish and mediate fibril diameter growth, 
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ensuring that a collection of many small collagen I fibrils is formed rather than one large 
structure (19). For collagen to gain the mechanical properties required to function as a 
tendon a complex pattern of cross linking is required. This increases both the Young’s 
Modulus (the ratio of the stress along an axis over the strain along that axis in the range of 
stress in which elastic deformation is maintained) and reduces the strain (the amount a 
material deforms as a percentage of its original length in one axis) at failure, making the 
tendon better suited to transmit forces. Cross linking can be achieved either enzymatically 
with lysyl oxidase, where adjacent amino acids are linked (15) or when reducing sugars 
bind permanently to the matrix proteins (glycation) (20). Collagen fibrils are linked in 
many different ways, not just longitudinally, but also horizontally and transversely. Five 
different cross link patterns are described by Jozsa et al (21). The specific cross links found 
vary greatly between not only different tendons, but different areas of the same tendon. 
The variation is thought to be due to differences in the force loading, with the fibrils 
adapting to transmit load in the most efficient way.  
 
Proteoglycans form a major part of many extracellular matrices (ECM), being responsible 
for holding water molecules and providing binding sites for cells to adhere to ECM 
structures. The proteoglycan content of a tendon is dependent on its location and role in the 
body, with compression bearing regions of bovine tendons being shown to have a 
significantly higher proteoglycan content than those in tension (3.5% vs. 0.2% of total 
tendon dry weight) (22). Proteoglycans are mainly found in the extracellular matrix 
surrounding the tendon cells. The major proteoglycans present in tendon are decorin and 
aggrecan. Both molecules have been found to play a role in allowing the fibrils to slip over 
each other during mechanical deformation and allowing tendons to bear compressive 
forces by trapping water throughout the tendon structure (23) (24). Glycoproteins are also 
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present in the extracellular matrix. Fibronectin is found on the surface of the collagen 
fibrils and its synthesis is increased when injury to the tendon occurs. It then aids in 
healing and remodelling of the tendon structure (13).  
 
Elastin is present in tendon, in the form of elastic fibres and make up around 1-2% of the 
total dry mass. It is thought that the role elastin plays in tendons is to allow the fibrils to 
contract and recover after deformation caused by muscle contraction and are responsible 
for structural flexibility (17). 
 
The predominant cell type found in the tendon is the tenocyte (25). Tencocytes are a 
specialised form of a fibroblast cell. Fibroblasts are responsible for maintaining 
extracellular matrix throughout the body. To do this in tendon, large quantities of 
tropocollagen (the base molecule of collagen) need to be expressed along with the other 
structural molecules; elastin, decorin and aggrecan (26). Located between the fibrils, 
tenocytes are found in small numbers and are not very metabolically active, although 
tendon reconstruction and remodelling does occur in response to injury (10). In total, 
tenocytes account for around 95% of all cells present in the tendon. Other cells present in 
tendons are chondrocytes, which are found at the insertion sites, synovial cells in the 
tendon sheath and vascular cells (13), and in addition there are a very small number of 
tendon stem cells up to late adolescence (27). 
 
1.2.3. Tendon Blood Supply. 
 
Tendon is a relatively avascular tissue with blood entering from 3 major sources: the 
musculotendon junction, the osteotendon junction and the surrounding connective tissue 
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(28). The paratenon is a relatively highly vascularised tissue, supplying around 35% of 
total blood to the tendon, with the remaining 65% supplied through the junctions with the 
bone and muscle (29). Blood supply has been implicated in the rupture of tendon, with 
supply being found to decrease with increased age and physical inactivity, however it is 
likely that other factors, such as increased activity in older age, have a greater influence 
(30). It has also been suggested that the low blood supply present in the mid-section of 
tendon is at least partly responsible for the high incidence of injuries occurring at this 
position, as external cells cannot easily migrate into the tissue to repair minor damage, 
although other factors have to be considered such as twisting and thinning (31). 
 
1.2.4. Tendon Mechanical Properties. 
 
The mechanical properties of tendon are typically evaluated using methods that stretch the 
tissue to failure while continually measuring forces applied. This continual evaluation 
results in the generation of a stress-strain curve which displays the force required to stretch 
the tendon to a given elongation. Tendons typically demonstrate four distinct regions while 
in tension under force (32), which can be seen in Fig. 1.2. Region I is referred to as the toe 
region. Here, the crimp angles present between the fibres are reduced, resulting in the 
tendon becoming longer and thinner, however no fibre stretching takes place. Region II is 
the linear region, where fibres start to be stretched, resulting in some starting to break. In 
region III the fibres start to break unpredictably throughout the structure, making it a lot 
weaker as a result. Finally region IV is where the tendon completely fails. 
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Fig. 1.2 Typical stress strain curve of a tendon. During loading tendon fibrils lose the initial ‘crimp’ 
pattern seen in unloaded samples, becoming straightened (region I, toe region). Fibrils begin to 
elastically stretch in region II (linear region) before fibrils begin to break uncontrollably in region III, 
before complete tissue rupture in region IV.  
 
The specific mechanical properties change with species and location of the tendon being 
tested. Normalised tendon analysis demonstrates that typical adult human tendons have a 
Young’s Modulus of 1-2 GPa, an ultimate stress of around 100 MPa and an ultimate strain 
of 4-10% (33). These figures have proven very difficult to replicate using synthetic 
materials. In this instance normalisation was performed against the thickness of the tendon 
sample, with tendons from several areas of the body used to gain a more accurate 
assessment. 
Tendon is a viscoelastic material that it is affected by stress relaxation, creep and hysteresis 
(34). This means that it does not stretch elastically, and will behave differently at different 
stages of growth or force application. Stress relaxation occurs when the force needed to 
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elongate a material to a constant strain decreases over time in a predictable way. Creep is 
the tendency of a solid material to move deform permanently under the influence of 
constant high stresses near to, but not at the failure stress (35). This allows for tendons to 
stretch to beyond normal physiological limits without rupture if forces are applied over a 
prolonged period of time.  Mechanical hysteresis occurs when a material resorts back to its 
original length after elastic deformation at a slower rate to that which it was loaded, 
creating an open loop in the stress/strain plot representing energy being dissipated via heat.  
This has been found to have a value of between 5 and 10% in human tendons (36). 
 
1.2.5. Natural tendon repair. 
 
There are 3 stages in the natural repair cycle of a damaged tendon: exudative, fibroblastic 
and remodelling (37). The exudative stage occurs between days 0 and 5 after injury in 
humans. During this time, inflammation occurs and extrinsic cells flood the wound site. 
The damaged ends of the ruptured tendon also start to soften, allowing for molecules to 
move into the injury site more easily. By analysing tendon repair in a mouse Achilles 
defect model it was found that ‘tendon gel’ (constituting the major compositional 
molecules of tendon, such as collagens I and III, GAGs, but in an unordered state) was 
secreted from the damaged tendon end 3 days post injury as identified by transmission 
electron microscopy. After a further 2 days the ‘gel’ started to form into an area of denser 
tissue, which was then subsequently aligned into fibrils after a 21 day period of muscular 
contraction or in vitro mechanical loading (38). 
 
The fibroblastic stage occurs between weeks 1 and 3 post injury. Fibroblasts from the 
epitenon migrate into and populate the wound site. After an ill-defined critical number of 
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cells are present, production of extracellular matrix begins, leading to a steady rise in 
tensile strength with more ECM being produced. The final stage of repair is remodelling 
where collagen fibrils start to reorganise themselves in accordance with the loads being 
applied to them, eventually leading to a fully functioning tendon (38). From this, methods 
of creating artificial tendon can be created. By placing appropriate cells, like autologous 
tenocytes or MSCs into an area rich with the components of tendon, they may start to 
remodel the collagen into fibrils, especially if a physiological loading pattern (e.g. 
simulating general movement) were placed across the new structure (39).  
 
1.2.6. Surgical repair of tendon injury. 
 
Tendon injury is an increasing problem worldwide. In the USA, over 75,000 Achilles 
tendon  ruptures, 55,000 rotator cuff injuries and over 5 million new cases of tennis elbow 
are diagnosed and treated annually (40). There are three grades of tendon injury: I, II and 
III. Grade I injuries are small overstretches that do not result in chronic pain. Grade II are 
the result of small tears in the tendon fibres that can result in some joint instability. Grade 
III is a complete tear of the tissue and leads to significant joint instability (31). Treatment 
usually starts by using conservative methods (e.g. physiotherapy). However, surgical 
intervention is frequently needed if no improvement is observed. Traditional treatment of 
small lacerations involve suturing the damaged ends together, followed by a programme of 
physiotherapy designed to manage the weight bearing of the repairing tissue over time. 
When the defect is too large, constructs are required to bridge the gap. Graft tissues are 
frequently used with varying effectiveness. Autografts (taking an undamaged section of 
tendon from another part of the patient – usually hamstring) provide minimal chance of 
immunorejection, but problems with donor site morbidity and pain are commonly 
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associated with this procedure (40). Allografts from donor or cadaveric tissue are 
frequently used, however lack of supply, greater failure rates and immunorejection 
problems persist (11). Decellularised xenograft tissues from animal sources are starting to 
be used more widely, however major concerns remain regarding long term viability and 
cross species disease transmission (12). Commercially available artificial tendon graft 
products are also in wide clinical use, but a prolonged immune response and post-operative 
infection have been widely reported (41). Due to the problems associated with tendon 
repair surgery, new techniques and materials need to be developed in order to meet the 
increasing clinical need. 
 
1.2.7. Collagen fibril formation.  
 
Fibril formation from a dissolved collagen solution is a diffusion gradient guided process 
where solvent molecules disperse forcing collagen molecules (oligomers) to gather 
together, resulting in circular form morphologies. Randomly ordered small diameter fibrils 
(20-70nm) form in collagen gels when acid soluble collagen molecules are neutralised and 
the temperature increased to between 20
o
C and 34
o
C for 1-2 hours (42). This process 
occurs in three phases: lag, growth and plateau. When approximately 20% of the available 
molecules have formed into fibrils, further de novo assembly is restricted, resulting in 
fibrils joining together into a hierarchical structure. Fibril alignment in embryonic tendon 
formation is controlled intracellularly by specific sites between the Golgi apparatus and 
cell membrane, which act as ‘fibropositors’. Procollagen (a precursor to collagen that is 
water soluble as opposed to collagen being acid soluble) molecules are arranged into small 
diameter collagen fibrils which are then excreted in hexagonally shaped bundles by the cell 
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from these fibropositors, parallel to the axial direction of the tendon(43). Further 
fibrilogenesis then occurs via alignment and joining to form larger units.  
 
 
1.2.8. Growth factors in tendon repair.  
 
Growth factors are molecules which bind with cells to enable a specific cellular function to 
occur, with the focus in tendon stem cell research being on inducing or maintaining 
differentiation (44). Several growth factors have been linked with tendon repair and 
development.  
 
Increased Early Growth Response protein 1 (EGR-1) and Early Growth Response protein 2  
(EGR-2) expression in tendon cells is correlated with an increase in collagen expression 
during tendon cell differentiation in embryonic chick limbs, suggesting a strong link 
between EGR and de novo tendon formation (45). Transforming Growth Factor β (TGFβ) 
is essential for the maintenance and recruitment of tendon progenitor cells in the 
embryonic mouse. Through a series of knockout studies it was determined that if TGFβ 2 
or 3 were removed between E12.5 and E14.5, tendon and ligament tissue would not 
develop in limbs (46). Controlled release of basic Fibroblast Growth Factor (bFGF) from 
scaffold materials has been found to increase the expression of collagen I and increase the 
stiffness and maximum load capacity of poly(lactic-co-glycolic acid) PLGA electrospun 
scaffolds seeded with bone marrow stem cells (47).  
 
Bone Morphogenic Protein 12 and 13 (BMP-12/13, also known as Growth Differentiation 
Factor (GDF-6/7)) are members of the Transforming Growth Factor – Beta (TGF-β) 
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superfamily that have been found to play important roles in matrix synthesis, 
differentiation, chemotaxis and proliferation (48) (49) (50). BMP12 can induce tenogenesis 
in rat bone marrow-derived MSCs. Upregulation of tenomodulin, tenascin C and scleraxis 
(generally considered as being tendon markers(31)) were all observed in colonies formed 
in BMP-12 containing media when compared to cells cultured in media containing no 
growth factors. It was also noted that increased matrix production and remodelling 
occurred when BMP-12 treated cells were implanted into an injury site in a rat tendon 
(48,51). BMP-12/13 can promote ectopic tendon formation and repair (48)(52). BMP-12 
induced both in-vitro and in-vivo tenogenesis of MSCs (48)(53)(51). BMP-12 and BMP-13 
can both induce increased  production of thrombospondin 4 (a specific tendon marker) 
along with a characteristic wave like pattern found in tendon histological samples after 14 
days implantation into a rat defect model (54). A combination of BMP-12, BMP-13 and 
vitamin C have also been found to induce tenogenisis in human Embryonic Stem Cells 
(hESCs) in static physiological O2 (2% O2) monolayer culture conditions (in house data). 
Fibroblast Growth Factors (FGFs) are a group of 23 family members ranging in molecular 
weight from 17KDa to 34KDa that have been shown to play a vital role in limb 
development and organogenesis during embryonic development (55)(56). Three members 
of the FGF family have a prominent role in the maintenance of mesenchyme during limb 
development; FGF-4, FGF-6 and FGF-8. FGF-4 has been shown to play a role in early 
stage embryonic patterning and the maintenance of mesenchyme within the developing 
embryo (56) (57 )(58) (59). Further research using FGF-4 knockout studies found that limb 
buds fail to develop in mice where FGF-4 is not present (57,58)(59). FGF-6 expression has 
been shown to be present in developing skeletal muscle. Studies conducted using murine 
models have shown FGF-6 to be exclusively present in the myotomal compartment (early 
stage of skeletal muscle development) of the somite at E9.5 (60) (61) (62). Due to the close 
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interaction of tendon, muscle and bone it is feasible that FGF-6 could play an integral role 
in the development of tendon and muscular-tendon junctions. FGF-8 has also been shown 
to play a pivotal role in murine limb development by inducing ectopic limb development 
and replacing the Apical Ectodermal Ridge (the group of cells at the developing front of 
the embryonic limb) (63) (64). FGF-4, FGF-6 & FGF-8 have been shown to be present in 
the AER providing signalling to maintain mesenchymal cells in the proliferative state at 
the limb bud end during development. A brief summary of further growth factors that have 
been implicated in tendon development and repair can be found in table 1.1.  
 
Table 1.1. Growth factors associated with tendon development and repair. Several factors have been 
shown to have some effect on the tendon development cycle, acting during different stages to create a 
final tissue. Tendon development is however poorly defined and as yet, not fully understood. 
 
Growth Factor Role/Function 
TGF-β Promotes angiogenesis and collagen 
production(31) 
EGF  
 
Induces mitosis in fibroblasts and promotes 
collagenase activity to remodel the 
extracellular matrix(31) 
PDGF-β Induces mitosis fibroblasts, chemo attractant 
to macrophages, and assists 
angiogenesis(31) 
Basic FGF (FGF 2) 
 
Promotes angiogenesis and granulation(31) 
VEGF Vasculogenesis and angiogenesis(31) 
Hepatocyte growth factor (HGF) Expressed in wound fibroblasts to regulate 
growth, motility, and morphogenesis(31) 
Early growth response factor-1 (EGR-1) Transcription factor that upregulates 
collagen and accelerates wound closure(31) 
FGF 4, 6, 8 Present in early limb bud development and 
induces stem cell tenogenisis.(64) 
BMP-12, 13, 14 Promotes tendon-derived stem cell 
differentiation into tenocytes(65) 
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1.3. Cells in Tendon Tissue Engineering. 
 
Many different cell types can be used to produce tendon tissue. These include cells from a 
donor tendon (primary cells), cells from a different body tissue that can be made into 
tendon cells (adult stem cells) and cells produced from embryos in the laboratory 
(embryonic stem cells).  
 
1.3.1. Tenocytes. 
 
Tenocytes are the major cell type present in tendons, making up around 95% of the cellular 
mass. They are a highly specialised form of fibroblast that is responsible for maintaining 
the unique tissue capable of sustaining the high loads to which tendons are subjected (25). 
Their major role is the maintenance of the complex extracellular matrix composed of 
collagen I (the major component of tendon), collagens III and V, glycosaminoglycans 
(GAGs), elastin and fibronectin (26), and the reconstruction of tendon tissue either after 
injury or as part of normal physiological activity. 
 
Under normal physiological conditions, tenocytes are found in small numbers spread 
between the collagen fibrils. Because of the low cell number and the poor vascularisation 
(66) of healthy tendon, tenocytes have been shown to have a very low proliferative rate 
(67), perhaps explaining why tendons take so long to recover after injury. This low 
proliferative rate becomes problematic when considering cells for use in tissue 
engineering, as large volumes of tissue will have to be produced from a relatively small 
sample.  
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Identifying tenocytes can sometimes be difficult. Visually, tenocytes appear fibroblastic, 
but with long cytoplasmic processes (25) that form between the cells which aid in cellular 
communication. Cell surface markers can be used to determine if a cell is ‘tenocyte like’. 
Markers such as CD44 and CD90 have been found to be expressed by tenocytes from both 
rat and human origin, however Scutt et al (68) found the expression of CD90 to be much 
higher in rat tenocytes than those from a human. Other markers such as decorin, collagen 
1 (26), COL1a2 and scleraxis (69) have also been found to be more specific markers of 
tenocytes, especially under conditions of tension or stress such as those found in the leg 
tendons of race horses. 
 
Fibroblast cell culture is well defined, with many different groups using similar methods 
and gaining good results. As tenocytes are a form of fibroblast, a starting point has already 
been established. Typically, Dulbeccos Modified Eagles Media (DMEM) is used as a base, 
with 10% Foetal Bovine Serum (FBS) added to enhance cellular growth. Additional 
supplements such as L-Glutamine (L-Glut) and Non-Essential Amino Acids (NEAA) can 
also be added along with anti-bacterial substances such as penicillin/streptomycin to 
reduce the chance of infection. These antibacterials are more important when using 
primary tissues. A breakdown of the culture conditions used by different groups culturing 
tenocytes can be found in table 1.2. In addition to media conditions, the gaseous 
environment can also be investigated. Cell culture is typically performed in physiologically 
hyperoxic conditions at 20% O2 (70), but in vivo these conditions rarely exist. Normoxic 
concentrations in vivo are around 3% O2, (71) however as tendon is so poorly supplied 
with blood the levels of O2 a tenocyte would be exposed to would be slightly lower. 
Multiple types of fibroblasts can be cultured for longer in hypoxic (1.5%- 2% O2) 
conditions before the onset of senescence (72). Different seeding densities were 
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investigated where Schulze-Tanzil et al reported that tenocytes can be successfully 
cultured in high densities in pellet culture. qRT-PCR revealed gene markers for collagen I 
and scleraxis were being expressed in significant amounts throughout the culture period, 
indicating that favourable conditions for tenocyte differentiation were being achieved  (25). 
This study shows how tenocytes can be cultured in different environments and still 
produce extracellular matrix that is required for generating tendon tissue. 
 
Tenocyte Isolation and Culture Methods. 
 
Many methods have been used to successfully isolate and culture tenocytes from primary 
tendon tissue. Many of the differences in method come about because of slight changes in 
the tendons that the specific groups were working with. Even with these differences, many 
of the steps taken are similar (table 1.2).  
 
Enzymatic Digestion. 
 
Human tenocytes have been isolated in many different ways. Scutt et al (68) isolated both 
rat and human cells by digestion in 1mg/mL collagenase in DMEM at 37
o
C for 18 hours on 
a rotary blood mixer. After this, the samples were sieved through a 70 µm sieve and 
viability determined before being cultured in media consisting of DMEM with FCS, 
ascorbate-2-phosphate, ultra glutamine and dexamethasone for at least 2 passages. Anitua 
et al (73) used a similar method to isolate cells from human skin, synovium and tendon. 
The samples were removed and placed in sterile PBS with pen/strep and 0.3% collagenase 
at 37
o
C and stirred for 90 minutes. The suspension was then centrifuged, re-suspended and 
cultured in a mixture of DMEM and F12 media (1:1) with 15% human serum, glutamine 
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and penicillin/streptomycin. A study comparing the effects of isolation method has recently 
been published, finding that enzymatic digestion by 0.2 % collagenase for 18 hours 
resulted in 14x more cells being collected from the same volume of human tendon as after 
50 days continuous isolation via adhesion culture, without any substantial loss of cellular 
properties (74). This demonstrates that for any potential clinical use, enzymatic digestion 
of tissues should be the preferred method of cell isolation.  
Animal tenocytes have also been isolated and cultured using enzymatic methods. 
Collagenase is the most common enzyme used for removing tenocytes from canine (75), 
bovine (76), murine (77) and rabbit (78) tendons, with alternative enzymes such as trypsin 
(26)  and pronase (76) being used in conjunction with the collagenase for some or part of 
the digestion process. A breakdown of the isolation methods used for these groups can be 
found in table 1.2. Enzymatic digestion methods can result in tissues being placed in 
enzyme solutions for prolonged periods of time, potentially leading to damage to the cells 
if the enzyme concentration is slightly too high (79). Other methods are therefore also 
being used to isolate tenocytes from tendon samples. 
 
De Moss et al (80) used an explant method to isolate human tenocytes from tendon with 
the paratenon layer removed from the samples. The remaining tissue was then cut into 
3mm
3
 pieces and placed into a 6 well plate with DMEM, 10% foetal calf serum (FCS), 50 
g/ml gentamicin and 1.5 g/ml fungizone. After 10 days the fibroblasts in the tendons 
had migrated onto the tissue culture plastic. Shultz-tanzil et al (25) found a similar effect 
using human finger tendons. The tendon was placed in media (Ham’s F-12/Dulbecco’s 
modified Eagle’s medium (50/50) containing 10% foetal calf serum, 25 mg/ml ascorbic 
acid, 50 IU/ml streptomycin, 50 IU/ml penicillin, 2.5 mg/ml amphotericin B, 1% glutamine 
and 1% essential amino acids) for 1-2 weeks, during which time cells migrated from 
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tendon to the culture plastic. Weirich et al 2007 (81) explanted tenocytes from the long 
biceps tendon from bovine shoulder joints. The surrounding fasciae were removed with the 
remaining cells detached by digestion with trypsin-EDTA. The remaining tendon tissue 
was then diced with scissors and rinsed in 70% ethanol, before being placed into Petri 
dishes containing DMEM/Hams F12 media. Explant methods provide a way of isolating 
cells from tissues without the need for sometimes damaging enzymatic digestion, however 
due to the longer times needed for explant methods to gain a large number of cells 
digestion methods remain popular. 
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Table 1.2. Methods used to isolate and culture tendon cells. Tendon cells are isolated using two major 
methods; enzymatic digestion or tissue explant. Variations of enzymes used, times, size of initial sample 
and media used to culture cells were found according to research group and species of tendon cells 
being isolated. 
 Pronase Collagenase Trypsin Minced Media 
Bernard-Beaubois 
et al 1996. 
n/a 1.1mg/mL, 30 
mins 37
o
C, 30 
mins room 
temp + stirring 
- 25mg/ml (18 
hrs) 
0.25% 
trypsin (60 
min + 
collagenase
) 
Small 
pieces 
Hams F12 
Ehlers et al 1998. 60% 
pronase 
(1hr) 
40mL 0.15% 
collagenase II 
in media for 12 
hours, 37
o
C  
n/a 4g McCoys 5A 
Archambault et al 
2001. 
 
n/a 0.5% (5 min) 0.25% (15 
min) 
n/a DMEM, 20mM HEPES 
(pH 7.2), 100U/mL 
penicillin, 100g/mL 
streptomycin sulphate, 
10% FBS. 
Ritty et al 2003 n/a type 1a 
(4000U/ml) 
(180 minutes) 
+ mechanical 
disruption 
n/a 3 – 5 mm DMEM, 2mM PMSF, 
1mg/mL BSA 
Salingcarnboriboon 
2003  
n/a -MEM 
containing 
collagenase at 
37°C for 20 
min 
n/a n/a -MEM, 0.5% FBS. 
Shultz-tanzil. 2004  n/a n/a n/a n/a DMEM/F12 10% FCS, 
25mg/mL ascorbic acid, 
pen/strep,  2.5 mg/ml 
amphotericin B, 1% glut, 
1% essential aa. 
De Moss et al. 
2007 
n/a n/a n/a 3mm
2
 DMEM, 10% foetal calf 
serum (FCS), 50 µg/ml 
gentamicin and 1.5 µg/ml 
fungizone. 10 days 
Weirich et al 2007 n/a n/a  trypsin-
EDTA  
n/a DMEM/Hams F12 
pen/strep 
Scutt et al 2008 n/a 1mg/ml (18hrs) 
on blood mixer 
n/a n/a DMEM, 10% FCS, 
pen/strep, L-Glut 
Anitua et al 2008. 
 
n/a 0.3%% (90 
min) 
n/a n/a DMEM/F12 
Mallick et al 2009 n/a 1mg/ml (18hrs) n/a n/a DMEM, 10%FCS, 
pen/strep 
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1.3.2. Tendon Derived Stem Cells. 
Tendon derived stem cells (TDSCs) are a population of cells resident in tendon that have 
the capacity to differentiate into bone, cartilage and adipocytes (27) (82). In addition to this 
differential potential, tendon stem cells (TSCs) have also been found to express the stem 
cells markers Oct 4 and SSEA-4 (83). These characteristics are not observed with mature 
tenocytes. TDSCs are isolated from tendon tissue by mincing and enzymatically digesting 
samples, then resuspending cells in single cell solutions and culturing in 96 well plates, one 
cell/well. Once colonies have been formed, the further addition of trypsin leads to TDSC 
detaching before mature tenocytes, allowing for collection and further culture. The 
concentration of TDSCs has been found to vary with age and position and species, with 
tendons from younger specimens being generally found to contain higher concentrations 
(84). 
 
TDSC have different morphologies to mature tenocytes. TDSCs have a “cobblestone” like 
appearance when cultured to confluency, with an enlarged nucleus. Tenocytes have an 
elongated “spindle” like morphology when confluent, with little contact seen between cells 
(Fig. 1.3). TDSCs have also been found to have significantly longer population doubling 
times when compared to tenocytes isolated from the same tendon source (83). 
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Figure 1.3. Visual comparison of tendon stem cells. Tendon derived stem cells (A) after over 60 days 
culture appear square and dense in culture. Tenocytes appear elongated when confluent (B). Figure 
adapted from Zhang et al 2010, figure 5 (83). 
 
Hypoxic (2%) oxygen conditions have been found to have a positive effects on the 
proliferative capability of several human stem cell types (70) (85). TDSCs have also been 
found to proliferate faster in 2% O2 compared to 20% O2, however differentiation capacity 
was seen to be reduced (86). This study suggests that hypoxic conditions are suitable for 
expanding TDSCs for specific use in tendon tissue engineered products/treatments. 
 
1.3.3. Mesenchymal Stem Cells for Tendon Tissue Engineering. 
 
Mesenchymal Stem cells (MSCs) are a multipotent pool of cells that are present in many 
tissues, with major concentrations found in bone marrow (87) (88) (89) and adipose tissue 
(90). A well-established approach to isolate MSCs from a bone marrow sample is to place 
them in complete media on tissue culture plastic (Fig. 1.4.) (87). After a few days MSCs 
adhere to the plastic surface, leaving the haematopoietic stem cells in suspension. The 
adhered cells then start to form fibroblast like colonies which undergo expansion (91). By 
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splitting the cultures before confluence, a more homogeneous cell population that in some 
instances can proliferate for up to 40 cell divisions, is created (92). 
 
 
Figure 1.4. Colony forming unit assay: MSC adherence to tissue culture plastic over time. Complete 
bone marrow aspirate is allowed to settle in tissue culture plastic vessels for a period of time. 
Mesenchymal stem cells adhere to the surface via integrin binding after around 2 days, forming 
distinct colonies by 7 days. Media/remaining suspended cells can then be removed, leaving adhered 
MSCs for further proliferation. 
 
Mesenchymal Stem Cells can be difficult to accurately characterise. Many different surface 
antigen markers can however be used to characterise a cell as “mesenchymal like”, 
although as yet no single definitive hMSC specific marker exists. Cluster of differentiation 
/ cluster of designation (CD) markers are cell specific surface markers that can be used to 
form panels to identify specific cell lineages, with both positive and negative markers 
being used. Several papers have investigated the different markers of human MSCs. 
Dominici et al identified the key makers of MSCs to be CD105, CD73 and CD90 positive, 
and lack expression of lineage specific markers such as CD45, CD34, CD14 or CD11b, 
CD79alpha (CD19) and HLA-DR. hMSCs must also be able to adhere to tissue culture 
plastic (93). This paper was written as a result of a 2006 meeting of the Mesenchymal and 
Tissue Stem Cell Committee of the International Society for Cellular Therapy group, and is 
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still considered as the reference point for defining hMSCs for human theraputical use (94). 
A further generic stem cell marker has also been used to identify MSCs. CD90 is expressed 
by human MSCs, haematopoietic stem cells and neural stem cells and has been found to 
play a role in fibroblastic cell differentiation (95). Further studies have identified similar 
marker profiles , with Kolf et al summarising that cells derived from bone marrow which 
show positive test results for Stro-1, CD44 (H-CAM) and CD73 along with negative 
results for CD31, CD34 and CD45 can be considered to be human MSCs (96). A 
secondary conclusion from this review is that different species can show different surface 
antigen markers. Murine MSCs were not consistently negative for CD34, with different 
groups reporting different outcomes, and mice cells do not express an equivalent to Stro-1, 
so this cannot be used.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alexander Lomas PhD Thesis Chapter 1 Introduction 
26 
 
Table 1.3. Common cellular expression markers used to characterise human MSC populations. Cells 
positive for CD29, CD44, CD73 and CD105 and negative for CD31, CD34 and CD45 are generally 
considered to be MSC or ‘MSC like’ in phenotype. 
 
Marker +ve/-ve Associated 
Lineage/role 
Reference 
CD29 + Involved in MSC 
migration in vivo  
Kolf et al 2007 (96) 
(97) 
CD44 (H-CAM) + stem cell (cancer) 
homing receptor 
Krampera et al 2006 
(92) 
CD73 + MSC migration in 
vivo  
Chamberlain et el 
2007 (98 )(97) 
CD105 + Mediator of cell-cell 
and cell-matrix 
interaction 
Molchanova et al 
2008 (44)  
Stro-l + Necessary for colony 
forming ability 
Roufosse et al 2004 
(89) 
CD90 + Generic human stem 
cell marker 
Kisselbach et al 
2009 (95) 
CD31 - Endothelial Modder et al 2012 
(99) 
CD34 - Haematopoietic Kolf et al 2007 (96) 
CD45 - Haematopoietic Chamberlain et al 
2007 (98) 
 
 
The potential for MSCs to produce many different types of differentiated tissue is well 
documented (87). MSCs have been used in vitro with varying success to produce muscle 
(100), fat (101), cartilage (102), bone (103) and cardiac muscle (104). However, this 
review will focus on what is known in regards to MSC differentiation into tendon/ligament 
cells.  
 
Mesenchymal stem cells provide a source of cells that can potentially differentiate into 
tenocytes under the correct culture conditions (100). Several groups report that by adding 
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BMP-12 to media, MSCs start to exhibit tenocyte like qualities. Horse MSCs were found 
to differentiate when exposed to 50ng/mL BMP-12 in the media, with tenomodulin and 
decorin (common tenocyte surface antigen markers) both being expressed by the cells post 
exposure (65). Similarly, rhesus monkey MSCs transfected with BMP-12 resulted in 
upregulation of collagen I and scleraxis (two other widely used surface antigen markers for 
tenocytes) when compared to a non-transfected control group. This study also showed 
significant increases in CD44 expression (commonly used tenocyte marker), adding to the 
claims made that tenocytes had been produced (53). BMP-2 is also reported as playing a 
role in MSC – tenocyte differentiation. Hoffmann et al (105) reported that murine MSC 
transfection with Smad8 resulted in the emergence of cells with a tenocyte phenotype 
which showed increased levels of collagen I and scleraxis expression after 7 days post 
transfection. When co-culturing MSCs with tenocytes in a non-contact culture vessel, 
MSCs were exposed to the growth factors excreted by the mature cells. After 14 days 
MSCs started to differentiate, with significant increased expression of scleraxis and 
collagen I being found when compared to a control group of singularly cultured MSCs 
(106). BMP12 and 13 are reported to induce increased  production of thromobospondin 4 
(a tendon marker) along with a characteristic wave like pattern (created by the crimp 
angles found between collagen fibrils) found in tendon histological samples after 14 days 
implantation into a rat hamstring muscle defect model (54). 
 
FGF4 was reported to activate the expression of EGR-1 and EGR-2 in cells isolated from 
chick embryos. Embryos were isolated at different gestation points, and cultured in the 
presence of FGF4 for 24 or 48 hours. Embryos were then harvested, dissected, and 
immunologically examined for collagen I, III and V expression. Increased expression was 
noted in comparison to controls. EGR-1 and EGR-2 expression was also significantly 
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increased along with expression of collagens I and III at 14.5 days post fertilisation 
compared to 12.5 days(45). 
 
Transforming growth factor β3 (TGFβ3) has also demonstrated an important role in 
ESC/MSC – tenocyte differentiation. When human MSCs were suspended in a 3D fibrin 
constructs and anchored to two fixed points, cells harvested after 5 days culture with 
TGFβ3 (0.02µg/mL) were incapable of differentiation into osteo, adipo or chondro 
lineages, even after a further 21 days static culture and showed marked increases in tendon 
like characteristics (fibril formation, collagen I expression) indicating that cells had 
permanently differentiated towards the tendon lineage (107).  
 
Many studies have focused on using MSCs to promote new growth or regeneration in 
damaged tendon tissue in vivo. MSCs isolated from a horse’s bone marrow and cultured in 
vitro were injected into tendons that had been subjected to injury. After 8 weeks the 
tendons were examined against a control group which received no MSCs. While no 
significant differences were apparent, qualitative trends appeared to show that the tendons 
which had received MSCs were in better condition than the control group, with higher 
histological scores and improved mechanical properties (108). In a study mentioned 
earlier, Hoffmann et al (105) implanted either MSCs transfected with Smad8 or non-
transfected MScs into surgically damaged rat Achilles tendons. Substantial remodelling of 
the wound site occurred with the transfected cells, while control group tendons were 
comprised of non-specific connective tissue. This study demonstrates that MSCs 
engineered to overexpress Smad8 could provide a more suitable cell source for tendon 
repair.  
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A potential problem when developing a tissue engineered tendon is how best to anchor the 
new tendon to bone. Ju et al (109) found that by adding MSCs to a rat model of a damaged 
bone tunnel (the junction between bone and tendon) signs of accelerated remodelling of the 
wound site were noted after 2 weeks when compared to a cell-free control. However, after 
4 weeks complete remodelling of the site had occurred in both groups. This demonstrates 
that external MSCs do have some effect on the healing time, but not necessarily on healing 
effectiveness. 
 
A further advantage of using MSCs to promote new tissue growth is that they are 
immunosuppressive. When immune cells were co-cultured with human MSCs, changes in 
the secreted molecules of the immune cells occurred, allowing the MSCs to remain in 
culture and not be attacked (110). In vivo studies using MSC seeded rat myocardial 
infarction models found similar conclusions, with immunohistochemistry showing that 
MSC seeded constructs could modulate immune response, although the mechanism by 
which this process occurs is still being investigated (111). This could potentially allow 
MSCs to be used in allogeneic implants, thereby creating a desirable product to industry as 
a bank of cells could be used for all implants, thus dramatically reducing the costs involved 
in manufacture.  
 
MSCs have also been shown to be able to produce tissues that would not normally be 
considered to be mesenchyme in nature. These include neurons (112) (ectodermic) and 
hepatocytes (113) (endodermic). The wide range of these studies demonstrates the 
plasticity of the cells and how slightly different culture conditions can alter the tissue 
capable of being produced.  
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MSC therapies in equine tendon therapy. 
 
Extensive experience has been gained in the treatment of horse tendon injuries with 
mesenchymal stem cells. Early studies in this area used full bone marrow extracted from 
the sternum of the animal and injecting directly into the damaged tendon area (114). This 
work demonstrated limited success thought to be due to the low concentration of stem cells 
actually being delivered, but led to the development of therapies where MSCs were 
isolated from the bone marrow before use, increasing the concentration of ‘active’ cells 
being introduced to the wound area, with results showing improvements over traditional 
treatment methods (115). This therapy has since been commercialised by several 
companies (Vet Cell, Vet-Stem) and as of 2010, over 1500 horses had been successfully 
treated with MSC injections into damaged tendons (116), however translation into human 
therapies has yet to occur. 
 
1.3.4. Embryonic Stem Cells. 
 
Embryonic Stem cells (ESCs) are pluripotent cells isolated from the inner cell mass of a 
blastocyst (Fig. 1.5) (117) (118). Human ESCs were first isolated by Thomson et al in 
1998 (119) using donated excess embryos from an in vitro fertilization (IVF) clinic. ESCs 
are unique in that they are characterised by the ability to differentiate into all three germ 
layers, endodermal, ectodermal and mesodermal (however ESCs are not considered as 
totipotent as they cannot differentiate into placental tissue) without showing signs of 
senescence over a prolonged period due to the high expression of telomerase (120).  
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Figure 1.5. Embryonic stem cell isolation. When donor embryos reach the blastocyst stage of 
development the inner cell mass is isolated using a micro-needle, removed and seeded onto a feeder 
layer of embryonic fibroblasts. Cell lines can then be established using local protocols. 
 
Human ESC culture. 
 
Human ESC culture has been developed from the procedures originally used for murine 
ESC culture. Broadly speaking there are two main methods, co culture and feeder free. Co-
culture methods use a feeder layer of mouse embryonic fibroblasts (MEFs). ESCs were 
found to form distinct colonies on the feeder layers, which when isolated, formed 
teratomas when implanted subcutaneously into an immune-deficient mouse, suggesting 
pluripotency (119). In feeder free culture, cells are cultured in media pre conditioned by 
MEFs, with serum replacement substitute and basic fibroblast growth factor (bFGF) (121). 
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Briefly, MEFs are isolated from mouse 11.5-12.5 day old embryos and cultured to 
confluency, before sub-passaging. Once around 60% confluent, media is changed to 
“knock out” media containing serum replacement and BFGF and allowed to culture for 24 
hours. This media is then collected and replaced, until MEFs are overly confluent (122).  
 
Embryonic Stem Cells for Tendon Tissue Engineering. 
 
Investigations into the applications of ESC for use in tendon tissue engineering are few in 
number. Many concentrate on differentiating cells before seeding into scaffold material as 
a way to induce an ESC population to start to act as tenocytes. Chen et al (123) found that 
by differentiating human ESCs into MSCs by exposure to foetal bovine serum and FGF 2 
they were able to create a tendon like structure when seeded into scaffolds consisting of 
silk and collagen. Follow-on studies by the same group also found that by mechanically 
stimulating this structure the effect on the cells was to further take on the characteristics of 
natural tendon. This study also utilised another two small animal models. The scaffolds 
described above were ectopically implanted in a nude mouse, sutured between vertebrae 
allowing for natural cyclical tension to be applied when the animal moved. A second 
model used Green Fluorescent Protein transfected ESC-MSC to seed the scaffold before 
implantation into a 6mm defect in the Achilles tendon of a rat, to ensure that the implanted 
cells were remaining in situ for the duration of the experiment. Increases in collagen 
alignment, expression of common tendon associated cellular markers (Collagen I & III, 
Epha4 and Scleraxis) and mechanical properties (failure force and stiffness) were observed 
in cell seeded scaffolds when compared to scaffold only controls, demonstrating that the 
cells were having a beneficial effect on tendon regeneration (124). 
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The healing capacity of embryonic sheep tendon when implanted subcutaneously into an 
adult mouse determined that the adult environment did not affect the healing properties of 
embryonic tissue. Sections of foetal sheep tendon and adult tendon were isolated and 
artificially wounded before being implanted into the back of a mouse. Foetal tendon 
sections demonstrated increased alignment of cells, increased mechanical properties and 
little inflammation response when compared to adult tendon controls (125). This study 
demonstrates that embryonic tissues could have a possible advantage over adult derived 
tissues for tendon regeneration. 
 
Equine embryonic stem cell containing materials have also been investigated as a potential 
source of cells for tendon repair. By using a commercially available pluripotent cell source 
and co-culturing with equine embryonic fibroblasts, cells were created that resembled 
ESCs. These cells were then injected into an induced defect in a race horse tendon and 
allowed to act for 8 weeks, before animals were sacrificed and further analysis taken. Ultra 
sound analysis was taken every 2 weeks during the experiment. It was found that cells 
amplified structural changes in the damaged area, making a more tendon like structure than 
the scar tissue formed in the acellular group. However, molecular analysis found little 
difference in the cell types present in the injury site (126). It has also been found that ESCs 
have a higher survival rate in damaged horse tendons and an increased capacity for 
migration compared with MSCs, with both cell types initiating no immune response (127). 
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1.4. Tendon Tissue Engineering Scaffolds. 
 
The scaffold of a tissue engineered product plays a vital role in cellular attachment, 
proliferation, and signalling as well as providing a mechanical environment that can 
perform the basic function of the tissue it is replacing before the cellular products begin to 
produce matrix and remodel independently. Many different materials have been used with 
varying success for artificial tendon, with both natural and artificial materials being used 
individually or as part of a hybrid scaffold. 
 
One of the most common materials used in tendon tissue engineering is collagen. Collagen 
is the major extracellular matrix component produced by tenocytes. Once secreted, 
collagen is formed into aligned fibrils by the action of a longitudinal force. Groups have 
tried to artificially induce this realignment in vitro. Building on previous knowledge that 
fibroblasts cause collagen gels to randomly contract (128), Feng et al (129) seeded 
tenocytes into type I collagen gels and applied both static and dynamic forces with the aim 
of trying to align the fibres more precisely, and thus create a more biomimetic tendon 
structure. Surprisingly, the static gels displayed better mechanical properties after nine 
days culture time, although no significant differences in the alignment of the collagen 
fibrils produced by either loading pattern were apparent.  
 
As tendon is composed of around 70% type I collagen (17) many groups see it as a logical 
ideal starting point, usually combining it with additional materials to add tensional 
strength. By combining woven silk fibres into a collagen gel Chen et al (130) found that a 
hybrid material applied to ligament and tendon tissue engineering gave better results than 
those from silk on its own. This study found that: cells were better aligned, that the 
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interface between natural tissue and implant was better, that the mechanical loads that can 
be carried by the implant were much more like natural ligament/tendon and that the 
internal space in the implant in which the cells grow is preserved when collagen and silk 
are used, aiding in cellular development. All of these factors indicate that this scaffold 
could be used to help in tendon regeneration. Chen et al (131) found that by using a hybrid 
scaffold made of a PLGA polymer mesh containing collagen cells from a canine cruciate 
ligament, the cells were able to adhere and proliferate, eventually remodelling the collagen 
and allowing the polymer to be absorbed by the body of the mouse into which the implant 
had been placed. However in this instance very little mechanical loading of the structure 
would have been applied to the implant in vivo, leading to an uncertainty of if the implant 
would be suitable for use as a replacement tendon.  
 
Silks have also been used without any other additional materials to culture tenocytes and 
ultimately replicate tendon tissue. Fang et al (132) found that tenocytes (isolated by 
enzymatic digestion of rat tail tendon) could be cultured in vitro on a braided A. pernyi silk 
scaffold for at least one week. Following this initial test, cell/scaffold constructs were 
implanted into a surgically damaged rabbit Achilles tendon. It was found that the early 
signs of tendon regeneration started to occur after 6 weeks, with the damaged tendon being 
visually almost indistinguishable from the negative control after 16 weeks. It was also 
found that by 16 weeks, type I collagen was the predominant collagen present, and that 
around 55% of the tendons tensile strength had been restored. This demonstrates not only 
that tenocytes can adhere and proliferate on silks in vitro, but that that this form of silk 
could potentially be used to aid in tendon regeneration in vivo. Fan et al (133) found that 
by seeding mesenchymal stem cells into a woven densely rolled scaffold that the cells had 
differentiated into a fibroblastic like lineage, with the common tendon cellular markers 
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(collagen I and III) starting to be released after 24 weeks post implantation into the anterior 
cruciate ligament position of a pig. The mechanical properties of the implant were also 
tested  at this time, with comparable results being found to natural tissue under normal 
physiological loading conditions. Although the author was looking to create a ligament, the 
conclusions made in this study could also be applied to tendon, owing to the two tissues 
being very similar and some of the experimental positive indicators (e.g. maximum 
tensional stress), being the same as they would be in a tendon investigation. 
 
Polymers are attractive materials to tissue engineers due to the ease with which their 
chemical and mechanical properties can be altered. Tendon is a particularly complex 
material to design a biomaterial for due to the high levels of mechanical stress put on it on 
a regular basis. Despite this, some polymers have been found to be usable for tendon tissue 
engineering. As stated previously, Chen et al (131) used a PLGA mesh as a strengthening 
agent in a collagen/polymer hybrid scaffold. The PLGA was found to be still present 8 
weeks post implant, but had been totally resorbed after 12 weeks, leaving the restructured 
collagen to take the mechanical loads.  
 
Commercial synthetic polymer based implants have been used to varying success for 
tendon and ligament repair. The Leeds-Kieo® implant is a non-absorbable synthetic 
prosthesis (used to completely replace a damaged ligament or tendon) that has been 
surgically used for over 20 years. Studies investigating the success of implanting the 
Leeds-Kieo® device have found that the overall performance of the implants is acceptable, 
but not to the same standard as the natural tissue or a donor tissue (134). Other problems 
that have been reported are engraftment tunnel enlarging, laxity in the joint after several 
years’ implantation, immune rejection and complete rupture (135). The Lars® Ligament 
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replacement device is also a non-absorbable synthetic ligament and tendon prosthesis that 
is approved for use in many countries. Follow up studies performed on Lars®  
implantations found failure rate and general satisfaction at 24 months post implantation to 
be similar to that of autograft controls, however some problems such as stiffness were 
reported (136). A major advantage over the Leeds-Keio® implant is that as yet, little to no 
immune rejection has been reported(40).  
Commercial biological scaffolds original designed for use in other surgeries are also 
starting to be used in tendon repair. The Zimmer Patch® is an acellular, cross-linked 
porcine derived collagen material that has been used for several applications, including 
rotator cuff repair. Conflicting clinical outcomes have been reported with using this 
material, with positive patient scores and increased range of movement being found in one 
study (137), but substantial tearing and inflammation being reported in another (138). This 
perhaps demonstrates that patch materials such as Zimmer patch® are suitable in some 
situations, but cannot be considered as being ideal tendon repair scaffolds. Graftjacket® is 
also used for many different surgical interventions, including Achilles tendon rupture 
repair. Produced from decellurised human cadaver skin, this product maintains the 
collagen architecture of the donor tissue while minimising the risk of immune response. 
Graftjacket® has been used in addition to traditional suturing for Achilles tendon repair, 
with patients being found to be able to perform a heal raise 6 months post-surgery (139), 
demonstrating that the scaffold can be used to support traditional therapies even if they are 
not suitable for use as direct tendon replacements.  
A major problem with these currently used tendon/ligament scaffolds is their comparably 
low mechanical properties to natural tendon. Table 1.4 shows the failure strength of the 
scaffolds discussed previously along with the tendons they are commonly used to treat. It 
is apparent that even the scaffold with the highest failure strength is still an order of 
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magnitude weaker than the lowest strength natural tendon (40). This demonstrates the need 
for the development of new implant materials and designs and is the focus of many current 
studies investigating tendon tissue engineering.  
 
 
 
 
 
 
 
Table 1.4. Mechanical properties of tendon and tendon scaffold materials currently available for 
clinical treatment of tendon and ligament injury. Numbers from Chen et al 2009 (40). 
Material Failure strength (N) 
Human Achilles tendon 5089 ± 1199 
Human Supraspinatus (rotator cuff) 1978 ± 301 
Human Patellar tendon 3855 ± 550 
Leeds-Kieo® (ligament) 780 ± 200 
Lars® (ligament) 998 ± 148 
Graftjacket® 229 
Zimmer Patch® 128 
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1.5. Polyhydroxyalkanoates. 
 
Polyhydroxyalkanoates (PHA) are a family of biopolymers (polymer molecules 
synthesised by organisms – usually bacteria) consisting of polyesters of many different 
hydroxycarboxylic acid molecules. They are produced by micro-organisms as an energy 
storage molecule when they are exposed to unbalanced growth conditions, typically the 
addition of lauric acid and a limited nitrogen and phosphorous supply during culture (140). 
Originally seen as a replacement for traditional petrochemical polymers, PHAs have 
become redundant as everyday materials due to the cost of producing large quantities of 
polymer being prohibitive (141), despite recent rises in oil cost. However, increasing 
interest in these new polymers is starting to arise from the medical device sector, where the 
potential benefits of using PHA mean the cost of materials can be absorbed by the high 
value added to products during manufacturing. These benefits include not inducing an 
immune reaction, non-toxicity and complete biodegrability (broken down entirely by the 
body) (142). It is the recent developments in the potential of PHA materials as scaffolds for 
implant products that this section will focus on. 
 
Many different implant types have been singled out as potential areas in which PHA could 
be utilised, ranging from shunts and meshes to bone substitutes and, importantly for this 
investigation, tendon repair devices (142). By altering the chain molecules used to create 
these polymers they can be optimised to suit the conditions needed to support the different 
cells that could be put on it. Properties such as Young’s modulus, maximum tensile strain 
and stress, melting and glass transition temperatures and degradation rates can be 
optimised easily according to what is required.  
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1.5.1. PHBHHx. 
 
PHBHHx is the designation of molecules consisting of random co polymers of 3-
Hydroxybutyrate and 3-Hydroxyhexanoate (Fig. 1.6) (143). It is one of the few PHA 
molecules that can currently be produced on a large enough scale to use for both scientific 
research and medical device construction (140). PHBHHx has a melting temperature of 
111.7
o
C, a glass transition temperature of -0.67
o
C, a tensile strength of 4.1MPa, an 
elongation at break of 103.8% and a Young’s modulus of 130.4 MPa (144), making it a 
potential material for many biomaterial applications. 
 
Figure 1.6. Chemical structure of PHBHHx. Monomers of polyhydroxybutyrate p(HB) C4H6O2 and 
polyhydroxyhexanoate p(HHx) C6H10O2 covalently join to form the complete molecule. Exact 
compositions of polymer can be altered according to need, with higher %HHx leading to changes in 
mechanical properties. 
 
Many different cell types have been successfully cultured in vitro using PHBHHx 
scaffolds, including both mature and stem cells. A lot of work has been focussed on using 
PHBHHx as a scaffold for bone tissue engineering. Wang et al (143) compared rabbit bone 
marrow cells seeded onto PHBHHx with PLA and PHB, two other widely used materials 
used for bone scaffolds. They found increases in both cell number and alkaline 
phosphatase activity, an early indicator of osteoblastic differentiation, demonstrating that 
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PHBHHx is a suitable material for osteoblast attachment, differentiation and proliferation. 
Bone marrow stem cells have also been found to proliferate at greater rates on PHBHHx 
and other similar PHA polymers compared to tissue culture plastic. The conclusions by Hu 
et al (144) in this study found that other PHA polymers (namely PHBVHHx) are best 
suited to BMSC culture, but that PHBHHx can still provide the correct environment for 
this cell type to survive and proliferate. Ji et al (145) made similar conclusions using 
human keratinocyte cells from the cell line HaCaT. Wang et al (146) found that by altering 
the surface properties of a PHBHHx scaffold using a lipase treatment they could alter the 
growth rates of mouse fibroblast cells, concluding the correct hydrophilicity and 
hydrophobicity are needed for cells to proliferate optimally. 
 
PHBHHx has also been used in successful in vivo studies. Ye et al (147) seeded PHBHHx 
hybrid scaffolds with adipose derived stem cells, differentiating them into chondrocytes. 
They found that typical indicators of cartilaginous tissue were formed by the cells after 14 
days culture, indicating that both adipose derived stem cells and chondrocytes can both be 
cultured on PHBHHx. The seeded scaffolds were then implanted into a mouse and left in 
vivo for 12 or 24 weeks, with the differentiated 24 week group showing no traces of the 
polymer and partially formed cartilaginous tissue remaining in its place. Bian et al (148) 
used porous PHBHHx tubes as conduits to join the damaged ends of nerves in rats. After 
one month of implantation compound muscle action potentials could be observed within 
the conduit, indicating that the nerve ends had re-joined and that functional recovery had 
been achieved. After 3 months in vivo, the conduits had been found to have lost between 
20 and 24% of their weight, indicating that resorption had started, adding to the claim that 
PHBHHx can be used as a nerve conduit, or indeed for any biomaterial application that 
requires resorption of the original material. Wu et al (149) coated decellularised porcine 
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aortic valves with PHBHHx and implanted the new structure into the pulmonary valve 
position of a sheep for 16 weeks. Cellular repopulation was found to be higher in valves 
which had been coated when compared to the uncoated control group, as well as a 
reduction in the amount of calcification that had occurred. It was also found that by coating 
the valves, a higher tensile strength could be achieved, creating a stronger implant. 
PHBHHx has also been investigated for use as a non-adherent film for use during surgery. 
By dissolving the polymer in non-harmful organic solvents such as dimethyl sulfoxide 
(DMSO), Dai et al (150) found it could be injected into a wound site to create a non-
permeable film upon contact with body fluids. Cells did not adhere to the film surface due 
to the unfavourable hydrophilic conditions produced using solvents other than chloroform 
to dissolve the polymer, demonstrating the need to select the correct solvent for the role the 
polymer scaffold created will be required to perform. 
 
1.5.2. PHBHHx scaffold production. 
 
Films. 
 
Hu et al (144) dissolved 1g of polymer powder in 50 mL organic solvent, in this case 
chloroform. This was then spread out over a glass container and allowed to dry at room 
temperature for 24 hours, after which the chloroform had fully evaporated. To ensure no 
chloroform remained in the structure, vacuum drying was then applied. Sun et al (151) 
used a similar method, but to ensure purity of the polymer the material was dissolved in 
dichloromethane and refluxed at 38
o
C until fully dissolved. This solution was then filtered, 
then hexane was added to precipitate out the PHBHHx. To form the films, 0.35g polymer 
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was dissolved in 7mL dichloromethane then poured into a 60mm glass Petri dish to 
evaporate for 24 hours. 
 
Electro-spun scaffolds. 
 
Cheng et al (152) created an electro-spun PHBHHx scaffold by dissolving polymer at 
varying concentrations in chloroform/dimethylformamide. This solution was then placed 
into a syringe pump and a voltage applied between the needle and the target. This was then 
left until a scaffold was formed that was at the desired thickness (6 hours produced a 70m 
thick sheet of material). They found that a polymer concentration of around 5 wt% (5g 
polymer in 100mL solvent) was needed to produce smooth fibres, and that 
dimethylformamide was needed as a solvent to prevent the needle from becoming blocked. 
They also found that by adding more dimethylformamide smaller diameter fibres could be 
produced.  
 
Porous scaffolds. 
 
Sun et al (151) used a leeching method to produce a porous PHBHHx scaffold. By adding 
sodium chloride at a ratio of 9:1 with the polymer, then dissolving all of this in 
dichloromethane a thick paste was formed. This was then poured into a 60mm glass Petri 
dish and allowed to dry for 24 hours at room temperature, producing a film. The film was 
then immersed in deionised water, allowing the salt particles to move out of the scaffold, 
leaving a porous final structure. This process was also replicated by Ye et al (147), with the 
scaffolds being stored at -70
o
C and being sterilized with -radiation after production. 
 
Alexander Lomas PhD Thesis Chapter 1 Introduction 
44 
 
Tubes. 
 
Bian et al (148) created PHBHHx tubes for use as nerve conduits. To do this they first 
purified the polymer by dissolving 1g in 10mL 1, 4 dioxane and refluxing at 60
o
C for 1 
hour. Sodium chloride (NaCl) crystals (30-50m) were then added to the solution 
homogeneously (achieved by continual stirring). Stainless steel wires (1.5mm diameter) 
were then dipped into the solution 3 times, rotating to ensure a uniform coating. After this 
the structures were air dried for 24 hours, allowing the solvent to evaporate. The dry tubes 
were then dipped in deionised water to remove the NaCl crystals, producing a porous 
membrane. By altering the size of the NaCl crystals different pore sizes were achieved. 
Wang et al (153) used a dipping method to create a slightly thicker tube using a different 
biopolymer to PHBHHx. By dipping and rotating a Teflon coated mandrill in polymer 
solution for 30 seconds then dipping in water for 5 minutes (repeating the process as 
necessary) a nerve guide conduit was formed, with a material thickness of over 100µm and 
a lumen (inner core) diameter of 1mm. This method could be adapted to create a much 
larger diameter tube than produced here, potentially making one big enough to be used in 
tendon tissue engineering. 
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1.6. Mechanical Stimulation Bioreactors in Musculoskeletal 
Tissue Engineering. 
Mechanical stimulation has been shown to be essential in the development of many 
different tissue types. This is especially true of orthopaedic tissue, where differentiation of 
progenitor cells, tissue organisation and cellular remodelling have all been linked heavily 
to mechanical loading.  
 
1.6.1. Bone 
Shear stress and compression have been shown to increase greatly the activity of 
osteoblasts on scaffolds (154). Several different designs and systems have been used 
successfully, with perfusion flow reactors are most abundant (155). By mechanically 
pumping media through a chamber containing the cell/scaffold construct conditions similar 
to those found in vivo can be produced, with media flow mimicking the movement of water 
through the internal bone structure, creating areas of shear where the water comes into 
contact with the bone architecture, thus encouraging cells to differentiate and behave as 
though present in a damaged bone. 
 
1.6.2. Cartilage 
Bioreactors used for cartilage tissue engineering are very similar to those used for bone. 
However the principle stress mechanism needed for MSCs to undergo increased 
chondrogenesis has been shown to be cyclical compression. Oxygen concentrations are 
also an important variable, with hypoxic (below 2% O2) conditions shown to further 
stimulate chondrocyte activity (156). Several studies have demonstrated the superiority of 
a bioreactor system when compared to a static culture when creating an MSC (or derivative 
of MSC) cartilage implant (102) 
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1.6.3. Tendon 
Several designs of bioreactor have been utilised for tendon tissue engineering(157). Early 
designs focussed on using variations of perfusion bioreactors originally designed for bone 
or cartilage (155), however it has been shown that perfusion alone is not sufficient to 
recreate the complex environmental stimuli required to create working tendon tissue (158). 
Direct strain bioreactors work by exposing tissue to a constant, static force in one direction 
while maintaining the flow of nutrients to the tissue via a sealed chamber (159). Cyclic 
strain bioreactors (now the most widely used for tendon tissue engineering) create a 
reciprocal mechanical force over the tissue which can be varied according to the desired 
loading regime of the investigator (160). Several types of loading patterns have been 
investigated, from sinusoidal to block waveforms (a period of loading followed by a period 
of rest (Fig 1.7.)), with positive results being found for most loading regimes when 
compared to static controls (161). Sinusoidal patterns mimic in vivo loading by constantly 
changing the force being applied to the construct, a situation that has been observed in 
rabbit Achilles tendons where a force was always found to be applied over the tissue, even 
in situations where the animal is inactive (162).  Block waveforms potentially allow for 
cells to respond to the mechanical loading more effectively. Cells have been found to react 
to stimuli over a time period of around 1 second. By applying a force for a period of time 
longer than this, a greater cellular response can potentially be stimulated (163). 
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Figure 1.7. Loading wave patterns used in tendon tissue engineering. Sinusoidal wave patterns follow a 
sine wave, moving in a smooth, unbroken motion from peak to peak. Block patterns have distinct ‘on’ 
and ‘off’ periods, with ‘on’ representing a sample being loaded and ‘off’ being a rest period. Typically: 
y-axis represents displacement, x-axis represents time. 
 
 
Mechanical loading has been used to influence cell/matrix behaviour in many different 
ways. It is now thought that in order for stem cells to take on connective tissue 
morphologies some form of mechanical loading is required (164). Static mechanical force 
has been used to create neotendonous structures using collagen gels. By applying a strain 
of 50% using a home-made rack system, greater alignment of collagen fibres has been 
observed over lower strain conditions (23). This study also found that mechanical 
properties were significantly improved by applying a strain of over 20%, a peculiar finding 
considering that this would normally be far beyond the natural maximum strain of a 
tendon. Comparing static with dynamic mechanical strain has shown collagen content in 
matrix, mechanical properties and scleraxis (a commonly used expression marker 
associated with embryonic tendon development) expression all being up regulated in 
dynamic samples (164). 
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Further investigation into the effect of cyclic strain on tendon scaffolds has determined that 
frequencies between 0.017 Hz and 1 Hz with strains between 2% and 10% elongation in a 
variety of systems (165) (161) (166) result in increased cellular alignment, up regulation of 
tendon specific cellular markers and improved mechanical properties being observed. It 
has even been found that very low frequency (0.0034 Hz) low strain (2.4%) mechanical 
stimulation over a long time period (8 hours/day, 12 days) can result in increased stiffness 
in MSC seeded collagen scaffolds compared to static controls (167). These studies 
demonstrate the need for mechanical stimulation when designing materials for tendon 
tissue engineering and that an ideal loading regime and bioreactor system type is yet to be 
found. 
 
Human embryonic stem cells have been induced to form tenocytes through a combination 
of growth factor addition and mechanical force. The addition of BMP-2 and TGF-β, 
coupled with a cyclic (1Hz) mechanical 10% strain over 14 days resulted in upregulation 
of collagen 1a, collagen 3a, scleraxis, as well as an increase in fibril density and 
mechanical properties (123) (124). 
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1.7. Project aim. 
 
Due to the demand for new advanced materials for tendon repair novel avenues of 
investigation have to be pursued. Previous work has highlighted PHBHHx as a possible 
new material to use as a scaffold to encourage tenocytes to remodel collagen, leading 
eventually to the production of an all-natural ‘artificial’ tendon, however much 
optimisation work remains to be completed. This thesis will aim to determine how best to 
use PHBHHx scaffolds for tendon tissue engineering, with cell type, mechanical loading, 
media supplements, scaffold design, in vivo scaffold breakdown and immune response 
investigated.  
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Chapter 2: 
Materials and Methods. 
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2.1. General Abbreviations/Consumables. 
The following materials were used in all experimental processes, unless otherwise stated. 
DMEM Dulbeccos Modified Eagles Medium (4.5g/L glucose) (12-604F, 
Lonza, UK) 
FBS   Foetal Bovine Serum (14-501F, Lonza, UK)  
NEAA   Non-Essential Amino Acids (13-114E, Lonza, UK),  
L-Glut   L-glutamine (17-605E, Lonza, UK) 
PSA Penicillin, Steptomycin and Amphotericin B (15240112, Invitrogen, 
UK) 
Trypsin  Trypsin/EDTA solution (CC-5012, Lonza, UK) 
KO DMEM   Knockout DMEM (03382, Gibco, UK) 
SR   Serum Replacement (10828-028, Gibco, UK) 
DMSO   Dimethyl Sulphoxide (R00550, Invitrogen, UK) 
PBS   Phosphate Buffered Saline (17-516F, Lonza, UK) 
T-25   Corning 25cm
2
 tissue culture flask 430639 (430421, SLS, UK) 
T-75   Corning 75cm
2
 tissue culture flask 4306 (413290 SLS, UK) 
T-175   Corning 175cm
2
 tissue culture flask 430825 (354639 SLS, UK) 
Well Plates 6: Costar 3516, 12: Costar 3512, 24: Costar 3524, 48: Costar 3548, 
96: Costar 96. (all SLS, UK) 
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Centrifuge tube 15ml SLS8002, 50ml SLS8110 (both SLS, UK) 
IMS   Industrial Methylated Spirit (64-17-5 Genta Medical, UK) 
PFA   Paraformaldehyde (P6148 Sigma Aldrich, UK) 
BSC   Biological Safety Cabinet class II (W05318 Envair, UK) 
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2.2. Cell Culture. 
2. 2. 1. General techniques. 
a. Media Change. 
Media changes were performed as necessary according to cell type and experimental need. 
Generally, MSCs and tenocytes had a media change twice weekly, ESCs daily, unless 
specifically stated.   Media was removed from cells by aspiration in a class II Biological 
Safety Cabinet, tilting the flask/vessel to ensure maximum amount of spent media was 
removed. New media was pre warmed in a water bath (2828 Thermo Scientific, UK) set to 
37
o
C before being pipetted onto the cells in appropriate measures. Cells were then placed 
back into the incubator at 37
o
C. 
b. Cell Passage.  
Cells were passaged by first aspirating off any media and washing with 5 mL PBS. The 
PBS was again aspirated off, and replaced with 37
o
C 1% trypsin/ PBS solution (1mL for T-
25, 4mL for T-75) and incubated at room temperature for 5 minutes. If cells remained 
attached after this time, agitation was used until detachment had taken place. The trypsin 
activity was then inactivated by adding an equal amount of complete media (DMEM, 10% 
FBS, 1% NEAA, 1% L-Glut) and mixed with a pipette, with the FBS acting to oversaturate 
the trypsin molecules. The cell solution was then centrifuged (IECCL30Thermo Scientific, 
UK) at 200g for 3 minutes, after which the supernatant was aspirated off. The pellet was 
then resuspended in a known amount of media, allowing for a fractional split to be made 
(e.g. Resuspend in 1mL media; add 500µL to each new flask if splitting 1:2). The cells 
were then plated into the appropriate flask with correct amounts of media. 
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c. Cryopreservation of cells. 
Cells were cryopreserved by detaching with 37
o
C 1% trypsin/PBS solution for 5 minutes, 
centrifuging (3 minutes, 200g), then re suspended in 1mL solution of 90% FBS: 10% 
DMSO at room temperature. This was then transferred to a 1.5mL cryovial, placed into a 
Nalgene ‘Mr Frosty’ (C1562 Sigma Aldrich, UK) container at room temperature, and put 
into a -80
o
C freezer (MDF-U54V Sanyo) for 24 hours. After 24 hours, the cryovials were 
transferred to liquid nitrogen for long term storage. 
 
d. Thawing of cells. 
Cryovials of cells were removed from liquid nitrogen storage and quickly transferred to the 
cell culture lab. They were then placed in a water bath set at 37
o
C and gently agitated until 
defrosted (around one minute). Once defrosted cells were transferred to a flask containing 
the appropriate media and allowed to adhere to the surface for 24 hours. One adhered; a 
media change was performed removing any non-viable (unadhered) cells. 
 
e. Cell Counting. 
Cells were suspended in a known amount of media. 10µL cell solution was then pipetted 
into each side of a haemocytometer. Cells were counted at 100x magnification (10x 
objective, 10x eye piece), using the lines of the haemocytometer to focus and define the 
area in which cells were counted. For each cell suspension the corner 4x4 square fields 
(Fig. 2.1 highlighted by red boxes) were counted and the values summed and averaged. 
Counting was done in a left to right, up to down pattern. If a large number of cells were 
present, a counter was used. If too many or too few cells (above 100, below 20) cells were 
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present, the solution was adjusted by either dilution or centrifugation and re suspension in 
a smaller volume. Once a value was obtained, the figure was multiplied by 1 x10
4
 to gain a 
cell concentration in cells/mL of the cell solution. 
 
Figure 2.1 
Haemocytometer diagram. For all cell counts, cells present in the red boxed areas were counted, 
summed, then the total number of cells present in all boxes averaged. This number was then multiplied 
by 1x10
4
 to gain a concentration of cells /mL of solution. 
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f. Cell Viability. 
Cell viability was determined using a trypan blue dye exclusion assay. A cell solution was 
obtained by trypsin dissociation. The solution was mixed using a pipette to create a more 
homogenous dispersion of cells, before a 10µL sample was removed and mixed with 10µL 
of trypan blue solution on a glass slide. 10µL of the mixed solution was then pipetted onto 
a pre-prepared haemocytometer with a glass cover slip used to seal the chamber. Cells 
were counted using the method as section 2.2.1.e. with both viable and non-viable cells 
counted separately and an overall average and percentage viable gained. Live cells appear 
clear in the centre with a blue outer membrane. Dead cells appear totally blue (Figure 2.2) 
If cells were suspended in collagen gel, the sample was immersed in 1mL 0.4 % type VI 
collagenase (Invitrogen)/PBS solution for 2 hours at 37
o
C, centrifuged at 200g for 3 
minutes and the pellet resuspended in media to count cells.  
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Figure 2.2 
Example image of viable and unviable cells stained with trypan blue as they appear on a 
haemocytometer. Viable (live) cells to not allow the stain to permeate their membrane and appear 
colourless. Unviable (dead) cells have a permeable membrane to trypan blue and thus appear blue. 
Image adapted from www.cellbiolabs.com. 
 
g. LIVE/DEAD fluorescence assay. 
Fluorescent live dead staining was performed using the LIVE⁄DEAD® 
Viability⁄Cytotoxicity Kit (L3224Invitrogen, UK). Media was removed from cells using an 
aspirator, followed by a double PBS wash. A dye solution of 5µL Ethidium-1, 1.2 µL 
Calcein AM, 2.5 mL PBS (leaving final concentrations of 2µM calcein AM and 4µM 
Ethidium-1) was made up, with sufficient solution to cover the cell surface used in each 
well. In cases where 3D structures were being investigated, enough solution to completely 
immerse the entire scaffold was used. This was then incubated at 37
o
C for 20 minutes, 
before reagents were removed by aspiration. Samples were then washed with PBS before a 
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final immersion of the sample in PBS and storage at 4
o
C if necessary. Either fluorescent or 
confocal microscopy was then performed as described in sections 2.8.5 and 2.8.6. 
i. Seeding.  
Seeding of cells was achieved by suspending cells at a known concentration using a 
haemocytometer as described previously. 
Scaffolds:  
Cells were seeded onto scaffolds by first creating a high density cell suspension. Cells 
were suspended at 1 x 10
6
 cells/mL by trypsin dissociation, counting and centrifugation. 
100µL of this high density solution was the pipetted into the centre of a dry scaffold pre 
prepared according to experiment. Once seeded, scaffolds were transferred to an incubator 
at 37
o
C for 6 hours to allow for cells to adhere to the surface. After 6 hours, scaffolds were 
immersed in 37
o
C complete media according to experiment and cell type. 
Flasks/Petri dishes: 
Cells were suspended at known concentrations as described previously before pipetting 
directly into flasks containing sufficient complete media pre warmed to 37
o
C to completely 
cover the cell growth surface. Flasks were placed into an incubator at 37
o
C after seeding. 
Adhesion was checked after 12 hours using light microscopy.  
 
2. 2. 2. Tenocytes. 
a. Tenocyte extraction and culture. 
Tendons were extracted from 8 week old male rats obtained from Keele University animal 
house by first sacrificing the animal, then surgically removing the Achilles tendon from 
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both hind legs. The tendons were then placed in a universal bijou flask containing a 
solution of phosphate buffered saline supplemented with 1000 U/m PS for transport to the 
lab. Samples were kept in this solution for a maximum of 1 hour. The tendon was removed 
from the solution in a Biological Safety Cabinet and placed into a sterile petri dish. One 
tendon from each rat was minced into approximately 2mm
2 
pieces using a scalpel. Each 
tendon piece was then placed into the centre of a dry petri dish. The dishes were placed 
into an incubator at 37
o
C for 1 hour, allowing the tendon to loosely adhere to the petri dish 
surface. Media (DMEM (4.5g/L glucose), 10% FBS, 1% NEAA, 1% L-glutamine) was 
then carefully dropped into the dishes, immersing the tendon, with care being taken to not 
detach the tendon piece from the culture plastic surface, and dishes placed back into the 
incubator for further culture. After around 5 days, cells started to migrate out of the tendon 
onto the petri dish surface. Once these cells reached confluence in the dish, the tendon 
piece was carefully removed using sterile tweezers and re-adhered to another petri dish 
using the same protocol as previously described. The remaining cells from the first dish 
were then detached from the surface using warm 1% trypsin/PBS solution for 5 minutes, 
pelleted by centrifuge (3 minutes, 200g), then divided into two T-25 flasks. One flask was 
then placed in a 2% O2 incubator (Galaxy R+, RS Biotech), the other into the standard 21% 
O2 incubator (MCO-17AI, Sanyo), after which the cells were expanded, passaging the cells 
when they reached 90-100% confluence. This process was repeated for the second dish the 
tendon piece was adhered into, with cell labelled as being from the second batch of cells 
gained from the tissue sample. This process was repeated with each tendon piece until cells 
were not seen to be migrating onto the culture plastic, up to a maximum of 3 times. 
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b. Tenocyte characterisation. 
Tendon cells were characterised using Tenomodulin immunofluorescence. Cell samples 
were cultured to around 60% confluence in complete tenocyte media (section 2.2.2.a.) in a 
12 well plate before being fixed in 95% methanol for 5 minutes and washed twice with 
PBS in the well of the plate. Samples were then immersed in 0.01% Triton X (T8787 
Sigma Aldrich, UK) solution for 5 minutes, before washing with PBS. Cells were then 
immersed in 3% bovine serum albumin (A8806 Sigma Aldrich UK) for 1 hour at room 
temperature, before a further PBS wash. Enough primary antibody (rabbit polyclonal IgG, 
SC98875 Santa Cruz, USA. 1:200 in PBS) to completely immerse the cells was then 
applied and left at 4
o
C overnight. The antibody was then removed by aspiration and 
samples washed with PBS. The secondary antibody (donkey anti rabbit IgG-FITC 
conjugated, SC 2090 Santa Cruz, USA. 1:200 in PBS) was applied and left at room 
temperature for 1 hour, before washing with PBS. A counterstain was then used to 
highlight the nucleus of the cells by adding 4',6-diamidino-2-phenylindole (DAPI) (Sigma 
Aldrich D9542) at a 1:500 concentration in PBS for 5 minutes at room temperature. A final 
PBS wash was then administered before immersing the sample in PBS for imaging. 
Samples were stored under PBS at 4
o
C after imaging. 
 
2. 2. 3. Mesenchymal Stem Cells. 
a. Fibronectin Coating.  
Tissue culture flasks were coated with fibronectin (F0895 Sigma Aldrich, UK) before use. 
A solution of 10ng/mL fibronectin/PBS was used to coat each flask, with 4mL used for a 
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T-75 (or enough to completely cover the surface). Flasks were left for at least 2 hours at 
room temperature before the solution was aspirated off and cells added. 
 
b. Isolation and Culture of Mesenchymal Stem Cells. 
Complete human bone marrow aspirate was supplied by Lonza, UK (1M-125). A total 
mononuclear cell count was performed on the incoming aspirate, before being seeded into 
fibronectin coated T-75 flasks at 1 x 10
5
 mononuclear cells/cm
2
 in 15mL media (DMEM 
(4.5g/L glucose), 5% FBS, 1% NEAA, 1% L-glutamine, 1% PSA). These were then 
incubated at 37
o
C for 7 days, before half of the media was changed and cells replaced back 
into the incubator. A full media change was performed on day 14 of culture. MSCs were 
initially identified by being the adherent cells that remain in the dish after the second full 
media change. After isolation, cells were either cryopreserved or expanded. 
For cellular expansion, cells were cultured in media (DMEM (4.5g/L glucose), 5% FBS, 
1% NEAA, 1% L-glutamine) until 90-100% confluent, when they were split 1:2. 
 
c. MSC characterisation. 
Further characterisation of cells was carried out using a Human Mesenchymal Stem Cell 
Characterisation Kit (Millipore SCR067) according to manufacturer’s protocol. Briefly, 
cells were cultured to around 60% confluence in a 6 well plate before being fixed in 4% 
PFA for 5 minutes. Cells were then immersed in 0.01% Triton X (T8787 Sigma Aldrich, 
UK) solution for 5 minutes. Cells were then washed in PBS before 3% bovine serum 
albumin (BSA) (3%BSA in FBS) blocking solution was applied for 2 hours. Supplied 
antibodies (mouse anti-THY-1 (CD90), mouse anti-STRO-1, mouse anti-H-CAM (CD44)) 
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were diluted according to specification in PBS (this kit specified 1:500 as optimum).  Cells 
were coated in antibody solution at 4
o
C overnight, with one antibody solution used per 
well. Cells were then washed with PBS and blocking solution before secondary antibody 
(donkey anti mouse IgG) solution was applied for 2 hours at room temperature in darkness. 
A final PBS wash followed, with cells stored immersed in PBS at 4
o
C. Imaging was then 
performed using fluorescence microscopy using FITC and TRITC filters according to the 
fluorescent tag associated with the antibody. 
2. 2. 4. Embryonic Stem Cells. 
a. Mouse Embryonic Fibroblast isolation.  
Mouse embryonic Fibroblasts (MEFs) were isolated from pregnant female mice at 
approximately 12 days after being plugged. The mouse was sacrificed by cervical 
dislocation, before being sprayed with generous amounts of 70% IMS. An incision was 
then made parallel to the hind legs across the abdomen of the mouse, before two further 
incisions were made, creating a V shape towards the animals head. The uterine horn was 
then removed using scissors and forceps into a sterile 90mm petri dish. Each embryo was 
then separated from the uterine horn, and the membrane surrounding it pierced, draining 
the amniotic fluid. The embryo was then removed from the membrane and the head 
removed using a scalpel. The body was then stored in 10%PS/PBS until ready for further 
processing, with a maximum of 10 embryos per 50mL.  
Three dishes of warm PBS were prepared in a Biological Safety Cabinet (BSC) . The 
embryos were transferred to the first bath, where the bulk of any organs or viscera (red 
matter) was removed using sharp sterile forceps. The remaining tissue was then washed in 
the second PBS bath, and then again into the final bath. The tissue was then transferred to 
pre warmed PBS/1% Trypsin/EDTA solution (2mL/embryo) and incubated for 5 minutes, 
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vortexed, and then incubated for a further 5 minutes. The trypsin was then neutralised 
using complete DMEM/10% FBS media and the sample vortexed. The liquid was then 
allowed to settle for 5 minutes before the top 3mL was removed and added to a T-75 flask 
containing 15mL complete media (DMEM, 10% FBS, NEAA, L-Glut, 1% PSA). This was 
then incubated for 48 hours, before a complete media change was performed with media 
containing no PSA.  
b. MEF culture. 
MEFs were seeded into a T-75 flask with complete media (DMEM, 10% FBS, NEAA, L-
glut) and allowed to reach full confluence. When split, cells were plated at 1:8 and allowed 
to reach approximately 70% confluence before 25mL conditioning media (KO-DMEM, 
20% Serum Replacement, 1%NEAA, 1% L-Glut, 4ng/mL β-FGF (F0291, Sigma Aldrich, 
UK), 909µL β-mecaptoethanol (M7522, Sigma Aldrich, UK)) was added, replacing the 
complete media. Conditioning media was removed daily, collected and stored at -20
o
C 
until use. Before use, conditioning media was defrosted and filtered (22µm Milipore 
stericup). At the time of filtering a further 4ng/mL β-FGF was added. 
c. Matrigel coating of flasks. 
Matrigel (354277 SLS, UK) was defrosted overnight at 4
o
C and diluted 1:100 in serum 
free KO DMEM at 4
o
C. This was then vortexed to ensure complete mixing, before being 
pipetted into tissue culture vessels, with enough Matrigel solution to completely coat the 
flask surface being added. Flasks were allowed to sit for at least 1 hour before matrigel 
solution was aspirated off and the flask used for cell culture. If flasks were stored, they 
were done so at 4
o
C for a maximum of 7 days. 
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d. ESC culture. 
SHEF 1 embryonic stem cells (UK Stem Cell Bank) were cultured on matrigel coated T-25 
flasks in a 21% O2, 5% CO2 incubator at 37
o
C. Pre conditioned media (from MEFs) was 
used throughout. Cells were split 1:2 when confluent, with media changed daily. This 
method was adapted from that originally described by Xu et al (122). 
e. Spontaneous Differentiation. 
Spontaneous differentiation of ESCs was achieved using the method described by Bandi et 
al (168). Briefly, 1 x10
6
 SHEF 1 were seeded into a Matrigel coated T-75 flask for 24 
hours in standard ES cell media (KO DMEM, 20% Serum Replacement, 4ng/mL b-FGF 
(100-18B Peprotech UK), 1% L-Glut, 1% NEAA, β-mercaptoethanol (31350-010 
Invitrogen, UK)), and allowed to adhere for 24 hours. Spontaneous differentiation was 
induced by changing the media to standard fibroblast media (DMEM, 10% FBS, 1% 
NEAA, 1% L-Glut) for 5 days, changing the media after 3 days.   
 
2. 3. Scaffold Production. 
2.3.1. Purification of PHBHHx. 
Poly-(3-hydroxybutyrate-3-hydroxyhexanoate) (PHBHHx) (Lukang Group, Shandong, 
China) (Mw 500KDa, 87.9% HB, 12.1% HHx)  was purified by immersing in 100% 
ethanol (CHE1932, SLS UK) for 12 hours, before filtering using a 22µm Milipore stericup. 
Any remaining ethanol was allowed to evaporate fully at room temperature before use. 
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2.3.2. PHBHHx films.  
Films were made by dissolving PHBHHx powder in Chloroform (472476, Sigma-Aldrich, 
UK) at varying concentrations between 0.8 and 2.4 weight (%) (0.08-0.24g 
PHBHHx/10mL Chloroform). This was left for 1 hour with regular shaking to allow the 
polymer to fully dissolve. 3mL polymer solution was then pipetted into a 60mm diameter 
glass petri dish on a flat surface in a fume cupboard and the solvent evaporated overnight. 
After complete evaporation had occurred, the films were removed from the dishes, cut into 
a circular shape using scissors and a template with a diameter of 35mm and immersed in 
70% Ethanol for 2-3 hours in a BSC to sterilise. After washing with sterile PBS 3 times, 
the films were used. 
2.3.3. PHBHHx tubes. 
2g PHBHHx powder was dissolved in 20 mL chloroform in a 50 mL conical flask. Tube 
construction was performed using a 2.5 mm diameter stainless steel mandrill which was 
dipped into the homogenised PHBHHx/NaCl solution for 1 second, removed, inverted, 
stood upright with the polymer coated end at the top of the mandrill, and slowly rotated by 
hand allowing the solvent to evaporate in a flow hood for 2 minutes. This process was 
repeated 5 times, after which the mandrill was fixed vertically for 60 minutes to allow the 
solvent to fully evaporate and the polymer to become rigid. The polymer tube was 
carefully removed by hand and immersed in deionised H2O overnight to further remove 
any remaining solvent. 
 
2.3.4. Porous scaffolds. 
Porous scaffolds were made by following the same protocol as used for making tubes. 
Briefly, 1g PHBHHx was dissolved in 10mL chloroform and allowed to stand for 1 hour to 
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allow the polymer to dissolve fully. 0.04g/10mL of Sodium Chloride particles (433209 
Sigma Aldrich, UK) (pre-sieved selecting for particles under 100µm in size) were then 
added to the solution and homogenised by vortexing. A tube was then formed as described 
in section 2.3.3. After forming, the construct was allowed to air dry for 24 hours, before 
removing from the mould by hand. The scaffolds were then placed in de-ionised water for 
30 minutes, allowing the NaCl particles to dissolve out of the polymer. Sterilisation by 
immersion on 70% ethanol for 2 hours, followed by washing with PBS 3 times, preceded 
use. 
2.3.5. Collagen Gels. 
Type I collagen gels were produced by combining 10x DMEM (D2554 Sigma Aldrich) 
with cells at 10x the final desired concentration (e.g. final gel concentration needed 1 x 10
5
 
cells/mL, 1 x 10
6
 cells/mL were suspended in the 10x DMEM before gels were produced), 
with 1mol NaOH, dH20 and high concentration type I collagen gel (BD354249 BD 
Biosciences). 2mL of gel was produced by mixing 980µL collagen (initial conc. 
9.41mg/mL), 200µL 10x DMEM/cells, 22µL 1M NaOH and 800 µL H20 for a 5mg/mL 
final collagen concentration. Gels were fabricated in the order 10x DMEM, NaOH, water, 
collagen stock to prevent premature gelation. Gels were mixed by pipette creating a 
uniform colour solution. All gels were mixed and stored on ice until use.  
 
2.3.6. Collagen Cylinders. 
To make a collagen tube, the procedure for making the gel solution is as previously 
described. To create a tube shape a mould was fashioned using two 1mL plastic syringes. 
On one syringe the tip was removed using sterile scissors. The plunger from the second 
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syringe was then used to seal the open end, creating a cylindrical mould. Collagen gel was 
pipetted into the open end of the syringe, with the plunger as near to the top as possible, 
withdrawing as the collagen solution filled the space. This stopped any air bubbles forming 
at the end of the cylinder. When the desired amount of gel solution was in the syringe, the 
second plunger was carefully placed on the open end sealing the chamber. The whole 
mould was then incubated at 37
o
C for 2 hours before carefully removing the cylindrical 
collagen gel into the desired culture vessel (Fig. 2.3). 
     
Figure 2.3. Forming a collagen cylinder. Gels were pipetted into an adapted 1mL syringe while still 
liquid, with a secondary plunger used to seal the gel in place. After 1-2 hours at 37
o
C, gels can be 
removed by pushing on one of the plungers, creating a cylinder of collagen gel. Media is then added to 
maintain gel and prevent dehydration. 
 
2.3.7. Scaffold Preparation for in vivo studies. 
PHBHHx porous tubes were prepared using the method described in 2.3.c. PHBHHx fibre 
was made by melt-spinning using a laboratory-size extruder (Ruojiang Chemical Fibre 
Machinery Co. Ltd., Beijing, China) with a single nozzle which had an inner diameter of 
300 µm. Briefly, PHBHHx powder (87.9% HB, 12.1%HHx) was melted, extruded, 
isothermally crystallized, drawn and annealed under tension as described in Chinese patent 
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application No. 200810052461. All fibre was provided by Tsinghua University, Beijing, 
China. 
 
 
 
Figure 2.4. PHBHHx/collagen hybrid scaffold. Collagen gel (containing or not containing cells) is 
pipetted into the centre of a porous PHBHHx tube at 4
o
C, before elevating the temperature to 37
o
C for 
1-2 hours to allow for the gel to set. Scaffolds were then either placed in static culture, or used for in 
vivo experimentation. 
 
2.4. In vitro testing. 
2.4.1. Cellular fluorescent tagging.  
Cells were first detached using trypsin and a cell count performed. Cells were suspended at 
1 x 10
6
 cells/mL concentration, along with 5µL DiO stain solution (V22889 Invitrogen) 
added for each mL cell suspension. This was then incubated for 10 minutes at 37
o
C. 
Solutions were the centrifuged and the pellet washed 3 times with PBS before using cells 
as required. Cells could then be viewed using fluorescent microscopy. 
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2.4.2. Mechanical testing. 
a. Stiffness was measured using a BOSE Electroforce 3200 system by clamping samples 
within appropriately sized grips and deforming by 0.5mm at 0.1mm/second in a uniaxial 
direction with the force required measured. Samples were placed into the grips with the 
approximate centre of the sample in the gap between the grips (Fig. 2.5). Stiffness was 
calculated using the equation: k = F/δ, where k = stiffness, F = force and δ = displacement 
in single direction of freedom (i.e. direction the force acts in).  
b. Failure stress was measured by clamping samples within appropriate grips and 
stretching to failure using a BOSE Electroforce 3200 system. Samples were loaded 
securely in the grips, with a minimum of 5mm of sample being between the grip tongs. The 
mid-point of the sample was always between the upper and lower grips. Samples were 
loaded to failure, or until a drop off in load bearing capability was observed. If samples 
failed in a position that was not more than 2mm from either the upper or lower grip, the 
test was considered invalid, minimising the effect of the grip altering the mechanical 
properties of the sample. A diagram of the set up can be seen in figure 2.5. 
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Figure 2.5. Diagram of sample clamping for mechanical testing. Samples were loaded with a minimum 
of 5mm inside both the upper and lower grips, with the mid-point of the sample being between the 
upper and lower clamp. 
2.4.2. Collagen contraction.  
Contraction was monitored over a period of 20 days using callipers. Media was aspirated 
off gels, with gels then being straightened using sterile forceps to ensure correct values 
were gained, taking care not to elongate the sample from its original length. Callipers were 
autoclaved or exposed to ultra violet light prior to use to reduce chance of contamination. 
Callipers were adjusted to approximate the length of gels prior to moving them into contact 
with gels, and further adjusted until contact was made. Contraction in diameter was 
measured using the same method, with readings being taken at 3 random points throughout 
the length of the gel, and an average taken.  
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2.4.3. Reverse Transcription –Polymerase Chain Reaction (RT-PCR). 
a. Cell lysis. 
Cells were pelleted using trypsin and centrifugation. If cells were suspended in collagen 
gel, samples were pre immersed in 0.4% type IV collagenase at 37
o
C for 1 hour or until gel 
was not visible. 350μl lysis buffer was added to the pellet and mixed with the pipette. The 
lysed cells were then transferred to a QIAShredder tube and centrifuged for 3 minutes at 
full speed (16000g), disposing of the spin column after use.  Samples were stored at -80
o
C 
before final extraction.  
 
 
b. RNA extraction. 
1 volume (350μL) of 70% ethanol was added to cell lysate before being transferred to an 
RNEasy spin column (total 700μL per column). Once transferred, the RNEasy column was 
centrifuged for 15-30 seconds at 9000g. The flow-through was discarded and the column 
retained. It was ensured that the column remained untouched through this process to avoid 
contamination. 700μl buffer RW1 was added to the column and the tube spun for 30 
seconds at 9000g. The flow-through was discarded and the column containing RNA 
retained. 500μl RPE wash buffer was then added to the column and spun for 30 seconds at 
9000G before discarding flow-through. RPE wash was repeated followed with 
centrifugation for 2 minutes at 9000g. The RNEasy spin column containing the extracted 
RNA was transferred to a new tube and spun again at 16000g for 1 minute. 15μL of RNase 
free water was added directly onto the polymer of spin column and allowed to stand for 3 
minutes. Following this time the column was spun for 1 minute at 9000g. The supernatant 
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was removed with a pipette and returned to the column and allowed to stand again for 3 
minutes prior to a final spin at 16000g. The spin column was then discarded and the 
microcentrifuge tube containing 15μL of concentrated extracted RNA placed on ice prior 
to measurement and PCR analysis. 
c. RNA Quantification. 
Quantification was performed using a Nanodrop 2000 spectrophotometer. Pedestals were 
cleaned and blanked with dH2O before use. 1µL RNA sample was loaded onto the pedestal 
and read using the RNA quantification tool in the associated ND-2000 software. RNA total 
concentration, 260/280 and 260/230 measurements were recorded. Nanodrop pedestals 
were cleaned with dH2O between sample readings.   
 
d. RT-PCR. 
A PCR master mix of 12.5μL per sample was created using 2X Reaction mix (6.25μL), 
forward and reverse primers (0.25μL at concentration 10 μM) SuperScript III RT/Platinum 
Taq High Fidelity Enzyme mix (0.25μL) and DNAse-free water (4.5μL).  
1µL RNA sample was loaded into a 0.2mL PCR tube, with a control of the same RNAse 
free H2O used to make up the master mix. 12.5µL master mix was then added to each 
sample tube and the lid applied before being briefly centrifuged to ensure all product was 
mixed and at the base of the tubes. Tube strips were then transferred to a pre-programmed 
PCR thermocycler.  
e. PCR cycling. 
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Samples were run according to the following procedure as previously used by Forsyth et al 
(85).cDNA synthesis and pre-denaturation: 1 cycle of 50°C for thirty minutes, 94°C for 
two minutes. PCR Amplification: 40 cycles of 94°C for fifteen seconds (denaturation), 
annealing temperature for thirty seconds (annealing – see table below) and 68°C for thirty 
seconds (one minute per kb) (extension).  
Final extension: 1 cycle of 68°C for 5 minutes (fully extending any remaining single 
stranded DNA), then cool to 15°C until retrieved for processing. 
f. Annealing Temperatures and Primer Sequences. 
 
Table 2.1. RT-PCR primer sequences, sequence lengths and annealing temperatures. Expression 
markers investigated were B-Actin (housekeeping gene), SOX-9 (cartilage), RUNX2 (bone), PPARγ 
(adipose), TNMD (Tenomodulin, tendon), TENC (Tenascin C, tendon), COL1a2 (collagen 1a2), 
COL3a1 (collagen 3a1), TBSD4 (thrombospondin 4, tendon). 
Name Forward (5'-3') Reverse (5'-3') Sequence 
length 
Annealing 
temperature 
o
C 
B-Actin GCCACGGCTGC
TTCCAGC 
AGGGTGTAAC
GCAACTAAGT
C 
504 55 
SOX-9 TCATGAAGATG
ACCGACG 
CTGGTACTTGT
AATCCGG 
506 54 
RUNX2 CCCCACGACAA
CCGCACCAT 
CACTCCGGCC
CACAAATCTC 
289 48 
PPARγ CTTTTGCTGAGCT
TCTTTCA 
TGAAAGAAGCT
CAGAAAGC 
203 55 
TNMD GCACTGATGAAA
CATTGG 
ATCCAATACAT
GGTCAGG 
274 49 
TENC AAGAGCATTCCT
GTCAGC 
CAGTTTGCCGG
TAAGAGG 
217 50 
COL1a2 GACTTTGTTGCTG
CTTGC 
CAAGTCCAACT
CCTTTTCC 
242 50 
COL3a1 AAGGACACAGAG
GCTTCG 
CTGGTTGACCA
TCAATGC 
210 51 
TBSD4 CCCCAGGTCTTTG
ACCTTCTCCC 
ACCTTCCCATCG
TTCTTCAGGT 
245 59 
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g. Gel Electrophoresis. 
2% agarose gels were made by fully dissolving 2g agarose in 100mL 1x  Tris Acetate-
EDTA (TAE) buffer (T9650 Sigma Aldrich, UK) with heating for 3 minutes at full power 
in a microwave. 10mg/mL ethidium bromide was added and mixed thoroughly before 
pouring into the casting tray and inserting a well comb. It was then allowed to set at room 
temperature for at least one hour before being immersed in an electrophoresis chamber 
filled with 1xTAE buffer.  
2µL loading dye was added to each sample after being removed from the PCR 
thermocycler. Samples were then briefly centrifuged and flicked to ensure thorough 
mixing. 5µL DNA ladder solution (Sigma) was added to control wells in the immersed gel. 
5 µL of sample was then loaded in consecutive wells. 
Electrophoresis was performed for 60 minutes at 100 V using a BioRad Power PAC 3000 
and imaged using a Syngene Gel UV illuminator and GeneSnap imaging software. 
 
2.5. Mechanical Stimulation.  
Mechanical stimulation was performed using the BOSE ElectroForce 3200 machine 
coupled to WinTest software. Scaffold/cell constructs were assembled and cultured in 
static conditions in complete media for 24 hours before loading took place. Samples were 
placed within the grips of the Biodynamic chamber adaption, with all vents and outlets 
sealed, inside a Biological Safety Cabinet (fig. 2.6). Samples were manipulated into place 
using sterile forceps. Once sealed the unit was transferred to the ElectroForce machine and 
connected in accordance to manufacturer’s protocol. Samples were stressed using an axial 
strain of 10% (ie. 5mm sample – 0.5mm elongation) in a sine wave pattern, with the high 
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being 10% strain and the low being the original length of the scaffold. All samples were 
loaded at a frequency of 1 cycle/minute (0.017 Hz) for 1 hour per day, 5 days on, 2 days’ 
rest.  
The Biodynamic chamber was assembled prior to use and autoclaved after 5 days of 
mechanical loading. After each batch of sample was loaded samples were removed using 
sterile forceps and placed back into static culture and the chamber comprehensively 
washed with 70% IMS to remove any remaining residue from samples. IMS was allowed 
to completely evaporate before new samples were mounted in.  
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Figure 2.6. BOSE chamber setup and mechanical loading. samples were mounted between the grips of 
the biodynamic chamber in a BSC before chamber was sealed (A). Samples were then mechanically 
loaded ‘dry’ for 1 hour per day for a maximum of 20 days (B) according to the conditions outlined in 
the figure, before being returned to static culture. 
 
 
 
 
 
 
Alexander Lomas PhD Thesis Chapter 2 Materials and Methods 
77 
 
2. 6. Scaffold Characterisation. 
2.6.1. Scanning Electron Microscopy. 
SEM (FEI Quanta 200, Tsinghua Medical School, Beijing) was carried out using samples 
of both fibre and tube to determine the topographical structure. Cellular adhesion was also 
investigated by first allowing rat MSCs and tenocytes to adhere to the polymer for 24 
hours before fixing with 70% methanol. Each sample was gold coated (15 nm) prior to 
analysis. 
2.6.2. Pore size. 
Pore size was quantified by taking 1mm
2
 areas of electron microscope images and 
analysing with Image J software. Random areas were taken, with each pore measured 
along its longest length using the line draw tool, giving a value of pixels for each pore. 
This was then adjusted using the appropriate scaling factor to convert to millimetres.  
2.6.3. Pore density. 
Pore density was measured by taking 1mm
2
 areas of electron microscope images and 
analysing using the grid and counter tools in Image J software. The grid was overlaid over 
the original image, and all visible pores counted. Pores were defined as being areas of the 
surface that were not uniform with the surrounding area, i.e., any indent that could be seen. 
 2.6.4. Fibre diameter. 
The diameter of fibres was obtained by viewing at 100x magnification along random area 
of the fibre length. Point to point lines were then overlaid onto the fibres using the 
microscope software (FEI Quanta 200), which calculated the length of the line. An average 
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was then obtained along with a standard deviation to determine how uniform the fibres 
were.  
 
2.7. In Vivo testing. 
2.7.1. Animals. 
Animal license and experimental design was approved by the Animal Ethical Committee 
of Tsinghua University, Beijing, 31.8.2010. 
15 180-200 g male Sprague-Dawley (SD) rats were purchased from the Centre for 
Biomedical Analysis, Tsinghua University, China. Animals were returned to the centre 
post operation and fostered by the staff there for the duration of the experiment. The 
animals were euthanized at 40 days post operation by cervical dislocation, with the 
Achilles tendons from both hind legs being removed for analysis. 
Experimental Groups: Animals were randomly assigned during surgery into 3experimental 
groups. Group 1 was a control group, where a 2mm defect was induced in the mid-section 
of the Achilles tendon of the right hind leg. This injury was then left to heal naturally, with 
only the outer skin sutured back into place to seal the wound site. Group 2 received the 
2mm defect in the same way as group 1, however after injury a PHBHHx tube/fibre 
scaffold was secured into place, using the fibres to fix the tube into the correct position. 
The surgical site was then closed using sutures. Group 3 also received a 2mm defect to the 
right hind Achilles tendon, with a PHBHHX tube/fibre scaffold being placed to bridge the 
injury site as with group 2, however before suturing the surgical site closed the tube was 
injected until full with 3mg/mL collagen gel. A full description of surgical method is found 
in section 2.7.2. 
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Surgical Preparation: Before surgery all scaffolds (5mm length tube with 3 fibres running 
through the lumen (Fig. 2.7)) were sterilized using 70% IMS/ deionised H2O solution 
overnight in a biological safety cabinet with the ultra violet sterilization system turned on. 
Scaffolds were then stored and transported in Sterile PBS/10% PSA solution in a sealed 15 
mL centrifuge tube. This was only opened prior to surgery and the scaffolds handled using 
aseptic surgical technique. 
 
2.7.2. Surgical Procedure. 
Surgical procedures were carried out by experienced (consultant grade) orthopaedic 
surgeons at the Surgical Training Centre, Peking University Hospital Number 1, Beijing, 
China. Animals were anesthetised using 50 mg/Kg sodium pentobarbital according to local 
practice. Once anesthetised, a lateral incision was made parallel to the Achilles tendon on 
the distal side of the right hind leg (Fig. 2.8.B) and the tendon exposed (Fig. 2.8.C). In the 
control group, a 2mm section was removed from the centre of the tendon (Fig. 1D), then 
the incision closed using 3 cross stitches using dissolvable sutures (Fig. 2.8.I). 
Experimental groups had a 2mm section removed, after which the gap was bridged using 
the scaffold. This was done by first knotting together the 3 fibres and passing each 
individually through one end of the damaged tendon (Fig. 2.8.E). The tube was then passed 
along the open end of the fibres, and manoeuvred into position (Fig. 2.8.F). The remaining 
open ends of fibre were then passed through the other damaged end of tendon, and the ends 
bought together to leave a 2 mm gap between the tendon ends. The fibres were then 
knotted together as previously, fixing the scaffold in place and the leg at the correct 
anatomical position (Fig. 2.8.G). In one experimental group, collagen gel was injected into 
the scaffold after it had been fixed in place using a syringe (Fig. 2.8.H). The surgery was 
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again then closed with 3 cross stitches using dissolvable sutures. Animals were separated 
until all had recovered from anaesthesia, then divided according to which experimental 
group they belonged to. 
 
Figure 2.7. Construct as used for in vivo implantation. Final construct consisted of a porous PHBHHx 
tube with 3 PHBHHx fibres running through the centre. Total construct length was approximately 5 
mm to allow for overlap of the injury site.  
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Figure 2.8. Scaffold implant procedure. A: Lateral incision in the right hind leg. B: Isolation and 
pinning of tendon. C: 2 mm injury induced. D: PHBHHx fibres passed through one end of tendon. E: 
Tube manoeuvred into place. F: fibres passed through other end of tendon and construct fixed in 
place. G: Collagen injected into tube. H: Surgery closed using dissolvable sutures. 
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2.7.3. Blood samples. 
Blood was taken from each rat at allotted times throughout the experiment. Rats were first 
isolated using a restraint tube then blood collected by making a small incision at the tip of 
the tail. If insufficient blood flow was present after the initial incision, warm water was 
used to warm the tail. Blood was then collected by drip into an eppendorf micro centrifuge 
tube. Rats were separated after sampling to ensure no repetition occurred. Rats were 
monitored for 1 hour after blood collection to ensure no adverse effects were caused during 
the procedure.  
2.7.4. Immune response analysis. 
Immune response was monitored by measuring C Reactive Protein (CRP) levels in the rats 
throughout the experiment.  Blood samples were taken from the tail of the rats on days -5, -
2, 2, 5, 10, 20 and 40, with day zero referring to the day of surgery. Day 0 blood samples 
were not possible to collect due to blood loss during surgery. Once collected, samples were 
immediately centrifuged at 300g for 15 minutes and the serum (clear liquid level at the top) 
collected and stored at -80
o
C. Once enough samples had been collected, CRP was 
measured using a Rabbit anti Rat CRP ELISA kit (557825BD Bioscience) according to the 
manufacture's protocol and read using a Molecular Devices' VersaMax' Micro plate 
Reader.  
2.7.5. Detection of breakdown molecules. 
The breakdown of the scaffold was quantified by measuring the concentration of a 
breakdown molecule of PHBHHx in the blood serum over time. This was done using a β-
hydroxybutyrate detection assay (Pointe Scientific USA, H7587-58, H7587-CTL) using a 
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scaled down (10x) version of the manufacturer’s protocol and read using a Molecular 
Devices 'VersaMax' Micro plate Reader.  
2.7.6. Restoration of mechanical properties. 
To test for the restoration of mechanical strength, a stretch to break test was carried out 
using 3 of the samples from each group. The non-operated tendons were taken as a positive 
control, demonstrating the strength of a tendon if undamaged and subjected to the same 
environmental factors. The samples were removed ensuring that the complete tendon was 
collected. The samples were loaded into the machine (Tension Compression Load Cell 
Tester, NTS Canada) so that only the ends of the tendon were held by the clamps, and 
stretched at a rate of 10 mm/min until complete failure was observed.  
 
2. 8. Histological Assessment. 
2.8.1. Paraffin wax embedding. 
Samples were fixed using 4% paraformaldyhyde (P6148 Sigma Aldrich UK)/PBS solution 
overnight at 4
o
C. They were then dehydrated using an ethanol sequence of 70% for 2 
hours, 80% for 2 hours, 90% for 2 hours than 100% for 2 hours. After dehydration samples 
were immersed in xylene for 20 minutes, then at 60
o
C in melted paraffin wax (Shandon 
Histoplast, Thermo Scientific) for 1 hour before being loaded onto a cassette in a Shandon 
Histocentre 2 (Thermo Scientific). They were then aligned in the direction of future 
sectioning (i.e. longitudinally), before wax was set on a cold plate. Samples were then 
stored at 4
o
C. 
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2.8.2. Microtome Sectioning. 
10µm sections of samples were created using a microtome (Shandon AS325, Thermo 
Scientific). Samples were placed onto pre warmed (around 20
o
C) glass slides to aid in 
sample adhesion and a cover slip applied using mounting solution (9369 Sigma Aldrich) 
2.8.3. Haematoxylin and eosin stain. 
Samples rehydrated by reverse ethanol sequence (immersion in 100% ethanol for 1 hour, 
90% ethanol for one hour, 80% ethanol for one hour, 70% ethanol for one hour, 50% 
ethanol for 2 hours, Xylene for 1 hour) and washed with water. Haematoxylin was applied 
for 10 minutes before washing with acidified water twice. Eosin was then applied for 5 
minutes before washing with water. Cover slips were then placed over the sample and 
fixed in place using mounting solution before imaging. 
2.8.4. Sirius red stain. 
Samples were rehydrated with ethanol sequence before haematoxylin was applied for 10 
minutes. Samples were washed with water twice before immersing in Sirius red solution 
for 1 hour at room temperature. Samples were washed of any excess stain with water 
before coverslips were added and samples imaged. 
2.8.5. Fluorescent imaging. 
Imaging was performed using a Nikon Ti S microscope coupled with a Nikon DSF11 
camera and Nikon C-HGFI fluorescent light source. NIS-Elements software was then used 
to process the images.   
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2.8.6. Confocal microscopy. 
Confocal microscopy (Olympus Fluoview, Olympus IX71) was performed to determine if 
cells had migrated into polymer films. A ‘z-stack’ representation of the polymer cross 
section was created by taking images at 5µm intervals. When then viewed in the z axis a 
fluorescent signal was observed where cells were located, allowing for a plane of reference 
to be made from the images. If all signals are detected in a single straight line, the cells 
were located on a single plane of reference. 
2.8.7. Polarised Light Microscopy. 
Samples were prepared according to experimental design. Images were taken using 
polarised light, with filters at 0
o
 and 90
o
 settings (ie. cross polarised) with samples 
orientated in the same direction. Images were taken with a Nikon N5 camera. 
2.8.8. Optical coherence tomography. 
Polymer thickness was measured using a home built Optical Coherence Tomogrophy 
(OCT) system according to a previously published method (169). Briefly, OCT generated 
images (laser wavelength interference patterns) were taken at random areas of 3 different 
scaffolds, with 3 images taken of each scaffold. Image J analysis software was then used to 
determine thickness, using the equation: line length x 0.0055 = length in mm.  
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2. 9. Statistical analysis 
Results were checked for normality before further analysis using the Column Statistics 
analysis tool in GraphPad Prism® version 5.01.The significance of difference between two 
groups was determined by paired, two-tailed Student t-test. Differences between three or 
more groups were analysed by one-way ANOVA with Post-hoc Tukey’s Multiple 
Comparison analysis. A ‘p’ value less than 0.05 was considered to indicate statistical 
significance. Data are presented as mean ± standard deviation (SD). Data was analysed 
using Microsoft Excel 2010® software with an additional stats plug in, or analysis was 
performed using GraphPad Prism® version 5.01 software for Windows (GraphPad 
Software, San Diego California USA). 
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Chapter 3 
Cell Isolation, Culture and 
PHBHHx Compatibility. 
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3. 1. INTRODUCTION 
Polyhydroxyalkanoates (PHA) are a family of biopolymers consisting of polyesters of 
many different hydroxycarboxylic acid molecules. Originally viewed as replacements for 
traditional petrochemical-derived polymers, PHAs are now largely redundant as everyday 
materials due to the prohibitive cost of large quantity production (141). There is now 
increased interest in these polymers from the medical device sector where the earlier 
prohibitive costs are reduced due to the reduced scale of operations. In addition PHAs 
display relatively high immunotolerance, low toxicity, and biodegradability which are all 
crucial for the medical device sector (142). 
 
PHBHHx is the designation of molecules consisting of random co polymers of 3-
Hydroxybutyrate and 3-Hydroxyhexanoate (143). It is one of the few PHA molecules that 
can currently be produced on a large enough scale for use in both scientific research and 
medical device construction (140). PHBHHx has a melting temperature of 111.7
o
C, a glass 
transition temperature of -0.67
o
C, a tensile strength of 4.1MPa, an elongation at break of 
103.8%, and a Young’s modulus of 130.4 MPa making it potentially useful for widespread 
biomaterial applications and different cell types (144) (148). 
 
As previously mentioned in section 1.2, tendons form the bridge between muscle and bone. 
They are typically slow to repair after injury or disease, have a poor blood supply and are 
relatively acellular when compared to other tissues (39). Tendon is composed mainly of 
collagen type I fibrils arranged in a hierarchical structure surrounded by a layer of 
endotenon (13). These fascicles come together to form larger and larger subunits, 
eventually forming the complete tendon. The arrangement of collagen I fibrils give tendon 
its strength in tension. Tenocytes are the major cell group present in tendons, making up 
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around 95% of the cellular mass (25). They are a highly specialized form of fibroblast and 
are responsible for the maintenance of tendon extracellular matrix (collagen I (the major 
component of tendon), collagen III, collagen V, glycosaminoglycans, elastin, and 
fibronectin) and for the repair of tendon tissue either after injury or as part of normal 
physiological process (16) (53). Under normal physiological conditions, tenocytes are 
found in small numbers spread between the collagen fibrils (16).  
 
hMSCs are viewed as a candidate cell source for tendon tissue engineering as, unlike 
tenocytes, they can be readily sourced, isolated and expanded in vitro. The exposure of 
hMSCs to external tensile forces and/or supplementation with additional growth factors 
can induce differentiation into cells that resemble tenocytes in physiological activity and 
marker expression profile (53) (92). 
 
Hypoxic cell culture is a term used to describe growing cells in atmospheres with reduced 
oxygen concentrations to those normally used. Typical values for O2 would be 1-3 %, 
compared to 21% in regular atmospheric conditions. Low oxygen tensions have been 
shown to have beneficial effects on human MSC cell proliferation and on tissue formation 
potential (170) (171). Tendon derived stem cells have also been recently shown to 
proliferate faster in hypoxic conditions (86), leading to the conclusion that tenocyte 
function and cellular activity should be increased by hypoxic atmospheres. 
 
The objective of this investigation was to monitor and quantify the interaction (attachment) 
and migration of tenocytes and hMSCs with PHBHHx polymer films of a variety of 
weight: volume ratios to characterize the optimal ratios for use in tissue engineering 
application.  
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3. 2. MATERIALS AND METHODS 
All materials and reagents were used as described in section 2.1 unless stated otherwise. 
Cells 
Tenocytes were isolated from rat Achilles tendon (RaT) and cultured according to section 
2.2.2 in both 21% O2 and 2% O2. Cells were imaged at P0, P4 and P8 at 100x 
magnification. Image J software was then used to measure cells along the longest axis and 
at 90
o
 to the longest axis, giving a value for cell length and width, before a ratio of width to 
length was found, giving a value of “squareness” or aspect ratio, with 1 being a perfect 
square and higher numbers denoting a more elongated shape (172).  hMSC were isolated 
from commercially acquired human bone marrow cultured according to section 2.2.3. 
Tenocytes were characterised by immunofluorescence with FITC conjugated Tenomodulin 
(TNMD) using protocol 2.2.2.b. MSCs were characterised using protocol 2.2.3.c.  
 
Polymer Characterization 
PHBHHx films were made as section 2.3.b. Polymer thickness was measured using a home 
built Optical Coherence Tomogrophy (OCT) system according to a previously published 
method (169). Briefly, OCT generated images (laser wavelength interference patterns) 
were taken at random sites of 3 different films, with 3 images taken of each film. Image J 
analysis software was then used to determine thickness using the line draw tool and 
adjusted using a pre-determined pixel: actual length factor. 
 
Stiffness was measured using a BOSE ElectroForce 3200 system as in section 2.4.2. Prior 
to testing, samples were cut to 22 x 5 mm ribbons and placed into the grips, with 10 mm of 
the polymer in each grip, leaving a 2mm initial sample length.  
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Cell Attachment 
Following preparation PHBHHx films were immersed in 3mL media containing 3 x 10
4
 
cells/ml in non-adherent, 6 well plates (Costar, UK). After 24 hrs incubation in either 21% 
O2 or 2% O2, films were removed from the dishes, gently washed in PBS, placed in a 15ml 
centrifuge tube and immersed in pre-warmed Trypsin/EDTA (Lonza, UK) for 5 minutes, 
before quenching with excess media and removing the film. The surface of the non-
adherent dish was also washed once with PBS, exposed to 1 ml Trypsin/EDTA for 5 
minutes, before quenching with excess media. After centrifugation cell pellets were re-
suspended and cell counts established from both film and non-adherent well by 
haemocytometer counts of trypan blue (Sigma Aldrich, UK) positive and negative cells 
gained. A control group where cells were seeded into wells containing no polymer film 
was also performed. The combined film and well cell counts were treated as 100% and 
used to establish percentage attachment. Sample cell counts were corroborated by a 
second, blinded observer experienced in cell culture methods. 
 
Cell Migration 
Cell migration was measured by labeling cells with DiO (Vybrant Multicolor Cell Labeling 
Kit, Invitrogen, UK) and inoculating them as described earlier onto 2% PHBHHx films. 
These were then incubated in a 21% O2 or 2% O2 incubator for 24 or 72 hours, after which 
time the media was removed, the well washed with PBS, fixed with 4% paraformaldehyde 
(Sigma Alrich, UK) for 5 minutes, and then re-immersed in PBS. Confocal microscopy 
(Olympus Fluoview, Olympus IX71) was performed to determine if cells had migrated into 
polymer films, by creating a ‘z-stack’ representation of the polymer cross section, giving a 
fluorescent signal where cells are located and allowing for a plane of reference to be made 
from the images. 
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Statistical analysis 
Results were deemed to be significant if P≤0.05, or as indicated in figure legends using a 
2-tailed, paired, Students t-test using Microsoft Excel 2010 software. 
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3. 3. RESULTS 
Cell Isolation. 
Tendon Explant 
Tendon samples were isolated from the Achilles region of 6 male wistar rats. After 
mincing, tendon tissue pieces were allowed to stick to a tissue culture plastic surface for 1 
hour before media was added. After 3 days, light microscopy found that a ring of 
extracellular matrix had formed around the tendon sample (Fig. 3.1). After 6 days, cells 
had migrated from the tissue sample out onto the culture plastic, with dense areas of cells 
immediately surrounding the sample, and migration evident in areas further away. Passage 
0 (P0) cells were small and spindle like in morphology, with contact inhibition preventing 
complete confluence. Cells had retained the spindle like morphology through to P4, but 
cells were found to be larger than P0 examples (Fig. 3.1).  
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Figure 3.1. Cells migrate from rat tendon samples in 21% O2. Day 2: ECM seen forming a surrounding 
layer on tissue culture plastic (area highlighted between dotted lines). Day 6: cells start to migrate from 
tissue to flask. Passage (P) 0: cells appear spindle like in shape. P4: cells retain spindle like qualities, 
but appear to gain in size (not quantified). Images at 100x, scale bar = 100µm. T identifies the original 
tendon piece.  
 
 
 
 
 
 
 
 
 
 
Alexander Lomas PhD Thesis Chapter 3 PHBHHx Compatability 
95 
 
Rat tenocyte isolation was attempted in both 21 and 2% O2 atmosphere incubators. No 
evidence of cellular migration from tissue samples was observed in 2% O2 atmosphere 
after 12 days culture (Fig. 3.2). When left for longer periods, cells were still not seen 
migrating from tendon samples (data not shown).  
 
 
Figure 3.2. Cells do not migrate from rat tendon in 2% O2 atmosphere. Phase contrast images of cells 
at 100x magnification. Cells are clearly seen migrating from tendon samples in 21% O2 after 6 days, 
with cells being confluent after 12 days. No cells are seen migrating from tendon at any time point in 
2% O2. Images at 100x, scale bar = 100µm. T identifies the original tendon piece.  
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Tenocyte Characterization 
Immunofluorescence was used to determine if the cells isolated from the tendon tissue 
pieces expressed Tenomodulin (a tendon specific gene(160)) . Cells were found to express 
tenomodulin at P1, indicating cells were tenocytes. 
 
Figure 3.3. Cells isolated from rat tendon express tenomodulin. Nucleus stained blue with DAPI, 
TNMD stained green with FITC conjugated antibodies. Cells were imaged using fluorescence 
microscopy, at 200x magnification. Scale bar = 100µm. 
Tenocyte phenotype over passage 
Cells were visualized over prolonged culture via light microscopy. P0 cells were spindle-
like in shape and small, with confluence being reached when cellular contact was achieved. 
Morphological changes were apparent with continued culture such that P4 cells were 51% 
larger than those at P0, but retained their elongated, spindle like morphology, as 
demonstrated by similar length: width ratios. P8 cells had adopted a cobblestone, square 
appearance, with a length: width ratio of 1.7, losing the spindle like processes which 
characterized those earlier passage cells (Fig 3.4). 
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Figure 3.4. Rat tenocytes change morphology with increased passage in 21% O2. P0 cells appear 
spindle like and small. P4 cells retain spindle morphology, but become larger. P8 cells appear 
cobblestone like. Images at 100x in the centre of culture vessels. Scale bar = 100µm. Cell length and 
width were quantified using ImageJ software using the line draw tool. Cells were measured along the 
longest axis and perpendicular to the longest axis. Table shows mean ± 1SD, from 3 images, 12 cells 
measured per image. 
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Normoxic vs. hypoxic tenocyte culture 
 
Tenocytes are found in an area of the body with low physiological oxygen tension (86). 
Cells were cultured in both hypoxic (2% O2) and normoxic (21% O2) conditions over 10 
days, with cell counts performed throughout after cells were isolated in 21% O2. After 5 
days cells were found to have proliferated significantly more (p = 0.01) in 2% O2 
compared to 21% O2, however a difference was not seen at 10 days (p = 0.45). The 21% 
O2 group was found to increase linearly where the 2% group saw a faster rate of growth in 
the first 5 days, then a slower rate over the subsequent 5 days (Fig. 3.6). 
 
 
Figure 3.5. Rat tenocytes expand faster in 2% O2 over 5 days culture, with no difference seen after 10 
days. Cells were enzymatically removed from scaffolds and counted using a heamocytometer. Average  
± 1SD shown on graph, n = 3. * indicates significant difference (p ≤ 0.05).  
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MSC characterization 
MSCs were isolated from human bone marrow aspirate using adhesion culture methods. P1 
MSCs were characterized using immunofluorescence. Positive stains for HCAM, STRO-1, 
and THY-1 demonstrated cells were mesenchymal stem cell like (Fig. 3.6) 
 
Figure 3.6. hMSC characterization. Positive expression of HCAM, STRO-1 and THY-1 demonstrate 
cells are mesenchymal stem cells. Images taken using fluorescent microscopy with TRITC and FITC 
filters, 100x magnification. Scale bar = 100µm. 
 
Polymer film characterization 
Films were first characterized by determination of both thickness and stiffness. Thickness 
was determined by producing wavelength interference patterns of films using an in-house 
built OCT system, with further analysis performed using the line draw tool in Image J 
analysis software (Fig. 3.7). The thickness of polymer films correlated directly with the 
initial polymer input (R
2
 = 0.947) where 0.8% wt/vol films had an average thickness 0.10 ± 
0.009 mm while the 2.4% wt/vol films had a measured thickness of 0.19 ± 0.018 mm (Fig. 
3.8.A). We next sought to determine the stiffness of the polymer films examined above. 
Stiffness was determined with mechanical testing with the Bose ElectroForce 3200 system 
as described in Materials and Methods 2.4.2. The calculated stiffness (resistance to 
elongation) values ranged from 153 ± 42 N/m (0.8%wt/vol PHBHHx) to 1706 ± 371 N/m 
(2.4% wt/vol PHBHHx). A biphasic increase in stiffness was observed between ≤1.6% 
wt/vol (N/m = 135.24*wt/vol, R
2
 = 0.9605) and >1.6% wt/vol (N/m = 570*wt/vol, R
2
 = 
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0.9657) A significant increase in stiffness was observed between films ≥ 2% wt/vol when 
compared to ≤ 1.6% wt/vol (p ≤ 0.024) (Fig. 3.8.B).  
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Figure 3.7. Thickness of films varies with increased wt% of PHBHHx. OCT interference patterns of 
PHBHHx films of 0.8, 1.2, 1.6, 2.0 and 2.4 wt%. Images were generated by measuring reflections of 
light from below the surface of the polymer sample. Images were then analyzed using image J 
software, taking an average thickness from 9 randomly chosen sites. Scale bar added using image J, = 
0.1mm. 
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Figure 3.8. Characterisation of PHBHHx films. A: Optical Coherance Tomography and Image J 
software analysis were used to determine PHBHHx film thickness. Average ± 1SD shown on graph, n = 
9. B: PHBHHX film stiffness was measured with the BOSE ElectoForce 3200 system. Average ± 1 SD 
shown on graph, n = 3. * indicates significant increase compared to ≤ 1.6% wt/vol PHBHHx. Trend 
lines (line of best fit) are indicated by hatched red lines. 
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Cellular attachment 
Rat tenocytes seeded onto PHBHHx films in 21% O2 displayed a significant increase in 
film-adherence between 0.8% wt/vol (3.87 x10
4
 ± 2.73 x10
4
 cells/film) and ≤2.0% wt/vol 
(≤9.47 ± 4.46 cells/film, p ≤ 0.02) (Fig.3.9.A). Similarly the percentage of cells attached to 
the film in relation to the overall number of cells in each demonstrated a significant 
increase between 0.8% wt/vol (19.36 ± 4.98%) and ≤ 1.6% wt/vol (≤68.38 ± 7.31%, p ≤ 
0.02) (Fig. 3.9.B). The use of physiological oxygen (2% O2) in RaT PHBBHx film 
adherence and percentage attachment studies yielded similar results to above. Significant 
increases in adherence were noted between films of 0.8% wt/vol and 1.6% wt/vol (0.87 ± 
0.42 x10
4 
vs.8.67 ± 3.84 – 13.73 ± 5.36 x104, p ≤ 0.05) (Fig. 3.9.A), demonstrating that 
RaT cells displayed greater adherence to substrates with a stiffness ≥ 420 N/m. Significant 
increases in percentage cell attachment were also noted between films of 0.8% wt/vol 
(34.37 ± 8.27%) and ≤1.6% wt/vol (≤84.36 ± 3.98%, p ≤ 0.01) (Figure 3.9.B). Direct 
comparison of attachment profiles in 21% O2 and 2% O2 revealed a significant increase in 
cell attachment to 1.6% wt/vol films in 2% O2 vs. 21% O2 (p = 0.05) (Fig. 3.9.B).  
 
hMSC adherence to PHBHHx films with varying weight/volume ratios was relatively 
consistent in 21% O2 across all films tested though a significant increase was noted 
between films of 1.2% wt/vol (5.33 ± 1.15 x10
4
 cells/film) and 2% wt/vol (8.66 ± 2.33 
x10
4
 cells/film) (p = 0.04) (Fig. 3.9.C). When expressed as a percentage of total cells 
present in the dish (film and well) considerable variability was noted. Non-significant 
increases in cell attachment were noted between 1.2% wt/vol (19.7 ± 8.4%) and 2% wt/vol 
(61.1 ± 22.9%) (p = 0.059) (Fig. 3.9.D), suggesting that hMSCs require a stiffer substrate 
than RaT cells for optimal attachment. Reducing atmospheric oxygen to 2% O2 created a 
non-significant rise in cellular attachment between 0.8% wt/vol (0.73 ± 0.41 x10
4
) and 
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1.2% wt/vol (1.0 ± 0.53 x10
4
) (p = 0.63) (Fig. 3.9.C). Little variation was seen between 
films where wt/vol ≥ 1.2%. When expressing values as a percentage of total cells present, 
non-significant increases were seen between 0.8 % wt/vol (28.7 ± 11.8%) and 1.2% wt/vol 
(53.8 ± 9.7%). However a significant increase is observed when 0.8% wt/vol (28.7 ± 
11.8%) and 2.4% wt/vol (77.1 ± 20.6%) (p = 0.03) (Fig. 3.9.D) are compared. Taken 
together this indicated that hMSC cultured in physiological oxygen display an adherence 
preference for PHBHHx films with stiffness of 240 N/m (vs. 1220 N/m in 21% O2). 
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Figure 3.9. Cell attachment to PHBHHx film after 24 hours. A: Number of tenocytes attached to 
PHBHHx films of varying % wt/vol polymer concentration. B: Tenocyte attachment to films of varying 
% wt/vol polymer concentration as a percentage of total cell number in the well. C: Number of hMSCs 
attached to varying % wt/vol concentration of polymer. D: hMSCs attachment to films of varying % 
wt/vol polymer concentration as a percentage of total cell number in the well. Axes are as labeled, 
error bars indicate one standard deviation, * indicates p≤0.05, ** p≤0.02, *** p≤0.01 vs. ≤0.8% wt/vol 
PHBHHx or as indicated. 
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Cellular Migration 
Results so far demonstrate that both MSCs and RaTs adhere to PHBHHx films, with 
higher stiffness films demonstrating significantly higher MSC and RaT adherence when 
compared to less stiff films. Our final investigation was intended to determine if cells 
rapidly migrated into PHBHHx films. As previous observations suggested high MSC and 
RaT adherence to a 2% PHBHHx film, this concentration was used throughout. No 
tenocyte or MSC migration was observed into the polymer film after 24 or 72 hours in 
either O2 concentration in x-z or y-z directions, as shown by the centre of the green 
fluorescent signals on the side images being aligned, indicating that cells remained on the 
film surface (Fig. 3.10). Substantial spreading across the surface of the PHBHHx was 
apparent after 72 hrs indicating biocompatibility with tenocytes and hMSCs (Figure 3.10 
F). 
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Figure 3.10. Representative images showing surface and cross section views through PHBHHx films 
gained using confocal microscopy. Cells pre stained with DiO tracking die, appear as a fluorescent 
signal. A: RaT 21% O2, 24 hours. B: RaT 21% O2, 72 hours. C: hMSCs 21% O2 24 hours. D: hMSCs 
21% O2 72 hours.  E: RaT 2% O2, 24 hours. F: RaT 2% O2, 72 hours. G: hMSCs 2% O2 24 hours. H: 
hMSCs 2% O2 72 hours. x-y indicates surface view, x-z and y-z indicate reconstructed cross section 
views through the polymer. Images at 100x magnification, scale bar = 100µm. 
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3. 4. DISCUSSION 
This study demonstrates for the first time that tenocytes will adhere to and spread across 
PHBHHx polymer films with a preferred rigidity of >420N/m. This supports the assertion 
of PHBHHx as a candidate material for tendon tissue engineering and adds to the body of 
literature supporting the biocompatibility of PHBHHx. 
 
PHBHHx has been previously used to culture mesenchymal stem cells, with 
hMSCs(144)and Adipose derived MSCs (147) being found to adhere to polymer scaffolds 
in previous studies. Investigation into RaT attachment to PHBHHx films as a total of all 
cells present in the well demonstrates that when wt/vol ratios of ≥ 1.6% were used a high 
number of cells adhered to the film in preference to the untreated plastic surface. This can 
in some part be explained by the increase in stiffness of the polymer film between 1.6% 
and 2.0% wt/vol. In other words increased polymer rigidity promoted increased tenocyte 
adhesion. This reinforces a number of previous studies which have demonstrated that 
material stiffness effects cellular behavior in many ways, including adhesion (173,174). 
hMSC have previously been shown to adhere to PHBHHx and many other different 
surfaces with differing mechanical properties (124),(143),(175), explaining why little 
difference was found between polymer concentrations. As cell fate was not investigated in 
this study it is not known what, if any, effect on differentiation potency this had. Ongoing 
3-D tissue engineering experimentation will address these questions. 
 
Tendon has a poor vascularization and a low mean oxygen concentration (176). We 
therefore performed our investigation in both room oxygen (21% O2) and tendon tissue 
normoxia (2% O2). Studies looking the effects of different oxygen concentrations on cells 
have also demonstrated many functional changes in numerous cell types including hMSCs 
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(70),(71),(85),(177),(178). When comparing 2% O2 with 21% O2 only small differences 
were found between cell number or percentage attachment at the same PHBHHx 
concentration for either cell type. A non-significant increase was observed in tenocytes (≥ 
1.6% wt/vol) in 21% O2 over 2% O2, however this was not significant. For reasons we do 
not fully understand we observed large standard deviations in a number of 2% O2 sample 
groups, which could be contributing to this. It should be noted that little difference in the 
percentage of cells attached to the polymer were observed between the differing oxygen 
conditions, demonstrating that oxygen tension was not affecting cellular attachment to the 
films per se but that rather reducing the population of cells available for attachment. 
hMSCs were generally noted to adhere better in hypoxic conditions to all polymer film 
compositions, however no significant rises were found, possibly due to large inter-group 
deviations. To our knowledge, this is the first study looking into the in vitro effects of 
oxygen tension on the interaction of primary mammalian cells with polyhydroxyalkanoate 
scaffolds. 
 
Migration into the polymer surface indicated that cells remained on the surface of the 
polymer as opposed to migrating into it, suggesting localized polymer degradation had not 
occurred. This observation is reinforced by reports stating that PHBHHx is broken down in 
vivo (179) and in vitro (180) at very slow rates via hydrolysis.  
 
During the early stages of the healing process of damaged tendon in vivo, extra cellular 
matrix secretions have been seen originating from the two damaged ends of the tissue. This 
ECM was found to contain high concentrations of collagens I and III, and was thus 
designated “tendon gel” by the author (38). The discovery of ‘tendon gel’ agrees with the 
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findings of our study, with an ECM prelayer being seen emerging from the tendon samples 
during explant culture onto which the cells started to migrate after a further few days.  
 
Hypoxic atmosphere (1 – 3% O2) conditions have been found to be beneficial to cells, 
delaying senescence and increasing proliferative capacity (72). Mesenchymal stem cells 
have been shown to have higher proliferation (30 fold increase) in 2% O2 compared to 
21% O2 (170). Human embryonic stem cell colonies have been found to be less heterogenic 
and have a more stable self-renewal capacity when cultured in 2% O2 (85). Tendon derived 
stem cells have also been found to proliferate faster at 2% O2 compared to atmospheric 
conditions (86). This study has demonstrated that tenocytes proliferate faster during the 
first stages of culture in 2%, but that this difference was not maintained over a longer 
culture period. It was also noted that cells did not migrate from tendon tissue samples in 
2% O2, leading to the conclusion that tenocyte isolation via explant requires higher than 
physiological oxygen levels to occur. 
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3. 5. CONCLUSION.  
This investigation demonstrates that tenocytes and hMSCs can adhere to and spread across 
PHBHHx films over 24 and 72 hour time periods. Film scaffolds fabricated with ≥1.6% 
wt/vol polymer/solvent, with a stiffness ≥ 420 N/m are the most effective in supporting this 
activity with RaT cells, however hMSCs displayed a capacity for adhesion to all polymer 
films of stiffness ≥ 240 N/m. However, other uninvestigated properties of the films could 
also be contributing to the greater cellular adhesion, such as wettability, porosity or 
localized surface chemistry. Physiological normoxia (2%O2) increased hMSC adhesion to 
most PHBHHx films, however no significant differences were seen due to large intergroup 
variation and little effect was observed on RaT cell adhesion. PHBHHx can now be 
considered to be a potential material for use in future tendon tissue engineering application.  
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Chapter 4. 
 
Design of a 
PHBHHx/collagen hybrid 
scaffold for tissue 
engineering applications. 
  
Alexander Lomas PhD Thesis Chapter 4 Scaffold Design 
113 
 
4.1. INTRODUCTION. 
Many different materials have been investigated as possible tissue engineering scaffolds. 
These include natural materials, such as collagen (130) and silks (132) (133) or 
manufactured materials such as polymers (142). A current focus for clinical application is 
on blending these materials to form a hybrid design to both encourage cellular in-growth 
and provide mechanical support during the remodelling stage of tissue recovery (12) (181). 
PHBHHx has great potential as a material for in vitro tissue engineering owing to its 
adaptable mechanical properties, biodegradability and apparent compatibility with many 
different mesenchymal cell types including rabbit bone marrow derived MSC (143), 
human adipose derived stem cells, human keratinocytes (145) mouse fibroblasts  (146) and 
rat peripheral nerve cells (148), rat tenocytes and human MSCs (182). 
Collagen is a major structural component of many different extracellular matrices. Tissue 
collagen composition varies according to function. The dry weight of articular cartilage 
matrix can contain 75 and 80% type II collagen depending on its position in the joint, 
allowing it to resist the high compression forces found in areas such as joints and 
intervertebral disks (183). Tendon and ligament dry weight matrices can contain 
approximately 90% type I collagen arranged in hierarchical fibrils to accommodate high 
tensional forces (176). Several collagen types (I, III, IV) vary with increased skeletal 
muscle activity, for example prolonged intense exercise can increasing the abundance of 
type IV collagen (184), whereas bone contains high amounts of collagens I and III 
allowing for bones to be slightly flexible during movement (185). Due to its abundance 
and prevalence collagen is viewed as an appropriate scaffold material, especially in 
orthopedic tissue engineering due to the wide-scope of potential applications and 
complementary clinical trial data (186). 
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Adult tissues contain multiple cell types; however dominant cell types are found within 
individual tissues. Tenocytes account for over 90% of the cellular mass of a tendon and are 
responsible for maintaining the collagen based extracellular matrix that forms the tendon 
structure (25). Cartilage has a similar percentage of chondrocytes that are again responsible 
for extracellular matrix maintenance (187). Bone has two main cell types responsible for 
maintaining extracellular matrix, osteoclasts which secrete molecules to break down 
calcified tissue and osteoblasts which are responsible for rebuilding it (188). Skeletal 
muscle cells differ from previous examples in that they play a larger role in tissue 
contractile function rather than extracellular matrix production (92). However, fully 
differentiated cells can be unsuitable for tissue engineering applications due to their limited 
proliferation capacity when cultured in vitro, so exploration of other less differentiated 
cells has become widespread (189) (190) (191). 
MSCs are a useful cell source for tissue engineering as they can be easily sourced, isolated 
and cultured in vitro (192). Exposure of MSCs to tensile forces and/or growth factor 
supplementation is described as producing cells that resemble connective tissue cells in 
expression marker profile and physiological activity (53) (65) (39) (53) (65) (92). 
Pluripotent human embryonic stem cells (hESC), derived from the inner cell mass of pre-
implantation blastocysts are also strong candidates for tissue engineering application (119). 
They are the precursor to almost all adult tissues in the body, including the mesenchyme 
layer of cells and thus tendon- (193), cartilage- (194)(195) and bone-like cells (190) have 
all been derived during in vitro and in vivo differentiation. hESCs are relatively readily 
available and could potentially be used to produce an allogeneic “off the shelf” cellular 
product following on from current safety trials underway in the UK and the USA. 
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Here we sought to determine the suitability of PHBHHx and collagen hybrid constructs for 
use with hESC, spontaneously-differentiated hESC (SDhESC), and hMSC with a view to 
creating a tissue engineered product.  
 
 
4.2. MATERIALS AND METHODS. 
 
4.2.1. PHBHHx scaffold preparation and characterisation:  
PHBHHx tubes were made according to section 2.3.3 and made porous by using the 
method outlined in section 2.3.4. Before experimental use scaffolds were sterilised with 
immersion in 70% IMS followed by 24 hours UV light exposure. Immediately prior to use, 
scaffolds were immersed in cell specific media for 1 hour. Characterisation of scaffolds 
was carried out using electron microscopy and image analysis as outlined in sections 2.6.2 
and 2.6.3.  
Collagen Scaffolds were formed by using method 2.3.5. Gels were injected into the 
casting apparatus and set via temperature elevation to 37
o
C for 2 hours. Gels were 
formulated to either 1.5 mg/mL or 3 mg/mL final collagen concentrations. Measurements 
of tube length and diameter after cell seeding were taken at days 0, 5, 10, 15 and 20. 
 PHBHHx/Collagen hybrid scaffolds were created by injecting 1.5 mg/mL or 3mg/mL 
collagen gel (as described previously) seeded with hESC, SDhESC or hMSC at a 1x10
4 
cells/mL concentration into the lumen of the PHBHHx tube before incubation at 37
o
C for 2 
hours. After incubation, constructs were transferred to 6-well plates and immersed in 3 mL 
cell-specific complete media (2.2).  
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Figure 4.1. Production of PHBHHx/collagen hybrid scaffolds. Cells are suspended in a neutralised 
collagen gel then quickly injected into a pre prepared PHBHHx tube lumen. Gels were then allowed to 
set via temperature regulation (37
o
C for 2 hours) before immersion in complete, cell specific media 
placed in static culture. 
4.2.2. Collagen gel contraction 
Collagen gels were made as previously described in section 2.3.5 at final collagen 
concentrations of 1.5 or 3 mg/mL. hMSCs, SDhESCs and HESCs were seeded into 
collagen gels at either 1x10
3
, 1x10
4
 or 1x10
5
 cells/mL, as section 2.3.6.  With gels 
solidifying at 37
o
C for 1.5 hours, before immersion in complete, cell specific media. 
Measurements of gel length and diameter were made at 0, 5 10 and 20 days, with the zero 
time point being before media immersion. Measurements were made using sterile callipers, 
with measurements being taken at both ends and the centre point of the gel, with an 
average being taken as section 2.4.2.  
4.2.3. PHBHHx tube pore size and density 
Pore size was quantified by taking 1mm
2
 areas of electron microscope images and 
analysing with Image J software. Random areas were taken, with each pore measured 
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along its longest length using the line draw tool, giving a value of pixels for each pore. 
This was then adjusted using the appropriate scaling factor to convert to millimetres. Pore 
density was measured by taking 1mm
2
 areas of electron microscope images and analysing 
using the grid and counter tools in Image J software. The grid was overlaid over the 
original image, and all visible pores counted. Pores were defined as being areas of the 
surface that were not uniform with the surrounding area, i.e., any indent that could be seen. 
4.2.3. Cell Culture. 
hMSCs were isolated from human bone marrow using adherence culture as described in 
section 2.2.3. Culture media was changed twice weekly and cells passaged at 90% 
confluency using method 2.2.1.b. according to 1:2 split ratios.  
hESC: SHEF1 were cultured in feeder free conditions according to the methodology 
outlined in section 2.2.4 using media pre conditioned by mouse embryonic fibroblasts 
(MEF). During expansion hESC media was changed daily and cells were split 1:2 at 90% 
confluency with fresh Trypsin/EDTA dissociation for <1 minute. Centrifugation and 
passage regimes are as described for hMSC. 
Spontaneous Differentiation of hESC: hESC (SHEF1) were seeded into Matrigel-coated 
T-75 flasks at fixed densities (1 x10
6
 per flask)
 
in conditioned hESC media. Spontaneous 
differentiation was induced using protocol 2.2.4.e. 
Cell Viability: Cell viability was determined with the trypan blue dye exclusion assay 
(Sigma Aldrich) according to the method outlined in 2.2.1.f. 
4.2.4. Cellular positioning and viability. 
The position and spread of cells was found by fluorescence microscopy. Gels were 
removed from the tubes, dissected longitudinally down the centre with a scalpel blade and 
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placed cut side down on a well plate. A fluorescent live dead stain was then performed 
using protocol 2.2.1.g and images taken using a Nikon microscope (section 2.8.5), with 
representative images taken of the edge and centre of the gel. Image J analysis was then 
used to count viable (green) and non-viable (red) cells, gaining a percentage of viable cells 
at the centre and edge of the gel.   
4.2.5. Osteogenesis. 
Osteogenic differentiation was induced by the use of osteogenic differentiation media 
(DMEM, 10% FBS, l-glut, NEAA, 0.1µM Dexamethasone, 10mM β- Glycerophosphate) 
(196). Cells were suspended in constructs and cultured in static culture for a maximum of 
20 days, with sampling at days 0, 5, 10 and 20. A control of standard MSC media was run 
concurrently. At each time point, gels were removed from tubes, immersed in 0.4% type 
IV collagenase for 1 hour at 37
o
C, pelleted and resuspended in lysis buffer, after which 
molecular characterisation was performed. 
4.2.6. Molecular characterisation 
RNA isolation, Reverse transcriptase polymerase chain reaction and electrophoresis were 
performed using the methods described in section 2.4.3. Primers investigated were BACT 
(housekeeping), SOX9 (cartilage), RUNX2 (bone), TNMD (tendon) and PPARγ (adipose).  
4.2.6. Statistical analysis 
Differences between groups were analysed by one-way ANOVA with Post-hoc Tukey’s 
Multiple Comparison analysis. A ‘p’ value less than 0.05 was considered to indicate 
statistical significance. Data are presented as mean ± standard deviation (SD). 
 
Alexander Lomas PhD Thesis Chapter 4 Scaffold Design 
119 
 
4.3. RESULTS. 
4.3.1. Collagen Gel Contraction 
We first sought to determine the maximal cell seeding density of hESC, hMSC, and 
SDhESC into collagen gel tubes at which contraction would not occur and cell viability 
was maintained. hESCs did not contract collagen gels at any collagen concentration or cell 
density combination explored over a 20 day time (Fig. 4.2 A, D, G, J). Unlike the parental 
hESC, SDhESCs with an initial cell seeding density of 1 x 10
5
 cells/mL contracted 1.5 
mg/mL collagen gel length and diameter after 10 days (1.63 ± 0.15 cm vs. 2.43 ± 0.06 cm, 
p = 0.02) (Fig. 4.2 B). Contraction continued progressively at days 15 (1.46 ± 0.25cm vs. 
2.24 ± 0.06 cm, p = 0.04) and 20 (0.87 ± 0.31 vs. 2.37 ± 0.15 cm, p = 0.02). Gel diameter 
contracted across these time points (p ≤ 0.03) (Fig. 4.2 E). SDhESC did not contract 3 
mg/mL gel length or diameter irrespective of initial cell seeding density (Fig. 4.2 H, K). 
hMSCs contracted both the length (1.26 ± 0.07 cm vs. 2.93 ± 0.05 cm, p=0.002) and 
diameters (0.23 cm ± 0.03 cm vs. 0.46 cm ± 0.06 cm ± , p = 0.035) of 1.5 mg/mL collagen 
gels after 10 days with an initial seeding density of 1 x 10
5
 cells/mL (Fig. 4.2C, F). 
Continued contraction was also apparent for both gel length and diameter at days 15 (p = 
0.02) and 20 (p = 0.002). Gel diameter also significantly reduced at these time points (p ≤ 
0.02). Where initial cell seeding densities of ≤1 x 104 cells/mL were used no significant 
collagen gel contraction was observed (Fig. 4.2C, F). hMSCs did not contract 3 mg/mL 
collagen gels (Fig. 4.2 I, L).  
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Figure. 4.2. Collagen gel contraction is dependent on both collagen concentration and cell 
concentration. A, D. 1.5 mg/mL gels do not contract when seeded with hESCs. B, E. significant 
contraction in both length and diameter seen after 10 days culture in 1.5 mg/mL gels seed with 1 x10
5
 
SDhESCs/mL. C, F. significant contraction in both length and diameter seen after 10 days culture in 
1.5 mg/mL gels seed with 1 x10
5
 hMSCs/mL. G, J. 3 mg/mL gels do not contract when seeded with 
hESCs. H, K. 3 mg/mL gels do not contract when seeded with SDhESCs. I, L. 3 mg/mL gels do not 
contract when seeded with hMSCs. Graphs show mean ± 1SD, n = 3. Significance determined using 
one way ANOVA and Tukeys post hoc analysis, p ≤ 0.05. 
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4.3.2. PHBHHx Tube Pore Characterisation 
PHBHHx tubes were manufactured to contain salt crystals that could be leached out to 
generate pores distributed across and within the tube structure. Analysis determined that 
pores had an average diameter of 0.025 ± 0.019 mm (n = 330) at a density of 68.6 ± 10.55 
pores/mm
2
 (n = 5) (Fig. 4.3). The majority of pores had a diameter of ≤ 0.04 mm [89.1 % 
(294/330)] while 33.0% had diameters in the range of 0.02 mm ≥ 0.03 mm, and. 1.5% 
(5/330) of pores had diameters ≥ 0.1 mm. 
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Figure 4.3. PHBHHx tube pore size determination. A: PHBHHx tube structure at 50x magnification. 
B: Representative tube section at 200x with line measurement indicators showing pore diameter. C: 
Pore diameter histogram. Measurements were taken from random 1 mm
2
 regions of polymer tube 
(n=5, total number of counted pores = 330). Error bars indicate one standard deviation.  
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4.3.3. Cell Viability in Collagen Gels 
Subsequent analysis of hESC cell viability at day 20 demonstrated that with 1.5 mg/mL 
gels ≤ 8.4 ± 7.5 % of cells remained viable (Fig. 4.4 A) and in 3 mg/mL gels ≤ 1.4 ± 2.4 % 
cells were viable (Fig. 4.5 B). SDhESC viability after 20 days was determined as ≥ 48.6 ± 
6.8% in 1.5 mg/mL gels (Fig. 4.4 A) and ≥ 52.3 ± 6.6 % in 3 mg/mL gels (Fig. 4.4 B) for 
all cell densities. hMSC viability after a 20-day incubation period within collagen gels was 
≥ 78 ± 6.3 % in 1.5 mg/mL (Fig. 4.4 A) and ≥ 89 ± 8.5% in 3 mg/mL (Fig 4.4 B) gels at all 
cell densities tested. 
 
 
 
Figure. 4.4. hMSC and SDhESC retain high viability levels after 20 days collagen gel suspension. % of 
trypan blue negative cells found as a total of all cells. A: cells seeded in 1.5 mg/mL collagen gels. B: 
cells seeded in 3 mg/mL collagen gels. Graph shows mean ± 1 standard deviation, n = 3.  
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4.3.4. Viability in PHBHHx/Collagen hybrid scaffolds 
PHBHHx/collagen/cell scaffolds were immersed in culture medium and maintained over a 
20 day period before cell removal by enzymatic digestion. hMSCs retained high viability, 
87.7 ± 4.6% after 20 days in culture (Fig. 4.5). SDhESCs displayed lower viability, with 
46.2 ± 16.1% viable after 20 days in culture when compared to hMSC. These values are 
broadly similar to those obtained following on from incubation in collagen gels alone 
indicating that the porous PHBHHx scaffold had little impact on cell viability.  
 
 
Figure 4.5. hMSC and SDhESC retain viability after 20 days in a PHBHHx/Collagen gel hybrid 
scaffold. An initial seeding density of 1 x 10
4
 cells/mL was evaluated for viability with Trypan Blue 
staining after 20 days. % of viable (trypan blue negative) cells shown, (n = 5). Error bars indicate one 
standard deviation. 
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4.3.5. Cell positioning 
Positioning in gels was monitored by removing gels from constructs, transversely slicing 
and imaging at representative areas of the edge and centre using fluorescence microscopy. 
Day 0 images were taken immediately after gelation. Cells were evenly spread throughout 
the gel, with high viability seen. At day 5 cells had become more fibroblastic in shape, 
becoming more elongated compared to day 0. Day 10 cells were again evenly spread 
throughout the gel, with more non-viable cells seen than on previous days. Cells at day 20 
were found to be evenly spread and viable at both the centre and edge of the gel (Fig.4.6).   
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Figure 4.6. hMSCs spread throughout the gel throughout 20 days culture. Gels were removed intact 
from PHBHHx tubes, sliced transversely in half and images taken using a live dead fluorescence assay 
in representative areas of the edge and centre of gels, using fluorescence microscopy. Images at 100x, 
scale bar = 100µm. 
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Image analysis was performed using image J software, using the counter tool. Viability at 
day 0 was found to be 91.1 ± 2.5 % in the centre and 88.3 ± 2.3 % at the edge. Day 5 
viability was found to have dropped to 79.2 ± 1.9% and 74.9 ± 5.2% at the centre and edge 
respectively, with a larger drop observed at day 10 at the edge of the gel compared to the 
centre (58.6 ± 0.7% vs. 76.2 ± 4.1%). Day 20 viability was found to be similar in both 
locations (71.9 ± 2.7% centre, 74.3 ± 2.0% edge) (Fig. 4.7). 
 
 
 
Fig. 4.7. Viability of hMSCs at the centre and edge of gels removed from PHBHHx tubes over time. 
Gels were removed, transversely sectioned, stained and imaged using fluorescence microscopy, before 
image analysis using image J software. Graph shows mean ± 1SD, n =3.  
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4.3.6. Molecular characterisation 
We finally sought to determine if the PHBHHx/Collagen hybrid scaffold played a role in 
directing spontaneous differentiation of hMSC or SDhESC into select musculoskeletal 
lineages. SOX-9 expression was maintained until Day 10 but lost thereafter whereas 
RUNX2 expression was rapidly lost in hMSC (Fig. 4.8.A). SOX-9 expression was again 
maintained until Day 10 but lost thereafter while RUNX2 expression was not detected at 
any time point in SDhESC (Fig. 4.8.A). BACT was included as a loading control. We were 
unable to detect expression of either PPARγ or TNMD in experimental samples indicating 
the absence of differentiation into either adipose or tendon lineages.  
4.3.7. Induced differentiation 
As a proof of concept and confirmation that differentiation can be achieved in stem cells in 
the construct, osteogenesis, chondrogenesis and adipogenesis was induced in hMSCs by 
changing culture media. RT-PCR for the RUNX 2 gene was found to be absent after day 0 
in control media. Osteogenic media prolonged RUNX2 expression throughout 20 days 
culture, although expression was reduced at days 5 and 10 (Fig. 4.8.B.)  
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Figure 4.8. A: hMSC and SDhESC did not undergo spontaneous differentiation after 20 days 
PHBHHx/Collagen gel scaffold encapsulation. RT-PCR-based evaluation of BACT, SOX9, and 
RUNX2 expression levels after 0, 5, 10 or 20 days in construct. Undifferentiated hESC are included as 
control for SDhESC. TNMD used a pre-established positive control. B: Osteogenic media 
supplementation results in RUNX2 being expressed in hMSCs over 20 days in PHBHHx/collagen 
hybrid scaffolds. Scaffolds were immersed in osteogenic media in static culture conditions, with cell 
lysates taken at days 0, 5, 10 and 20 and RT-PCR performed as described previously.  
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4.4. DISCUSSION. 
Tissue engineering and regenerative medicine aim to use scaffolds and cells to regenerate 
and restore function of tissue lost through damage, disease, and disorder. The use of 
PHBHHx has been explored by many labs investigating multiple potential applications 
including cellular interactions and its use as a scaffold in tissue engineering 
)(142),(143),(145),(146),(148),(182). Here we demonstrated the interaction of human 
embryonic and mesenchymal stem cells with collagen gels and PHBHHx/collagen hybrid 
scaffolds using a range of static in vitro experimentation to assess suitability for further 
tissue engineering applications. We show that hMSCs and SDhESCs can be cultured for 
extended periods on PHBHHx/collagen hybrid scaffolds and thereby confirm its suitability 
as a model system.  
The application and suitability of PHBHHx as a scaffold material in orthopaedic models 
and for human and animal stem cell biocompatibility has been described elsewhere (14), 
(36),(38),(182),(122),(197),(114),(180),(34),(35), with bone tissue being formed by rat 
MSCs (197) and cartilage like structures formed by human adipose derived stem cells 
when seeded onto PHBBHx scaffolds (147). We therefore conclude that PHBHHx is a 
suitable material for stem cell based tissue engineering and does not prevent differentiation 
toward the osteogenic lineage when osteogenic supplements are added to media. 
Type I collagen gels supported the differentiation of murine ESCs into either osteogenic or 
chondrogenic lineages when seeded into 2D and 3D 1.2 mg/mL scaffolds. The additional 
presence of lineage specific supplements was found to further increase differentiation 
above that found in control collagen gels, with apparent high cell viability after 15 days in 
culture (198). Human and murine ESC culture in 0.75 mg/mL type I collagen gels has also 
been achieved by pre differentiating cells into embryoid bodies before seeding onto gels 
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and covering with DMEM/F12 media, stimulating differentiation into fibroblast like cells 
over a 21 day period (199). Undifferentiated ESCs were not compatible with our 
PHBHHx/collagen gel hybrid scaffold system. Our study has demonstrated that hESCs 
required a prior spontaneous differentiation step induced by exposure to foetal bovine 
serum prior to collagen gel suspension to shift cell phenotype away from that of a self-
renewing ESC into a partially differentiated heterogeneous population. We found that pre-
differentiated hESC in PHBHHx/collagen gel hybrid scaffolds demonstrate a 40-60% cell 
viability after 20 days continuous static culture. 
Collagen gel contraction by fibroblastic cells is well established (200). This investigation 
sought to find the concentrations of collagen and cells that would not result in large 
collagen contraction over 20 days, potentially allowing for the construct to be implanted 
into a wounded tendon and the gel remain in contact with the damaged tendon ends for as 
long as possible, potentially increasing the probability of tissue integration. Decreasing 
collagen gel concentrations from 2.6 to 1.3 mg/mL was reported as having a greater  
impact on gel contraction kinetics than increasing the rabbit MSC density by the same fold 
increase (500K to 1M cells/mL) (167). Similarly human corneal fibroblasts can contract a 
4.5mg/mL collagen gel over a 25 day static culture period when seeded at a cell 
concentration of 5 x 10
5
 cells/mL, but not 1 x 10
5
 cells/mL (169). These reports correlate 
with our observations where little contraction was observed in the 3 mg/mL groups, and 
the rate of contraction slowed with 1.5 mg/mL gels seeded with lower cell densities. We 
have successfully identified a cell: collagen ratio with very little collagen contraction over 
20 days static culture, yet retain high cell viability in the absence of additional stimuli, for 
application in in vitro studies utilising either hMSCs or SDhESCs. 
SOX-9 is a master regulator of chondrogenic differentiation and is expressed by cells in 
both pre-cartilaginous and mature cartilage tissue (201). A cyclical, compressive 
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mechanical loading regime promotes chondrogenic differentiation of rabbit MSCs as 
demonstrated by increased SOX-9 and collagen II expression (202). We found that in the 
absence of either mechanical or biochemical stimuli SOX-9 expression was lost rapidly in 
hMSC or after approximately 10-days in SDhESC.  
 
Β-actin is frequently used as a housekeeping gene due to its consistent presence as a 
cytoskeletal component of mammalian cells, and is commonly used as a marker of cellular 
viability (203). We noted expression of β-Actin at all-time points which when coupled to 
the high cell viability provides an additional demonstration of viable cell transcriptional 
activity. RUNX2 transcription factor is critical for the promotion of osteogenic 
differentiation (204). A cyclic compressive strain upregulated RUNX2 in MSC seeded 
collagen-alginate gels demonstrated up regulation after 21 days (205). Mouse ESCs 
cultured on collagen I coated flasks displayed little RUNX2 expression change over tissue 
culture plastic after 21 days in static culture, remaining low throughout the 
experiment(206). Similar to our observations with SOX-9 we did not detect noticeable 
upregulation of RUNX2 during our experimental time course in the absence of mechanical 
stimuli.  
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4.5. CONCLUSION 
Herein we have demonstrated that undifferentiated hESCs are not viable after 20 days 
culture within a PHBHHx/Collagen gel hybrid scaffold whereas hMSCs and SDhESCs 
demonstrated good viability over the long term. Gel contraction was negligible with 
collagen concentrations of 3 mg/mL with all cell types at all investigated seeding densities 
over 20 day’s static in vitro culture. We were unable to detect any evidence of spontaneous 
differentiation into fat, bone, cartilage, or tendon lineages in static culture, but osteogenesis 
was achieved using osteogenic media. In summary we have developed a porous 
PHBHHx/Collagen gel hybrid scaffold which features good cell compatibility and an 
absence of spontaneous lineage-forming differentiation cues. This scaffold system is 
readily translatable into dynamic systems and differentiation models across multiple 
lineages.
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Chapter 5 
Mechanical Stress and 
Growth Factors with Cell 
Seeded PHBHHx/Collagen 
Hybrid Scaffolds. 
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5.1. INTRODUCTION. 
Mechanical loading has been used to influence cell/matrix behaviour in many different 
ways. A current hypothesis suggests that for stem cells to take on connective tissue 
morphologies some form of mechanical loading is required (164). Static mechanical force, 
where a load was applied to the construct continuously for a period of time, has been used 
to create neotendinous structures from collagen gels. By applying a constant strain of 50% 
for 24 hours to acellular unstructured collagen before adding a decorin cross linker, a 
structure similar to rat tail tendons could be created (23). More recent studies have 
focussed on evaluating different mechanical stimulation methods. Comparisons between 
static and dynamic mechanical strain (1% strain, 1Hz, 30 minutes/day, 7 days) in MSC 
seeded collagen gels revealed that matrix collagen content, mechanical properties 
(stiffness, maximum tensional load) and scleraxis gene expression (a commonly used 
expression marker associated with embryonic tendon development) were all upregulated in 
dynamic samples (164).  Cyclic strain at frequencies between 0.017 Hz and 1 Hz with 
strains between 2% and 10% elongation applied to collagen based tendon scaffolds  
resulted in increased cellular alignment, up regulation of tendon specific cellular markers 
(Scleraxis, Collagen I, Collagen III) and improved mechanical properties being observed 
(165) (161) (166). It has even been found that very low frequency (0.0034 Hz) low strain 
(2.4%) mechanical stimulation over a long time period (8 hours/day, 12 days) can result in 
increased stiffness in MSC seeded collagen scaffolds compared to static controls (167). 
These studies demonstrate the need for mechanical stimulation when designing materials 
for tendon tissue engineering, but that an ideal loading regime is yet to be found. 
Growth factors are molecules which bind with cells to enable a specific cellular function to 
occur, with the focus in tendon stem cell research being on inducing or maintaining 
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terminal differentiation into tendon specific cells (44). Bone Morphogenic Protein 12 and 
13 (BMP-12/13, also known as GDF(growth differentiation factor)-6/7) are members of 
the Transforming Growth Factor – Beta (TGF-β) superfamily and play important roles in 
matrix synthesis, differentiation, chemotaxis and proliferation (48) (49 )(50). BMP-12/13, 
have also been found to promote ectopic tendon formation and repair (48) (52). Singularly, 
BMP-12 has been reported to induce both in-vitro and in-vivo tenogenesis of MSCs (48) 
(53) (51). BMP-12 and BMP-13 have been found to separately induce increases in 
production of thromobospondin 4 (a specific tendon marker) along with a characteristic 
wave like pattern found in tendon histological samples after 14 days implantation into a rat 
defect model (54). A combination of BMP-12, BMP-13 and vitamin C has also been found 
to induce tenogenesis in hESCs in static physiological O2 (2% O2) culture conditions by 
our research group (in house data). 
Fibroblast growth factors (FGFs) are a group of 23 growth factors which play a vital role in 
limb and organ development during embryogenesis (55) (56). Three members of the FGF 
family have a prominent role in the maintenance of mesenchyme during limb development; 
FGF-4, FGF-6 and FGF-8. FGF-4 has an integral role in early embryonic patterning and 
the maintenance of mesenchyme within the developing embryo (56) (57) (58) (59). FGF-4 
knockouts revealed  that limb buds fail to develop (57) (58) (59). FGF-6 expression is 
found in developing skeletal muscle. Studies conducted using murine models have shown 
FGF-6 presence at E9.5 and to be exclusively present in the myotomal compartment (early 
stage of skeletal muscle development) of the somite (60) (61) (62). Due to the close 
interaction between muscle and tendon as the conductor of forces between muscle and 
bone it is feasible that FGF-6 could play an integral role in the development of tendon and 
muscular-tendon junctions. FGF-8 has also been shown to play a pivotal role in murine 
limb development by inducing ectopic limb development and replacing the Apical 
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Ectodermal Ridge (AER)(a collection of cells at the front of the developing embryonic 
limb) (63)(64). FGF-4, FGF-6 and FGF-8 are all present in the AER and provide the 
signalling required to maintain mesenchymal cells in the proliferative state at the limb bud 
end during development. In house experimentation has shown that combinations of FGF-4, 
6 and 8 may be required for the control of differentiation and proliferation of stem cells 
towards the tendon lineage in 2D cell culture.  
We therefore sought to investigate the effect of dynamic mechanical stress and growth 
factor addition in conjunction with 3D PHBHHx/ collagen hybrid scaffolds seeded with 
human stem cells in relation to tendon tissue engineering.  
 
 
5.2. MATERIALS AND METHODS. 
5.2.1. Cells. 
hMSCs were isolated from human bone marrow using adherence culture as described in 
methods section 2.2.3. SHEF1 hESCs were cultured in feeder free conditions according to 
methodology 2.2.4. Spontaneous differentiation of hESC was performed by seeding into 
Matrigel-coated T-75 flasks at fixed densities (1 x10
6
 cells per flask) in conditioned hESC 
media. Spontaneous differentiation was induced by changing base media to MEF media for 
5 days, changing the media after 3 days as method 2.2.4.e. RaT cells were isolated from 
the Achilles tendon of 6 week old Wistar rats and cultured as method section 2.2.2. 
5.2.2. Growth factor supplementation. 
Growth factors were reconstituted before use by defrosting and dissolving product in either 
water or sodium hydroxide according to the manufacturer’s protocol. Basic media was 
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supplemented with a combination of either: BMP 12 (R&D Systems, UK) at 10ng/mL, 
BMP13 (Peprotech, USA) at 10ng/mL and Vitamin C 2ng/mL (concentrations as used by 
Berasi et al (54))  or a combination of FGF 4, FGF6, FGF8 all at 50ng/mL and Vitamin C 
2ng/mL (found to be optimal for tenocyte differentiation in hESCs, in house data) for each 
cell type during static culture throughout the 20 day experimental period. A control group 
with no growth factor additions was also run. 1% Penicillin, Streptomycin and 
Amphotericin B (PSA) (15240112, Invitrogen, UK) was also added during the 
experimental mechanical loading period. Table 5.1 provides an overview of the different 
media types used throughout this investigation. 
 
Table 5.1. Media compositions as used in experiments. Basic media was used as a control, with bone 
morphogenic protein (BMP) media and fibroblast growth factor (FGF) media used to determine the 
effects of growth factors on cells in dynamic culture conditions.  
Basic media BMP media FGF media 
DMEM, 10% FBS, 1% l-
Glutamine, 1% NEAA, 1% 
PSA 
DMEM, 10% FBS, 1% l-
Glutamine, 1% NEAA, 1% 
PSA 
DMEM, 10% FBS, 1% l-
Glutamine, 1% NEAA, 1% 
PSA 
 BMP 12 10ng/mL FGF 4 50ng/mL 
 BMP 13 10ng/mL FGF 6 50ng/mL 
 Vitamin C 2ng/mL FGF 8 50ng/mL 
  Vitamin C 2ng/mL 
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5.2.3. Scaffold 
Porous PHBHHx tube scaffolds were produced as described in section 2.3.4. At least 4 
scaffolds were produced for every experimental condition and time point. Polymer tubes 
were cleaned and sterilised in 70% IMS for 2 hours before collagen gels were added. 
Collagen gels were formed by first neutralising type I rat tail collagen as section 2.3.5. with 
5mg/mL final collagen concentrations. Gels were injected into the lumen of tubes using a 
1mL Gilson pipette, before cross-linkage through temperature elevation to 37
o
C for 2 
hours. 
5.2.4. Mechanical stimulation. 
Mechanical stimulation was performed using a BOSE ElectroForce 3200 machine coupled 
to WinTest software as described in Section 2.5. Scaffold/cell constructs were assembled 
and allowed to sit in complete media for 24 hours before loading took place. All samples 
were maintained in static culture when not in the BOSE chamber throughout the 
experiment, with groups of scaffolds stimulated for 0 days (no loading), 5 days, 10 days 
and 20 days. All measurements were carried out at each end point, i.e. day 20. 
5.2.5. Histological analysis. 
Samples were fixed using 4% paraformaldyhyde (P6148 Sigma Aldrich UK)/PBS solution 
overnight at 4
o
C. They were then embedded in paraffin wax (section 2.8.1) and sectioned 
using a microtome (section 2.8.2) Haematoxylin and eosin stain (section 2.8.3) and Sirius 
red (section 2.8.4) stains were applied to sections after rehydration and mounted on glass 
microscope slides. Polarised light microscopy was performed as section 2.8.9 and images 
of a single field of view were taken with polarisers set at 0
o
 and 90
o
 differences using a 
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Nikon N5 camera, with constant light brightness. A corresponding bright field image of the 
same view field was also taken as a reference.  
5.2.6. Mechanical testing. 
Stiffness and ultimate tensile stress (maximum load) were measured as method 2.6.1. using 
a BOSE Electroforce 3200 system.  
5.2.7. Cellular Viability 
A 2 x 2 x 2mm section of collagen gel from each sample were removed, digested in 0.4% 
type IV collagenase (C5138, Sigma Aldrich UK)/PBS solution for 1 hour before a trypan 
blue exclusion assay was performed to assess cell viability (2.2.1.f.).  
5.2.8. Control. 
An acellular group was used as a control. Tubes and collagen were made as with cellular 
constructs, with cells left out of the collagen gel. Constructs were mechanically loaded and 
stained as with the cellular groups. 
5.2.9. Molecular Characterisation. 
Gels were removed from tubes and immersed in 0.4% type IV collagenase for 1 hour. 
Molecular characterisation was performed via RT-PCR (method 2.4.3). Genes investigated 
were Beta Actin (BACT), Collagen 1a2 (COL1a2), collagen 3a1 (COL3a1), tenascin-C 
(TEN-C), tenomodulin (TNMD) and thrombospondin-4 (TBSD-4). Primer sequences and 
annealing temperatures can be found in table 2.1. 
 5.2.10. Statistical analysis 
Results were deemed to be significant if P ≤ 0.05, or as indicated in the text using a 2-
tailed paired Students t-test or one way ANOVA with Tukey’s post hoc test.  
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5.3. RESULTS. 
5.3.1. Cell viability. 
Cell viability in PHBHHx/collagen hybrid scaffolds was measured using a trypan blue 
exclusion assay. The number of cells in all media conditions was reduced by around 50% 
(42.4 – 52.9%) after 5 days loading. Cell viability remained high throughout the culture 
period (95.8 ± 8.3 - 82.5 ± 13.70 %) in all conditions at all-time points (Fig. 5.1). 
 
Figure 5.1. Cell number and cell viability in PHBHHx/collagen hybrid scaffolds after 0, 5, 10 and 20 
days mechanical loading. A: total number of viable cells present in the collagen gel after loading. B: 
percentage of viable cells in collagen gel after loading. White bars indicated hMSCs, light grey bars 
SDhESC and dark grey bars RaT cells. Mean ± 1SD. n = 3.  
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5.3.2. Mechanical testing. 
Mechanical testing (maximum load and stiffness) was performed using a BOSE 
Electroforce 3200 by applying a tensional elongation of 0.1mm/s until failure. Freshly 
dissected rat Achilles tendon controls had a maximum load of 3.24 ± 0.30 N and a stiffness 
of 3826 ± 261 N/m.  
hMSC seeded scaffolds ranged in maximum load from 2.13 ± 0.82 N to 3.7 ± 0.06 N, and 
4073 ± 120 N/m and 6724 ± 1052 N/m stiffness. Unstimulated constructs had similar load 
to failure to rat achilles tendon controls. Stimulation led to maximum load increases being 
seen in standard media after 20 days (p=0.01), but decreases after 5 days loading in BMP 
media (p = 0.04). Significant increases were seen in construct stiffness after 5 days 
stimulation in standard and FGF media (p =0.01, 0.00 respectively), but not in BMP media 
(p = 0.8). hMSC seeded constructs were significantly stiffer after 10 days in standard 
media, with no difference seen in FGF media and a reduction seen in BMP media. 
Significant increases were seen after 20 days loading in standard media (p=0.01), but not 
BMP (p=0.2) or FGF (p=0.08) medias (Fig. 5.2). Statistical significance was determined 
by one way ANOVA followed by Tukey’s post hoc test.  
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Figure 5.2. Stiffness and maximum load of hMSC seeded constructs increases with length of time of 
mechanical stimulation. Significant increases in stiffness are seen in most sample types after 5 days 
stimulation, Mean ± 1SD. n = 3, * significant (p ≤ 0.05) compared to rat tendon control or as indicated.  
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Maximum loads between 2.13 ± 0.30 N and 4.07 ± 0.04 N, and stiffness of 7766 ± 147 and 
3833 ± 450 N/m were recorded for SDhESC seeded constructs. Unloaded samples had a 
significantly lower maximum load in all media types compared to rat Achilles tendon 
controls. Mechanical stimulation increased maximum load in all media after 5 days, 
showing no difference from rat Achilles tendon. Significant increases in maximum load 
were seen in all media types after 10 days stimulation when compared to unloaded controls 
(p≤0.03). This trend was repeated after 20 days stimulation (p≤0.04). Stiffness of SDhESC 
seeded scaffolds was found to be similar in all unloaded samples to rat tendon controls. 
Stimulation increased seeded scaffold stiffness after 5 days in FGF media (p=0.05) and all 
conditions after 10 days (p≤0.03) and 20 days (p≤0.03) (Fig. 5.3). Statistical significance 
was determined by one way ANOVA followed by Tukey’s post hoc test. 
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Figure 5.3. Stiffness and maximum load of SDhESC seeded constructs increases with length of time of 
mechanical stimulation. significant increases in both maximum load and stiffness are found after 10 
days stimulation. Mean ± 1SD. n = 3 * significant (p ≤ 0.05) compared to rat tendon control or as 
indicated. 
 
Alexander Lomas PhD Thesis Chapter 5 Bioreactor Study 
146 
 
RaT seeded constructs had the highest overall load to fail at 2.56 ± 0.22 and 5.12 ± 1.40 N 
and stiffness at 4680 ± 783, 9840 ± 1334 N/m, seen after 5 days stimulation in basic media 
and FGF media correspondingly. Differences between conditions were obscured by high 
standard deviations, leading to constructs being similar in both maximum load and 
stiffness in all conditions, however significant increases in maximum load were seen after 
10 and 20 days in standard media (p=0.03, 0.02 respectively) compared to unstimulated 
controls. Significant increases in stiffness were also observed after 10 and 20 days in 
standard media (p= 0.01, 0.01 respectively), but not in other media types (Fig. 5.4). 
Statistical significance was determined by one way ANOVA followed by Tukey’s post hoc 
test.  
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Figure 5.4. Stiffness and load to fail of RaT seeded constructs increases with length of time of 
mechanical stimulation. large variation prevents statistical significance in many samples. Mean ± 1SD. 
n = 3 * significant (p ≤ 0.05) compared to rat tendon control or as indicated. 
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5.3.2. Normalised mechanical properties. 
Normalised values of ultimate tensile stress were gained by subtracting acellular values 
from cellular construct results, giving a trend of the effect of the cells on the mechanical 
properties of the final constructs. Although these results cannot be taken as absolute, as 
only average values were taken into account,  it is possible to ascertain where the duration 
of mechanical stimulation using these conditions has the largest general effect on the 
mechanical properties on the constructs. 
hMSC seeded constructs without mechanical stimulation were less stiff than acellular 
constructs in all media. Load to fail was unafected, with unloaded constructs found to be 
within ±0.5N of acellular. Stimulation led to increases in both stiffness and max stress in 
both no growth factor and FGF media, with maximal values for all media types found after 
10 days stimulation. FGF had the largest effect, with load to fail of 1.52N and stiffness of 
3314N/m. Further stimulation to 20 days had a negative effect on mechanical properties. 
hMSCs in BMP media were found to reduce stiffness and load to fail after 5 days 
stimulation, with normalised values dropping to 0.82N and -1480N/m (Fig. 5.5 a, b).  
Unloaded SDhESC seeded constructs had lower stiffness and max stress than acellular 
controls in all media. Stimulation increased stiffness and load to fail in all conditions, with 
maximal vaules at day 10 and FGF media having the largest effect with 1.79N and 
3826N/m. Further stimulation had a negative effect on mechanical properties (Fig. 5.5 c, 
d). 
RaT cells had the largest effect on mechanical properties. Unloaded samples without 
growth factors had similar normalised load to fail (-0.12N) but lower stiffness (-1100N/m)  
values compared to acellular controls. BMP and FGF media increased unloaded sample 
max stress and stiffness (BMP: 1.38N, 1640N/m. FGF: 0.85N, 800N/m) in unloaded 
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samples. Mechanical stimulation for 5 days increased properties in no growth factor and 
FGF media, but not in BMP media. Maximum values were seen after 10 days stimulation 
with the largest effect being seen in FGF media (3.14N, 6106N/m). Further loading had a 
negative effect on properties (Fig. 5.5 e, f). 
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Figure 5.5. Normalised effect of cells. Graphs show average values from mechanical testing normalised 
to an acellular control. Trends show initial slow increase in properties between days 0 and 5, with large 
increases being made between days 5 and 10, before plateauing to day 20. RaT cells had the largest 
impact on construct properties.  
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5.3.3. Polarised light microscopy. 
Polarised light can be used to identify areas of birefringence or areas where structural order 
exist (207). Problems with sectioning being inconsistent, with folds and air bubbles 
sometimes present, restrict the conclusions that can be made to overall observations, and 
prevent quantitative assessment being made.  
Little evidence of remodelling was present in MSC seeded samples in the absence of 
growth factors, with only small areas of birefringence being seen at day 20. BMP12/13 
increased the amount of birefringence in comparison to no growth factors, with increased 
mechanical stimulation also increasing the amount of sample visible when viewed through 
cross polarisers at day 20, perhaps suggesting increased matrix organisation. FGF 4/6/8 
increased the amount of sample visible compared to no growth factor samples, with almost 
complete birefringence of the sample visible at day 20 (Fig. 5.6).  
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Figure 5.6. Growth factors induce matrix remodelling of hMSC seeded constructs over 5, 10 or 20 days 
stimulation. Little matrix ordering is apparent in no growth factor media. Extensive matrix ordering 
was seen after 10 days stimulation when growth factors present. Sections stained with Sirius red. 
Shown are images taken through crossed polarizers (at 90
o
 to each other). White arrows indicate 
loading orientation. Images taken at 100x magnification. Scale bar = 100µm. 
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Embryonic stem cell seeded scaffolds displayed increased sample birefringence with 
increased mechanical stimulation. Samples had remodelled after 10 days stimulation in all 
media conditions, with large areas of sample demonstrating birefringence. The addition of 
FGF 4/6/8 increased the amount of birefringence, but little difference was seen between 
BMP12/13 media and no growth factor samples (Fig. 5.7). 
 
 
 
Figure 5.7. SDhESCs remodel matrix with mechanical stimulation over 5, 10 or 20days. Stimulation 
resulted in matrix ordering in all media types after 10 days. Extensive matrix ordering observed after 
10 days stimulation in all media. Sections stained with Sirius red. Shown are images taken through 
crossed polarizers (at 90
o
 to each other). White arrows indicate loading orientation. Images taken at 
100x magnification. Scale bar = 100µm. 
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Rat tenocyte seeded constructs showed increased birefringence after 20 days stimulation in 
no growth factor and BMP 12/13 media, but not to any great extent in other conditions. A 
halo like artefact was present on the FGF media day 20 sample (yellow arrow) (Fig. 5.8). 
Acellular constructs showed little or no birefringence and therefore no evidence of ordered 
collagen remodelling occurring at any time point (Fig. 5.9).  
 
 
Figure 5.8. Rat tenocytes remodel collagen in response to mechanical stimulation over 5, 10 or 20 days. 
Evidence of matrix ordering was seen after 20 days stimulation in no growth factor and BMP media. 
No ordering was seen in FGF media. Sections stained with Sirius red. Shown are images taken through 
crossed polarizers (at 90
o
 to each other). White arrows indicate loading orientation yellow arrow 
indicates “halo” artefact surrounding sample. Images taken at 100x magnification. Scale bar = 100µm.  
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Figure 5.9. No matrix remodelling observed in acellular constructs over 20 days mechanical 
stimulation. No light is seen to be refracted by the sample, indicating that little to no ordering is 
present in the structure. Rat tendon shows high levels of birefringence throughout its structure. 
Sections stained with Sirius red. Shown are images taken through crossed polarizers (at 90
o
 to each 
other). White arrows of acellular images indicate loading orientation. White arrows on tendon indicate 
longitudinal tendon direction. Images taken at 100x magnification. Scale bar = 100µm. 
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5.3.4. Histology. 
Collagen gels were removed from the PHBHHx tube and sectioned and stained with 
Haematoxylin and Eosin. Evidence of collagen fibril formation was seen in no growth 
factor samples with 20 days mechanical stimulation in small distinct areas (white arrows) 
(Fig. 5.10). Little evidence was seen at other time points. BMP 12/13 addition increased 
the amount of fibril formation and alignment seen, especially in day 10 samples (white 
arrows) (Fig. 5.10). FGF addition increased the amount of matrix alignment with increased 
stimulation, with large areas of collagen being seen to be ordered (white arrows) (Fig. 
5.10). 
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Figure 5.10. Cellular and matrix remodelling of hMSC seeded scaffold collagen core. Regions of matrix 
ordering became visible after 20 days loading in standard media. No clear evidence of matrix ordering 
was seen in BMP supplemented media (white arrows). Regions of ordering were apparent after 5 days 
stimulation with FGF supplementation, becoming larger at day 10 and almost completely covering the 
gel volume after 20 days (white arrows). Black arrows indicate loading orientation. Images at 200x 
magnification. Scale bar = 100µm. 
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Distinct regions of matrix alignment were seen in SDhESC samples in no growth factor 
media after 5 days stimulation, with regions becoming larger with increased stimulation 
(white arrows) (Fig. 5.11). BMP 12/13 addition increased the size of matrix aligned 
regions at day 5, with most of the matrix being ordered at day 20 (white arrows) (Fig. 
5.11).  FGF 4/6/8 addition resulted in ordered areas of matrix alignment in unloaded 
samples, with stimulation leading to large cellular and ECM ordering after 5 days and 
complete ordering after 20 days (white arrows) (Fig. 5.11). 
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Figure 5.11. Matrix remodelling and cellular alignment of SDhESC seeded scaffold collagen core. 
Remodelling and cellular alignment became apparent after 5 days stimulation, with regions becoming 
larger at 10 and 20 days (white arrows). Ordering and cellular alignment of SDhESC seeded scaffolds 
supplemented with BMP media was apparent at day 5, with complete matrix alignment seen after day 
10 (white arrows).  Matrix ordering and cellular alignment of SDhESC seeded scaffolds supplemented 
with FGF media was apparent in samples with no stimulation. Larger areas are ordered at days 5, 10 
and 20 (white arrows). Black arrows indicate loading orientation. H&E stain. Images taken at 200x 
magnification. Scale bar = 100µm. 
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Evidence of matrix remodelling and cellular organisation in rat tenocyte seeded scaffolds 
was observed in unloaded samples without growth factor additions, with further limited 
remodelling being seen after increased stimulation (Fig. 5.12).  BMP 12/13 addition led to 
no matrix ordering being seen in unloaded samples, with distinct areas of ordering being 
seen after 5 days stimulation, getting larger with further stimulation (Fig. 5.12). No order 
was seen in FGF 4/6/8 unloaded samples, with areas forming after 5 days stimulation with 
little improvement seen at later time points (white arrows) (Fig. 5.12). Little to no matrix 
ordering or alignment was seen at any time point in acellular samples. Rat Achilles tendon 
shows cellular and matrix alignment in the direction of the tendon’s main orientation (Fig. 
5.13).  
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Figure 5.12. Cellular and matrix remodelling of RaT seeded scaffold collagen core. Matrix ordering 
was apparent in samples with no stimulation. Mechanical stimulation does not appear to have a large 
effect on ordering, with little difference seen between unloaded and loaded samples. Unloaded samples 
showed little sign of matrix ordering in BMP supplemented RaT seeded scaffolds. Distinct areas of 
ordering were seen after 20 days stimulation (white arrow). Regions of matrix alignment were seen 
after5 days stimulation in FGF supplemented RaT seeded scaffolds, with little further effect being 
evident (white arrows). Black arrows indicate loading orientation. H&E stain. Images taken at 200x 
magnification. Scale bar = 100µm. 
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Figure 5.13. Matrix remodelling of acellular collagen core and healthy tendon at 200x magnification. 
No evidence of matrix alignment is apparent in any sample. (H&E stain). Tendon section taken from a 
rat Achilles tendon, and stained and imaged at Tsinghua University centre for biological research.  
Black arrow indicates loading or tendon direction.  H&E stain. Images taken at 100x magnification. 
Scale bar = 100µm. 
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5.3.5. Molecular Characterisation. 
Cell fate was assessed using reverse transcriptase polymerase chain reaction (RT-PCR). 
Due to small yields of cells, samples were pooled from 3 scaffolds into one before RNA 
isolation in order to give sufficient amounts of RNA to test for multiple markers. Beta 
Actin (BACT) was expressed in all cell types at all-time points, demonstrating cellular 
viability, however expression was limited in hMSCs after 20 days loading and BMP media 
at 10 days loading. Expression of COL1a2 was maintained in MSCs in standard media and 
BMP media to day 20, and day 5 in FGF media. COL3a1 was expressed by MSCs at all-
time points in all media types. TENC expression was maintained throughout 20 days in 
BMP and FGF media, and up to day 5 in standard media. TBSD-4 was present in unloaded 
hMSCs, with some evidence of expression after 20 days stimulation in FGF media only 
(Fig. 5.14.). RNA extraction of sufficient amounts from SDhESC and RaT cells was not 
found to be possible for unknown reasons. 
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Figure 5.14. Molecular Characterisation of cells isolated from collagen tubes. Tendon specific markers 
expressed in FGF and BMP media. Markers: BACT beta actin, COL1a2 Collagen 1a2, COL1a3, 
Collagen 1a3, TENC tenascin C, TBSD4 Thrombospondin-4.   
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5.4. DISCUSSION. 
Tendon injury and disease is notoriously difficult to cure, with the chance of success of 
treatment being dependent on many factors, including patient age, type of injury and time 
between injury and medical intervention (10). As a result there remains a need for new 
treatments to be developed incorporating novel biomaterials and cellular components that 
provide a clinical advantage over current best treatment methods (39). This investigation 
has for the first time investigated the effects of growth factors, mechanical stimulation and 
PHBHHx/collagen hybrid scaffolds on human stem cells, finding that mechanical 
stimulation has positive effects on hMSC seeded scaffolds, with increased matrix 
organisation and maintenance of commonly used tendon molecular markers over a 20 day 
culture period. 
Cellular viability in 3D PHBHHx/collagen has been found to be above 82% throughout 
long term in vitro culture. Previous studies investigating other additions to collagen gels 
have also demonstrated its suitability for long term cell culture. Silk/collagen hybrid 
scaffolds have been shown to sustain high viability and function of differentiated hESCs 
(ESC-MSC cells) over 14 days with mechanical stimulation (124). Viability of all cell 
types was found to be high throughout the experimental time period, building on previous 
work demonstrating the suitability of PHBHHx/collagen hybrid scaffolds for tendon tissue 
engineering applications. Cell numbers were reduced after mechanical stimulation. This 
could be due to collagen gel being lost from the centre of the tube during the BOSE 
chamber stimulation process, although this loss was not quantified. Our investigation also 
identified a drop in viability of around 50% in SDhESC cells. This can be explained by the 
number of cells that had not differentiated or remained embryonic stem cell like, which 
were found in previous chapters to be unviable in this construct design.  
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Human movement is controlled by contracting muscles acting through tendons. As a result, 
tendon tissue is consistently under high levels of mechanical stress, usually applied in a 
cyclical motion (158). Investigations into the mechanical stimulation of tendon tissue 
engineered constructs have been shown to influence cell behaviour in many ways. Long 
term mechanical stimulation resulted in tenocyte seeded PGA constructs becoming dense 
fibrillar structures with higher levels of tendon specific proteins being expressed by cells in 
the overall matrix, with higher mechanical properties when compared to non-loaded 
controls (160). This work corresponds with our findings, with mechanical stimulation 
significantly increasing both load to fail and stiffness in tenocyte seeded samples where 
growth factors were added. 
The effect of mechanical loading was found to be highest using these loading conditions 
after a period of 10days. Continued loading over a period of 20days was found to 
contribute to a drop in overall mechanical integrity. This could have been caused by the 
high amplitude being used to load the constructs being quite close to the natural ultimate 
strain a tendon can withstand in vivo (33), which could have led to some damage being 
caused to the developing collagen fibres (158). Alternatively, the repetitive moving of the 
constructs from static culture to the bioreactor could also have led to small defects being 
formed in the tube structure, which could have led to reduced overall mechanical 
properties (208). 
Bone marrow derived human mesenchymal stem cells have been shown to create tendon 
like structures when exposed to dynamic cyclical mechanical stress when seeded in 
collagen scaffolds. Up regulation of fibrillar collagen marker expression, along with 
embryonic tendon markers were seen in samples after 7 days, 30 minutes per day loading 
(164). This study also demonstrated the need for continued dynamic stress to be applied to 
maintain tendon like cellular characterisation. This study agrees with our findings, with 
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collagen 1a2, collagen 3a1 and tenascin C expression maintained in hMSC seeded collagen 
scaffolds exposed to dynamic stress with the addition of BMP 12 and BMP13 or FGF4, 
FGF6 and FGF8 added to media. 
MSC seeded collagen constructs have been found to become stiffer after 14 days of low 
level, low frequency loading. The authors found that the direct contact with cells that 
collagen sponges provide created a system that was more efficient at transmitting forces to 
cells than basic collagen gels. This study also suggests that the original scaffold 
architecture that cells initially adhere to is an important factor when designing materials for 
tendon tissue engineering. (209). It has also found that slow stretching of collagen 
scaffolds increased the amount of fibrillar alignment and overall scaffold mechanical 
properties, significantly increasing stiffness and ultimate tensile stress after 4 days 
continuous loading (159). These studies agree with our findings, with mechanical loading 
significantly increasing both stiffness and ultimate tensile stress (load to fail) of scaffolds 
seeded with any of rat tenocytes, human adult or embryonic stem cells.  
Fibril alignment in embryonic tendon formation has been found to be controlled by 
intracellular specific sites between the Golgi apparatus and cell membrane. Procollagen 
molecules are arranged into small diameter collagen fibrils which are then excreted in 
hexagonally shaped bundles by the cell parallel to the axial direction of the tendon (43). It 
has been suggested that further fibrillogenesis then occurs when other small collagen fibrils 
start aligning and joining together to form mature tendon after birth (210). No evidence of 
these intracellular sites in adult cells has yet been found, perhaps explaining the increases 
in mechanical properties seen in embryonic stem cell seeded scaffolds when compared to 
MSC seeded constructs, with both load to fail and stiffness being found to be higher. It has 
also been found that the absence of mechanical loading leads to the loss of fibropositors in 
embryonic tendon cells (211), explaining how constructs seeded with ESCs were generally 
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mechanically stronger and stiffer after mechanical loading and showed increased matrix 
organisation when compared to other cell types exposed to similar culture conditions.  
This investigation has for the first time investigated the combined effect of FGF 4, FGF 6 
and FGF 8 on cells seeded into a 3D scaffold environment. FGF 4 has been shown to play 
a crucial role in mesenchyme patterning during embryonic development (57) (58). FGF 6 
is strongly linked with skeletal development in embryos (60),(61), with studies also finding 
that it is needed during adult skeletal muscle development and repair (212). FGF 8 is 
associated with embryonic patterning of mesenchyme tissues and in embryonic limb bud 
development (63),(64),(213). As tendon tissue forms in the developing embryo at similar 
time points to muscle tissue, shortly after the development of a limb bud, it can be assumed 
that combinations of FGFs 4, 6 and 8 are closely associated with the formation of the 
collagen extracellular matrix of both tissue types.  We have demonstrated in this study that 
a combination of FGF 4, FGF 6 and FGF 8 lead to tendon specific cellular expression 
markers being expressed by hMSCs in 3D PHBHHx/collagen hybrid scaffolds in static 
culture conditions, with mechanical loading prolonging the expression of TBSD-4 
indicating that cells are maintaining a tendon like molecular characterisation. 
BMP 12 has been found to induce tenogenesis in rat bone marrow derived MSCs (48). 
BMP13 has been previously shown to play a role in tendon matrix regeneration after injury 
(214). Previous work performed in our laboratory has also found strong evidence of 
BMP12/13 influencing human ESCs towards tenogenic lineages in 2D culture. Our work 
adds to the body of evidence linking BMP12 and 13 with tendon development and repair, 
reporting for the first time the influence of these molecules in conjunction with 
PHBHHx/collagen hybrids scaffolds, finding that growth factors are needed to maintain 
tenascin C expression in hMSCs for over 5 days culture. 
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Experimental issues regarding the sectioning of samples greatly limited the conclusions 
that can be made from the histological analysis. During the sectioning process it was found 
that the blade was not slicing the sample consistently and as a result, sections were 
frequently too thick, folded or contained air bubbles, factors which prevented solid 
conclusions from being made from the polarised light images (207). This could have been 
prevented by using a cryostat, however due to equipment malfunction and time constraints 
this option was not available. A potential alternative to polarised light that could have been 
used is immunohistochemistry, looking for collagen I or other commonly used tendon 
markers such as scleraxis or collagen I expression (215). 
During the RNA extraction process for RT-PCR it became apparent that sufficient amounts 
of RNA could not be extracted from SDhESCs or RaT seeded samples. This could have 
been caused by insufficient homogenisation during the enzymatic steps of the isolation 
procedure, resulting in cells being lost or cells being retained in solid sections of tissue that 
were filtered out during the cell lysis process(216). A potential way of remedying this 
problem in future studies would be to use higher concentrations or volumes of collagenase 
and lysis solution. Repeating the centrifugation step through the QIA Shredder (section 
2.4.3) by placing the flow through back onto the Shredder membrane, leaving for 3 
minutes, then re centrifuging, ensuring that all the sample has passed through into the 
collecting tube could also lead to more RNA being collected from the samples. 
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5.5. CONCLUSION. 
This investigation has demonstrated the need for mechanical pre conditioning of cell 
seeded constructs before use in tendon tissue engineering. All cell types used showed 
potential evidence of increased matrix modelling in response to low frequency cyclical 
mechanical stress, resulting in constructs adopting higher mechanical properties, similar to 
those found in similarly sized natural tendon tissue. Mesenchymal stem cells were found to 
maintain or adapt tendon like molecular characteristics, with tendon specific RNA 
sequences being expressed by cells in response to mechanical stimulus. Mechanical 
loading was found to have no effect on acellular controls, with no signs of matrix ordering 
being noted at any time point. PHBHHx/collagen hybrid scaffolds, in conjunction with 
tendon specific growth factors and cyclical mechanical stimulus have been found to 
maintain expression of cellular markers associated with tendon by hMSCs over a 20 day 
culture period. 
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6.1. INTRODUCTION. 
Tendon injury is an increasing problem in medicine, with over 300,000 tendon procedures 
performed annually in the United States (217). Tendon is characterised by poor repair 
following injury or disease, is relatively acellular and has a poor blood supply (176). 
Treatment can involve many different types of surgical intervention, such as a xenograft or 
an allograft to treat large tendon defects, however potential problems with this method 
(such as foreign body reaction) can occur (12). A lack of adequate strategies for repair of 
tendons had led to development of engineered replacement tendon tissues for use in 
surgical transplantation. It is because of these reasons that tendon has been identified as an 
area where tissue engineering could be used to aid in tissue repair (39). 
Traditionally, small tendon lacerations are treated by suturing the damaged ends together, 
followed by a programme of physiotherapy designed to manage the forces exposed to the 
repairing tissue. For large defects constructs can be required to bridge the gap. Graft tissues 
are frequently used with varying effectiveness. Autografts (taking a section of donor tissue 
from another part of the patient – usually the hamstring) provide the current gold standard 
treatment, with minimal chance of immunorejection, however donor site morbidity and 
pain are commonly associated (40). Allografts from donor or cadaveric tissue can also be 
used, however immunorejection, low numbers of donors, and greater failure rate problems 
are common (11). Xenograft tissues from animal sources are starting to be investigated for 
use; however major concerns regarding long term viability and cross species disease 
transmission remain (12). Commercially available artificial tendon graft products are in 
clinical use; however prolonged immune response and post-operative infection have been 
widely reported (41). Due to the problems associated with tendon repair surgery, new 
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techniques and materials need to be developed in order to meet the increasing clinical 
need. 
Several in vivo models for tendon injury have been used to determine the effectiveness of 
novel treatments. Induced defect models are commonly used and generally fall into three 
categories according to the problem being investigated: taking a small area out of the 
overall tissue (119), bisecting the tissue and reconnecting the severed ends (222), or 
completely removing a section of tissue leaving a gap between the severed ends (124). 
Small animal models used include mouse (123), rat (222) and rabbit (116), (203), with the 
Achilles tendon usually investigated, owing to its ease of access, relative comparative size 
to larger animal tendons and direct comparability with the undamaged tendon on the other 
limb (223). Larger animal models can be used to determine if graft constructs can be scaled 
up in size to match the dimensions and mechanical properties of human tissue. A common 
large animal model is the equine digital flexor tendon, where constructs placed into an 
induced defect model (119) and autologous stem cell (bone marrow MSC) treatment for 
induced tendonitis (103) have provided data that could lead to future clinical applications 
in humans. 
PHBHHx is one of the few PHA molecules that can currently be produced on a sufficiently 
large scale to use both in scientific research and medical device construction (140). The 
aim of this study was to explore the use of PHBHHx and PHBHHX/collagen hybrid 
scaffolds for the in vivo treatment of damaged tendon, monitoring in vivo immune 
response, scaffold breakdown and restoration of mechanical properties and tendon 
microstructure. 
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6.2. MATERIALS AND METHODS. 
6.2.1. Animals. 
15 male Sprague-Dawley (SD) rats 180-200 g were obtained from the Centre for 
Biomedical Analysis, Tsinghua University, China. Animals were treated as section 2. 7. 1., 
being kept in authorised facilities and under local ethical and handling guidelines 
throughout the experiment.  
6.2. Scaffold Preparation. 
PHBHHx/ collagen hybrid constructs were prepared using the method as section 2. 3. 7. 
Overnight salt leeching resulted in scaffolds having a porous overall structure (Fig. 1 A). 
PHBHHx fibres were included in the final scaffold design to aid in suturing and 
positioning of the constructs into the injury site. Construct designs consisting of multiple 
combinations of fibres and tubes were analysed, with fibres either passed individually 
through the tube or woven in a French braid (Fig. 6.1). 
PHBHHX/collagen gel hybrids were created by injecting pre made collagen gel (section 2. 
3. e.) into the centre of the tube after implantation using a 12 gauge hypodermic syringe. 
Individual gels were created for each rat used in the experiment, with the gel being injected 
into the scaffold once fixed in the animal (described below). 
Before surgery scaffolds were sterilized using 70% IMS/ deionised H2O solution overnight 
in a biological safety cabinet under UV. Scaffolds were then stored and transported in 
sterile PBS / 10% antibiotic PSA solution in a sealed 15 mL centrifuge tube. Scaffolds 
were then only handled using aseptic surgical technique. 
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Figure 6.1. PHBHHx scaffold design. Constructs were constructed using a PHBHHx outer tube and up 
to 3 PHBHHx fibres. Fibres were included to aid in the suturing of scaffolds in the animal model. 
Several designs were considered for use, with 3 fibres woven in a French braid pattern being the final 
design chosen. 
 
6.2.3. Scaffold Characterisation. 
Scanning electron microscopy was used to determine the microstructure of the tube and the 
fibre elements of the scaffold as section 2.6.3. Measurements were taken using the supplied 
electron microscope software, with 8 measurements of 3 fibres taken at random points 
along the fibre diameter. Stretch to break testing was carried out on a variety of scaffold 
combinations to determine which was most closely aligned to natural tendon strength using 
a material testing machine (Tension Compression load Cell Tester, NTS Canada) at a rate 
of 10 mm/minute. A control of healthy tendon from rats of comparable age was used as a 
benchmark. All samples were immersed in warm complete media for 2 hours prior to 
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testing, with samples tested in a wet state. 3 samples were tested for each scaffold type, 
with each sample being prepared separately.  
Scanning electron microscopy (SEM) (FEI Quanta 200, Tsinghua Medical School, Beijing) 
was carried out using samples of both fibre and tube to explore the topographical structure.  
6.2.4. Surgical Procedure. 
Surgical procedures were carried out by experienced (consultant) orthopaedic surgeons at 
the Surgical Training Centre, Peking University Hospital Number 1, Beijing, China. 
Surgery was carried out as per the procedure described in section 2. 7. 2. A brief 
description and overview of the surgical groups and the differences in surgery can be found 
in figures 6.2. and 6.3. 
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Figure 6.2. Surgical procedure diagram explaining experimental groups. Group NS (no scaffold) were 
animals with an induced 2mm defect injury that was left open and allowed to heal naturally. Group S 
(scaffold) were animals with an induced 2mm injury with a PHBHHx tube/fibre construct implanted 
into the wound site. Group SC (scaffold + collagen) were animals with an induced 2mm defect injury 
with a PHBHHx tube/fibre scaffold that was filled with collagen gel. 
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Experimental Groups 
Group Description Scaffold 
Components 
Cells Number of 
Animals 
CRP/AFI 
animals 
sampled 
Mechanical 
testing 
Histological 
Analysis 
NS Control# - - 5 3* 3** 2 
S Scaffold Only 
3 x PHBHHx 
Fibres and 1 x 
PHBHHx Tube 
- 5 3* 3** 2 
SC 
Scaffold and 
Collagen 
3 x PHBHHx 
Fibres , 1 x 
PHBHHx Tube 
and Collagen gel 
- 5 3* 3** 2 
# 2mm section of tendon excised with no surgical repair 
* n=3 sampled randomly from each experimental group of 5 animals at each time point, ** n=3 picked at random from each 
experimental groups of 5 after 40 days with the remaining 2 samples used for histological analysis 
 
Figure 6.3. Experimental groups and numbers of animals used for each analytical procedure. 5 
animals were chosen at random from a 15 strong colony of 180 – 200g male Sprague-Dawley (SD) rats 
during surgery. Blood samples were taken from 3 randomly chosen rats at each consequent time point 
after surgery, with 3 rats being chosen post sacrifice for mechanical evaluation, with the remaining 2 
rats being used for histological analysis. 
 
6.2.5. Immune response analysis. 
Immune response was monitored by measuring C Reactive Protein (CRP) levels in blood. 
Blood samples were taken from rat tail veins, with serum isolated by centrifugation and 
analysed using an ELISA kit and plate reader according to method 2. 7. 4.  
6.2.6. Detection of breakdown molecules. 
The breakdown of the scaffold was quantified by measuring the concentration of β-
hydroxybutyrate in blood serum over time. Serum was isolated by immediate 
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centrifugation (within 5 minutes of the blood being collected) from blood samples taken 
from tail veins, before analysis with a colorimetric assay according to method 2. 7. 5.   
6.2.7. Restoration of mechanical properties. 
To test for restoration of mechanical strength to pre injury levels, a stretch to break test 
was carried out using 3 of the samples from each group. The non-operated tendons were 
taken as positive control. Following removal the tendon was loaded into the Tension 
Compression Load Cell Tester (NTS Canada) so that the tendon ends were held by the 
clamps, and stretched at a rate of 10 mm/min until complete failure was observed.  
6.2.8. Histological Assessment. 
Structural analysis of one sample from each group was performed using H & E according 
to standard procedures. Prior to staining the sample was first fixed using 70% methanol for 
24 hours, then embedded in paraffin wax before sectioning into 8 µm thick sections and 
placing onto a glass slide. Sections from the injury site and healthy areas of tendon were 
analysed. Images were taken using an Olympus IX 71 microscope and TH4-200 digital 
camera. 
6.2.9. Statistical Analysis. 
Results were deemed to be significant if P<0.05 using a 2 tailed Students T-test. 
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6.3. RESULTS. 
6.3.1. Scaffold design and characterisation. 
SEM was used to determine the microstructure of both the fibre and the tube elements of 
the scaffold. The fibre had an average diameter of 247.1 ± 20.3 µm (Fig. 6.4). 
Rat Achilles tendon has an average breaking load of 17.35 ± 1.76 N (Fig. 6.5). Several 
designs of porous PHBHHX scaffold with 1-3 fibres (woven and non-woven) had their 
mechanical properties evaluated. The nearest in mechanical performance to natural tendon 
was a tube with 3 fibres running through the centre of it (Fig. 6.5), with comparable 
breaking loads observed (23.73 ± 1.08 N) compared to rat Achilles tendon (p=0.24).  The 
addition of collagen gel to the centre of the scaffold was found to have minimal effect on 
the initial mechanical strengths of the constructs, registering break forces of 25.14 ± 1.25 
N, which was significantly higher (p=0.03) than rat Achilles tendon. 
 
Figure 6.4. SEM images of fibre. 3 fibres at 100x with markers indicating diameter. Image taken at 
Tsinghua University Medical School. 
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Figure. 6.5. Mechanical loading of scaffold designs. Scaffolds were immersed in PBS for 1 hour before 
tensional mechanical properties were established. Ultimate tensile stress was established by a stretch to 
break test. Scaffold designs tested included a single tube, a single fibre, 3 fibres, 3 fibres combined with 
a tube and 3 fibres combined with a tube filled with collagen. A control of a freshly dissected rat 
Achilles tendon was also included. Graph shows mean ± 1SD, n = 3.  * significant difference (p≤0.05) 
compared to rat tendon. 
 
6.3.2. Mechanical strength. 
Once removed from the animals at day +40 stretch to break tests were performed on the 
excised repairing tendon/scaffold samples. The scaffold/collagen group had comparable 
load at failure (18.02 ± 7.45 N) to undamaged tendon (17.35 ± 1.78 N) (Fig. 6.6). The no 
scaffold and scaffold only groups were found to have lower average breaking loads than 
healthy tendon, but had similar values to each other, (no scaffold: 10.99 ± 7.62 N, scaffold: 
9.55 ±4.49 N) indicating that an implant of both scaffold and collagen is required to 
achieve tendon-like stretch to break test scores. The scaffold only group was found to have 
significantly lower load to failure (p = 0.04) compared to undamaged tendon. 
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Figure. 6.6. Mechanical testing of remodelling tissue/constructs 40 days post implantation. Tissue was 
removed from sacrificed animals and stored in PBS until testing. Ultimate tensile stress was obtained 
using a stretch to break test, with tissue from animals with no scaffold, a PHBHHx tube/fibre scaffold 
and a PHBHHx tube/fibre + collagen gel scaffold. An undamaged tendon was included as a control. 
Graph shows mean ± 1 standard deviation (n=3). (* indicates significant to undamaged tendon 
control). 
 
6.3.3. Histological analysis. 
Microscopic evaluation of the damaged tendon sites with Haematoxylin and Eosin 
demonstrated evidence of cellular infiltration and partial structure regeneration to varying 
degrees dependent upon the scaffold implanted. Cellular migration into the defect site was 
apparent throughout where increased migration was observed SC group implant had been 
introduced to the wound site when compared to either healthy tendon (Fig. 6.7) or a wound 
site with Group S (Fig. 6.7). A characteristic of tendon tissue is the crimp pattern which is 
presented by the elongated sinusoidal wave like patterning of the nuclei and cytoplasm of 
the cells as apparent in the undamaged tendon sample. The emergence of the wave-like 
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patterning was observed in the SC group (yellow arrows). Cells formed a consistent wave 
pattern when in contact/close proximity to the fibre or tube component of the implant. This 
demonstrates that morphological tendon-like cell presence within the tissue was observed 
being created around the implant, rather than just overlaying fibrous tissue. This was less 
evident in the group S (Fig. 6.7), indicating that tendon regeneration was more efficient in 
the SC implant group.  
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Figure 6.7. H&E stained samples taken from the damaged region of the tendon and from the same 
region of an uninjured control tendon. Samples were taken from either the inside of the scaffold or the 
injury site where no scaffold was present. NS: no scaffold implanted into injury site. S: PHBHHx tube 
and fibre construct implanted into injury site. SC: PHBHHx tube and fibre construct filled with 
collagen implanted into the wound site. White arrows show areas of scaffold/tissue interaction. Yellow 
arrows indicate wave like alignment of cells and matrix. Scale bar = 100µm. Sectioning and staining 
were performed by Tsinghua University centre for biological research. 
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6.3.4. Polymer breakdown. 
β-hydroxybutyrate (HB) is a naturally occurring molecule found in the body. The base 
level concentration was found by measuring blood serum samples from animals with no 
scaffold implantation at days 10 and 40, finding an average value of 0.16 mM. When 
scaffold and scaffold/collagen groups were normalised to this value it was apparent that the 
scaffold only group was degrading at a greater rate than scaffold/collagen up to days 2 (p= 
0.03) and 10 (p= 0.05), after which the trend was reversed at day 20 (p=0.01 ) (Fig. 6.8).  
 
Figure. 6.8. Normalised β-Hydroxybutyrate levels in blood serum over time. Values of PHBHHx and 
PHBHHx/collagen scaffold groups normalised to no scaffold group values. Graph shows mean values 
zeroed to average levels found in no implant group ± 1 standard deviation (n=3). (* significant 
difference between groups (p≤0.05). 
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6.3.5. Immune response. 
Immune response was quantified by measuring the concentration of C-Reactive Protein 
(CRP) in the blood serum. Samples were taken at time points pre- and post-surgery. Prior 
to surgery all rats were considered as one group (n=15) with an initial CRP concentration 
at day -5 found to be 878.06 ± 147.80 µg/L (Fig. 6.9). This was elevated slightly at day -2 
to 985.47 ± 128.92 µg/L possibly due to the injury caused by taking a blood sample. 
Surgery was performed on day 0. Blood samples were not taken at day 0 due to blood loss 
during surgery. CRP was found to have increased significantly in all groups at day +2 after 
surgery, with the largest reaction being seen in the scaffold only group (1299.05 ± 121.23 
µg/L) and the lowest in the scaffold/collagen group (1131.35 ± 117.40 µg/L). CRP was 
found to be the highest 48 h post-surgery. No statistical difference between the groups at 
this time point was observed. By day +5, CRP dropped back to pre-surgery levels, and 
levels continued to drop slightly at day +10, with the scaffold only group recording the 
lowest level at 905.78 ± 54.00 µg/L. A small secondary response was observed in both no 
scaffold and scaffold groups at day+ 20 which was significantly higher (p=0.004, 0.0003 
respectively) than the level of the scaffold/collagen group. At day +40 all animals were 
found to have CRP at or below pre surgery levels with the scaffold/collagen group showing 
the lowest (727.77 ± 42.30) and scaffold only the highest (817.71 ± 21.7) concentrations 
(Fig. 6.9). 
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Figure. 6.9. Blood concentration of CRP in recipient rats. No scaffold: rat with induced 2 mm tendon 
injury. Scaffold: rats with injury bridged with PHBHHx construct. Scaffold/Collagen: rats with injury 
bridged with PHBHHx/collagen construct. Surgery occurred on day 0. Pre surgery all rats were 
considered as one group (n=15).  Post surgery animals were separated into separate groups (n=5*). 
Graph shows mean ± 1 standard deviation with group numbers as described. *Group A lost one rat 
during surgery, and one at day 29. Group B lost one rat on day 30. (* significantly lower than other 
groups at time point). 
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6.4. DISCUSSION. 
The aim of this investigation was to identify a PHBHHx scaffold design that could be used 
to improve the rate of damaged tendon tissue healing while not initiating a prolonged 
immune response. To do this a design that would induce cellular migration and tissue 
remodelling while at the same time allowing for limited restoration of movement was 
required and found. The physiological demands placed on tendon tissue are high. A design 
consisting of a porous tube containing three individual fibres was identified as being 
mechanically similar to the rat Achilles tendon and to other commercially available human 
tendon repair materials (208). Further analysis of the scaffold using SEM revealed a 
consistent porosity across the tube structure and a constant fibre diameter.  
Mechanical testing of samples recovered from the rats at day +40 found that the 
scaffold/collagen group had a comparable mechanical load capability to undamaged 
tendon, matching the performance of traditional tendon laceration treatments (218), and 
bettering the performance shown by porcine intestinal sub mucosa (219) and PLGA based 
(7), (29) (131),(220) treatment methods. However, the success of the implant and the 
healing rate caused was variable. This could be explained by variability in manufacturing 
although intra-group mechanical properties were within a narrow range. It has also been 
shown that small differences in components of the surgical procedure, such as suturing, 
can affect the failure rate of tendon implants (208). What is apparent that the addition of 
the scaffold/collagen implant at the wound site increased the mechanical strength 
significantly when compared to the no scaffold control group, and that the scaffold alone 
increased the overall mechanical strength. This highlights the importance of collagen in the 
remodelling of tendon and concurs with previous studies suggesting collagen is a 
beneficial inclusion in tendon graft material (37), (131). 
Alexander Lomas PhD Thesis Chapter 6 Pilot in vivo study 
189 
 
C-Reactive Protein (CRP) is an early marker for inflammatory response caused by an 
implanted material (221). As expected, CRP rose dramatically after surgery in all 
experimental groups to a maximum value after 48 hours, returning to pre surgery levels at 
day +5 [31]. Day +10 results showed that CRP levels either continued to fall or remained 
stable, however at day +20 a small increase was observed in no scaffold and scaffold only 
groups. This could have been caused by several factors, including small re-injury (such as 
one of the stitches becoming dislodged) (208) or that the rats started causing injury to 
themselves (fighting). It could also be caused by the tendon's natural development cycle 
creating a small amount of inflammation around the wound site, which would not be 
unusual at around 2 weeks post injury (37). Day +40 results show low CRP concentrations 
in all groups, indicating that no long term immunological response was occurring due to 
the presence of a PHBHHx scaffold; improving on similar conclusions made by previous 
studies (222). This also creates a possible advantage over many commercially available 
synthetic tendon graft materials which have been found to present long term 
immunological risk (40). The drop in CRP concentration to levels seen below those 
measured before the surgery could be explained by the longer periods of time between 
blood sample collections, allowing for any potential inflammation caused by the collection 
process to subside. It could also be caused by the relative size of the injury in comparison 
to the size of the animal being smaller as the rats became larger (223).  
β-Hydroxybutyrate is a constituent monomer of PHBHHx (143). Measurement of HB 
concentration in blood over time demonstrated that scaffold breakdown was erratic, with 
large error bars showing the discrepancies between the individual samples. The trend 
shows that scaffolds without collagen seemed to breakdown at an earlier stage than those 
containing collagen, with higher values found at days 2, 5 and 10. At days 20 and 40 this 
trend was reversed. Further refinement of the production method should improve the 
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variation. By comparing the β-hydroxybutyrate concentration with the CRP level it 
becomes apparent that there is no link between the factors. This agrees with a previous 
study (179) in suggesting that the breakdown products of PHBHHx are immunologically 
inert, as when large increases in HB concentration are present no rise in CRP is seen. 
Cellular infiltration into the scaffold was observed in both the Group S and Group SC 
designs along with sinusoidal cellular alignment, a key marker in the histological analysis 
of tendon tissue, signifying the presence of crimp angles between collagen fibrils (224). 
However, Group SC showed a denser cellular presence with sinusoidal morphology along 
the surface of the PHBHHx scaffold, implying a more favourable environment for cells is 
produced when a collagen lumen is present within the scaffold design (15). The sinusoidal-
elongated morphology could indicate force transmission from the fibre to the cells 
resulting in mechano-transduction promoted tendon cell proliferation and alignment. 
Earlier studies highlighted that the addition of collagen within scaffold design can aid 
integration within the implanted tissue (131). This further highlights the importance of 
collagen addition, not only in the tissue integration and remodelling of tendon but as a 
means of delivering cells to a point of repair, and further adds to previous studies 
suggesting collagen is a beneficial inclusion in tendon graft material (124), (129).  
Cellular therapies for tendon healing have been found to produce promising results in the 
equine model (116), (127); however the relative high costs and secondary surgical 
procedures required to harvest cells for inclusion in tendon repair scaffolds could be 
preventing their current widespread use in the clinic (39). Our study suggests that the 
inclusion of exogenous or endogenous cells is not necessarily required to produce tendon 
healing, although further experimentation with the addition of cells to the construct would 
be required before absolute conclusions can be made.  
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6.5. CONCLUSION. 
This study has demonstrated that PHBHHx can be used as a scaffold material for the 
treatment of damaged tendon tissue in vivo and that its breakdown products are 
immunologically inert in the rat model. It has also shown that cells migrate into a 
PHBHHx scaffold in vivo and begin remodel damaged tissue, with a PHBHHx plus 
collagen scaffold resulting in the greatest mechanical properties of the healing tissue after a 
40 day time period. When considered together, these results provide a foundation to 
proceed with a larger, more in depth in vivo study, where further indications can be 
investigated.
Alexander Lomas PhD Thesis Chapter 7 General Discussion 
192 
 
 
 
 
 
 
Chapter 7. 
 
Discussion. 
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Tendon injury and disease is increasingly prevalent and notoriously difficult to cure. 
Treatment success is dependent on many factors, including patient age, type of injury and 
time between injury and medical intervention, with many injuries being untreatable (10). 
Because of these issues, a strong clinical need exists for new treatments to be developed, 
incorporating novel biomaterials and cellular components to provide a clinical advantage 
over current best treatment methods (39). Tissue engineering or regenerative medicine 
aims to use scaffolds and cells to regenerate and restore function of tissue lost through 
damage, disease, and disorder (1). The use of PHBHHx has been explored by many groups 
investigating multiple potential applications including cellular interactions and its use as a 
scaffold in tissue engineering (142), (143), (145), (146), (148), (182). 
A key consideration when designing a tissue engineered construct is how cells interact 
with the scaffold material. Many cells require contact adhesion to remain viable (225). It is 
therefore vital to establish early on in the design of tissue engineering scaffolds that the 
specific cell type to be used is compatible with the materials chosen.  PHBHHx has been 
previously used to culture many different cell types. A previous report demonstrated that 
hMSC adherence was greatly improved on PHBHHx films when compared to both tissue 
culture plastic and other PHA molecules (144). Adipose derived MSCs were also 
successfully cultured in 3D PHBHHx scaffolds before being stimulated into chondrogenic 
differentiation (147). This chapter and corresponding journal manuscript (182) demonstrate 
that rat tenocytes and human mesenchymal stem cells adhere to and spread across 
PHBHHx polymer films, with a preferred rigidity of >420N/m over at least a 72 hour 
culture period. This supports the assertion of PHBHHx as a candidate material for tendon 
tissue engineering and adds to the body of literature supporting the biocompatibility of 
PHBHHx. 
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Investigation into rat tenocyte attachment to PHBHHx films as a total of all cells present in 
the well demonstrates that when wt/vol ratios of ≥ 1.6% were used over 90% of cells 
adhered to the film in preference to the untreated plastic surface. This could in some part 
be explained by the increase in stiffness of the polymer film between 1.6% and 2.0% 
wt/vol, suggesting that increased polymer rigidity promoted increased tenocyte adhesion. 
This reinforces a number of previous studies which have demonstrated that material 
stiffness affects cellular adhesion and behaviour (173) (174). hMSC have previously been 
shown to have less preference when adhering to surfaces with differing mechanical 
properties, although differentiation and proliferative capacity are altered (124), (143), 
(175) explaining why little difference was found between polymer concentrations. 
Tendon tissue is poorly vascularised with a low mean oxygen concentration (176). 
Hypoxic atmospheric (1 – 3% O2) conditions have been found to be beneficial to cells, 
delaying senescence and increasing proliferative capacity (72). Mesenchymal stem cells 
have been shown to have higher proliferation (30 fold increase) in 2% O2 compared to 
21% O2 (170). Human embryonic stem cell colonies have been found to be less heterogenic 
and have more stable self-renewal capacity when cultured in 2% O2 (85). Tendon derived 
stem cells have also been found to proliferate faster at 2% O2 compared to atmospheric 
conditions (86). Initial investigations were therefore performed in both room oxygen (21% 
O2) and tendon tissue normoxia (2% O2). Previous studies into the effects of different 
oxygen concentrations on cells have demonstrated enhanced proliferation, enhanced 
clonogenicity, reduced karyotypic abnormalities, reduced spontaneous differentiation, 
altered transcriptional profiles, and altered FTIR profiles across numerous cell types 
including hMSCs (70), (71), (85), (177), (178). When comparing 2% O2 with 21% O2 only 
small differences were found between cell number or percentage attachment at the same 
PHBHHx concentration for either cell type. hMSCs were generally noted to adhere better 
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in hypoxic conditions to all polymer film compositions, however no significant rises were 
found, possibly due to large inter-group deviations. To our knowledge, this was the first 
study looking into the in vitro effects of oxygen tension on the interaction of primary 
mammalian cells with polyhydroxyalkanoate scaffolds. In our study, rat tenocytes were 
found to proliferate faster during the first stages of culture in 2% O2, but this difference 
was not maintained over a longer culture period. It was also noted that cells did not migrate 
from tendon tissue samples in 2% O2; leading to the conclusion that tenocyte isolation via 
explant requires atmospheric oxygen to take place. The proportion of HHx in the polymer 
has been proposed as an important modulator of cell behavior. Proliferative capacity of rat 
smooth muscle cells was enhanced by 20% HHx though attachment at seeding was optimal 
with 12% HHx (226). In our study we have also found robust attachment of hMSC and 
RaT to 12% HHx polymer films when used at the optimal wt/vol ratio, although further 
work is required to identify the optimum %HHx in the polymer for use any potential future 
tendon therapeutic products. 
Cell spreading was monitored across polymer surfaces in the absence of mechanical 
stimuli or directional forces over a period of 72 hours by marking cells with fluorescent 
tracker dye (DiO). This method was essential due to polymer opacity. After 24 hours the 
cells were clumped together on the surface of the polymer. This behavior is not uncommon 
in cell culture and can be explained by the cells not being separated sufficiently when re-
suspending after centrifugation. After 72 hours the cells were seen to move apart from each 
other, filling the available space on the polymer. Yang et al (227) found that mouse islet 
cells showed increased metabolic activity when cells were cultured on PHBHHx in 
comparison to tissue culture plastic and Poly Lactic Acid. This investigation also looked 
into cell migration across a PHBHHx film surface, finding that cells were moving from an 
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even distribution to clump together to start to form functional units. These findings agree 
with our work that cell locomotion is possible across PHBHHx surfaces. 
DiO and other similar dyes used for tracking cells can be expelled by the ABCG2 multi-
drug transporter pathway (228). HMSCs retained dye more efficiently than tenocytes 
although both had undergone reductions in intensity after 72 hours suggesting that some of 
the dye may have been exocytosed. Migration into the polymer surface was measured with 
confocal microscope generated z-stacks, allowing for cross sectional views to be created in 
both the x-z and y-z directions. Cells were always found to be in one plane of view, with 
no further fluorescent signatures being seen above or below the single plane. This indicated 
that the cells remained on the surface of the polymer as opposed to migrating into it 
indicating that localized polymer degradation had not occurred over the time period tested. 
This observation is reinforced by previous reports which state that PHBHHx is broken 
down in vivo (179) and in vitro (180) at very slow rates via hydrolysis.  
Tendon stem cells are a sub population of cells present in tendon that are capable of 
differentiating into bone, cartilage and adipocytes (27). TDSC have different morphologies 
to mature tenocytes. TDSCs have a “cobblestone” like appearance when cultured to 
confluence, with an enlarged nucleus, whereas tenocytes have an elongated “spindle” like 
morphology when confluent, with little contact seen between cells. TDSCs have also been 
found to have significantly longer population doubling times when compared to tenocytes 
isolated from the same tendon source (83). After passage 8, it was found that cells isolated 
from tendons started to change morphology, becoming shorter and squarer in appearance. 
Due to this apparent shift in cell phenotype, experimentation using cells isolated from 
tendons was performed using cells at or below passage 4, making it far more likely that a 
population of tenocytes were used rather than tendon stem cells. 
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This work has demonstrated the potential of using PHBHHx as a material for tendon tissue 
engineering, promoting cellular adherence and migration across a 2D scaffold surface and 
maintaining viability over a 3 day time period in both 21% O2 and 2% O2, providing a solid 
foundation for further work investigating the polymer’s use for potential tissue engineering 
applications. 
The next stage in construct development was to identify a scaffold design that was both 
capable of withstanding the mechanical loading of tendon tissue and allowing for cellular 
growth and matrix development. By incorporating the major constituent molecule of 
tendon (collagen I), a hybrid scaffold of a PHBHHx tube and a collagen core was found 
that was mechanically similar to rat tendon and capable of maintaining cellular viability 
and phenotype over a 20 day culture period. The interaction of human embryonic stem 
cells with the construct was also assessed, providing for the first time a study on the effects 
of PHBHHx/collagen scaffolds on human embryonic stem cells in vitro.  
The application and suitability of PHBHHx as a scaffold material in 3D models for human 
and animal stem cell biocompatibility has been described in several previous studies (148), 
(222), (147), (122), (197), (114), (180). The microstructure of PHBHHx scaffolds has also 
been shown to influence cellular behaviour. Rat MSCs adhere to and elongate along the 
length of electrospun PHBHHx scaffolds, demonstrating that fibre orientation played a 
strong role in promotion of differentiation toward a specific lineage (aligned promoted 
osteogenesis whereas random promoted adipogenesis) (197). Cartilage like structures have 
also been formed by human adipose derived stem cells pre-seeded onto salt leached, 
porous 3D PHBHHx foams, then successfully implanted subcutaneously into a nude mouse 
model (147).  
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Type I collagen gels supported the differentiation of murine ESCs into either osteogenic or 
chondrogenic lineages when seeded into 2D and 3D 1.2 mg/mL scaffolds. The additional 
presence of lineage specific supplements (beta-glycerol phosphate – bone, chondroitin 
sulphate – cartilage) was found to further increase differentiation above that found in 
control collagen gels, with greater expression of SOX-9 measured using qRT-PCR after 15 
days culture. Viability within the collagen gels was unclear but surface viability was 
approximately 60% after 15 days culture(198).  Human and murine ESC culture in 0.75 
mg/mL type I collagen gels has also been achieved by pre differentiating cells into 
Embryoid Bodies before suspension (199). Undifferentiated ESCs were not compatible 
with our PHBHHx/collagen gel hybrid scaffold system. Our study has demonstrated that 
hESCs required a prior spontaneous differentiation step induced by exposure to foetal 
bovine serum prior to collagen gel suspension to shift cell phenotype away from that of a 
self-renewing ESC into a partially differentiated heterogeneous population for long term 
culture in type I collagen gels. Here we report viability and contractile behaviour of hESC 
and pre-differentiated hESC in PHBHHx/collagen gel hybrid scaffolds after a pre-
differentiation stage, and demonstrate a 40-60% cell viability of SDhESC after 20 days 
continuous static culture. Viability of hMSCs in constructs was found to be 70-80% after 
20 days, indicating no adverse effects of the scaffold in the cells. 
Differentiation of MSCs in hydrogel based scaffolds has been well researched. Bone 
marrow derived MSCs and umbilical cord derived MSCs were compared in a study 
investigating differentiation on collagen I/III gels, finding that in the absence of lineage 
specific media, neither osteogenesis nor adipogenesis was stimulated, however 
osteogenesis was induced in both cell types after 21 days (185). Mechanostimulation has 
been suggested as an alternative to chemostimuli when inducing MSC differentiation on 
collagen scaffolds. A cyclic compressive strain study on hMSC seeded collagen-alginate 
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gels demonstrated up regulation of CBFA-1 (RUNX2) after 7 days when compared to 
static unloaded controls (205). This suggests cells were becoming more osteoblastic, as the 
RUNX2 transcription factor has been shown to be critical for the promotion of osteogenic 
differentiation (204). By inducing chondrogenic differentiation of MSCs in collagen I gels 
it was found that increased chondrogenesis could be achieved by increasing both collagen 
concentration in the gel and the initial cell seeding density. However, similar to our study, 
they found that little evidence of chondrogenesis was induced in 3mg/mL collagen gels 
seeded with 1x10
5
 MSCs (229). Β-actin is frequently used as a housekeeping gene due to 
its consistent presence as a cytoskeletal component of mammalian cells, and is commonly 
used as a marker of cellular viability (203). We noted expression of β-actin throughout the 
20 day period which, when coupled to the high cell viability provided an additional 
demonstration of viable cell transcriptional activity. Expression of lineage specific 
molecular markers for multiple tissue lineages also suggested that cells were maintaining 
phenotype over 20 day static culture in PHBHHx/collagen hybrid scaffolds. 
For this scaffold design, minimal collagen contraction is essential to facilitate the 
integration of implanted cells into host tissue when placed in vivo, increasing the likeliness 
of cellular infiltration and the overall rate of recovery (230). Collagen gel contraction by 
fibroblastic cells is well established (200). Cells interact with the surrounding ECM via 
strong inward tractions located at the tips of long slender extensions, similar to those used 
by a cell to migrate across a surface (231). Platelet derived growth factor (PDGF) is 
believed to be one of the stimuli considered to be responsible for causing the extensions to 
contract (232) (233). Decreasing  collagen gel concentrations from 2.6 to 1.3 mg/mL was 
reported as having a greater  impact on gel contraction kinetics than increasing the rabbit 
MSC density by the same fold increase (500K to 1M cells/mL) (167). This suggests that 
availability of fibril binding sites in the collagen is the major factor in gel contraction and 
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not seeding density per se. Similarly human corneal fibroblasts can contract a 4.5mg/mL 
collagen gel over a 25 day static culture period when seeded at a cell concentration of 5 x 
10
5
 cells/mL, but not 1 x 10
5
 cells/mL (169). These reports correlate with our observations 
where little contraction was observed in the 3 mg/mL groups, and the rate of contraction 
slowed with 1.5 mg/mL gels seeded with lower cell densities. We have therefore identified 
a cell:collagen ratio with negligible collagen contraction at cell seeding densities of 1 x 10
6
 
cells/mL or lower, and provide high cell viability in the absence of additional stimuli for 
application in studies utilising either hMSC or SDhESC. 
The use of mechanical loading has been highlighted in several papers as being necessary 
for long term expression of cellular markers for many different tissue lineages in 3D 
culture models. These tissues include tendon (165), muscle (234) and bone (154). Further 
work investigating the effects of mechanical stimulus to PHBHHx/collagen scaffolds 
seeded with several cell types was therefore required to establish further if forces could act 
through the construct and induce cells towards a tendon specific lineage. This investigation 
demonstrated for the first time the effects of growth factors, mechanical loading and 
PHBHHx/collagen hybrid scaffolds on human stem cells, finding mechanical loading to 
have positive tenogenic effects on hMSC seeded scaffolds, with increased mechanical 
properties and maintenance of tendon specific molecular markers over a 20 day culture 
period. 
Cellular viability in PHBHHx has been found to be high throughout long term in vitro 
culture. Cells previously cultured on PHBHHx include rabbit MSCs (197), murine islet 
cells (227), smooth muscle cells (226) and osteoblasts (143). 3D collagen gels have also 
demonstrated the ability to sustain high cell viability throughout long term culture. 
Silk/collagen hybrid scaffolds were found to sustain high viability and function of 
differentiated hESCs (ESC-MSC cells) over 14 days with mechanical loading (124). Our 
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studies demonstrated that viability of hMSCs, hESCs and rat tenocytes was high 
throughout the experimental time period, building on previous conclusions demonstrating 
the suitability of PHBHHx/collagen hybrid scaffolds for tissue engineering applications. 
Our theory is that total cell numbers were reduced after mechanical loading due to collagen 
gel being lost from the centre of the tube during the BOSE chamber loading process, 
although loss was not quantified. 
Human movement is controlled by contracting muscles acting through tendons. As a result, 
tendon tissue is consistently under high levels of mechanical stress, usually applied in a 
cyclical motion (158). Investigations into the mechanical stimulation of tendon tissue 
engineered constructs have been shown to influence cell behaviour in many ways. Long 
term mechanical loading has been found to result in tenocyte seeded PGA constructs into 
dense fibrillar structures with higher levels of tendon specific proteins being expressed by 
cells and being found in the overall matrix when compared to non-loaded controls (160).  
This work corresponds with our findings, with mechanical loading significantly increasing 
both load to fail and stiffness in tenocyte seeded samples where specific combinations of 
growth factors were added.  
Bone marrow derived human mesenchymal stem cells have been shown to create tendon 
like structures when exposed to dynamic cyclical mechanical stress when seeded in 
collagen scaffolds (164). Up regulation of collagen I and III expression, along with 
embryonic tendon markers were seen in samples after 7 days of 30 minutes per day 
loading. This study also demonstrated the need for continued dynamic stress to be applied 
to maintain tendon like cellular characterisation. This study agrees with our findings, with 
collagen 1a2, collagen 3a1 and tenascin C expression maintained in hMSC seeded collagen 
scaffolds exposed to dynamic stress and fibroblast growth factors 4, 6 and 8 over a 20 day 
period. MSC seeded collagen constructs have been found to become stiffer after 14 days of 
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low level, low frequency loading (209). This study suggests that the original scaffold 
architecture that cells initially adhere to is an important factor when designing materials for 
tendon tissue engineering, finding that the direct contact with cells that collagen sponges 
provide were more efficient at transmitting forces to cells than basic collagen gels. It has 
also found that slow stretching of collagen scaffolds increased the amount of fibrilar 
alignment and overall scaffold mechanical properties, significantly increasing stiffness and 
ultimate tensile stress after 4 days loading (159). These studies agree with our findings, 
with mechanical loading significantly increasing both stiffness and load to failure of 
scaffolds seeded with both rat tenocytes and human adult and embryonic stem cells, with 
an insignificant increasing trend observed in hMSC seeded scaffolds. 
Fibril alignment in embryonic tendon formation has been found to be controlled 
intracellularally by specific sites between the Golgi apparatus and cell membrane. 
Procollagen molecules become arranged into small diameter collagen fibrils which are 
excreted in hexagonally shaped bundles through the cell membrane parallel to the axial 
direction of the embryonic tendon (43). Further fibrillogenesis occurs when other small 
collagen fibrils start aligning and joining together to form mature tendon after birth (210). 
No evidence of these intracellular sites in adult cells has yet been found, perhaps 
explaining why embryonic stem cells were found to show greater remodelling of collagen 
than MSCs and increases in both load to fail and stiffness. It has also been found that the 
absence of mechanical loading leads to the loss of fibropositors in embryonic tendon cells 
(211), providing a potential explanation of how constructs seeded with hESCs were 
generally mechanically stronger and stiffer after mechanical loading and showed increased 
matrix organisation when compared to other cell types exposed to similar culture 
conditions.  
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Vitamin C was added to media in conjunction with growth factors in small concentrations 
as it has been found by several studies to aid in tendon regeneration (235) and increases the 
cellular production of the major components of tendon (236). Ascorbic acid also acts as an 
anti-oxidant (237), helping to maintain the growth factor stability in the media for longer 
and prolonging the effectiveness of the molecules.  
This investigation has for the first time investigated the combined effect of FGF 4, FGF 6 
and FGF 8 on cells seeded into a 3D scaffold environment. FGF 4 has been shown to play 
a crucial role in mesenchyme patterning during embryonic development, with an absence 
of FGF 4 leading to a failure of proper development (57), (58). FGF 6 is strongly linked 
with skeletal development in embryos (60,61), with studies also finding that it is needed 
during adult skeletal muscle development and repair, possibly acting to recruit satellite 
cells to the wound site (212). FGF 8 is associated with embryonic patterning of 
mesenchyme tissues and in embryonic limb bud development (63), (64), (213). As tendon 
tissue forms in the developing embryo at similar time points to muscle tissue, shortly after 
the development of a limb bud, it was assumed that combination of FGFs 4, 6 and 8 would 
be closely associated with the formation of the collagen extracellular matrix of both tissue 
types.  We have demonstrated in this study that a combination of FGF 4, FGF 6 and FGF 8 
lead to tendon specific cellular expression markers being maintained or stimulated by 
hMSCs, but not in hESCs in 3D PHBHHx/collagen hybrid scaffolds. BMP 12 has been 
found to induce tenogenesis in rat bone marrow derived MSCs, with increases in scleraxis, 
tenomodulin, tenascin C and collagen 1a2 expression noted in treated cells compared to 
control samples, and tendon like tissues being formed when pre-treated cells were seeded 
into collagen scaffolds and implanted in vivo (48). BMP13 has been previously shown to 
play a role in tendon matrix regeneration after injury (214), with knockout studies in mice 
finding similar results (238). Unpublished work performed in our laboratory has also found 
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strong evidence of BMP12/13 influencing human ESCs towards tenogenic lineages in 2D 
culture. The data presented here adds to the body of evidence linking BMP12 and 13 with 
tendon development and repair, reporting for the first time the influence of these molecules 
in conjunction with PHBHHx/collagen hybrids scaffolds, finding that growth factors are 
essential for the maintenance of tenascin C expression in hMSCs for over 5 days culture, 
and that FGFs 4, 6 and 8 are needed for expression of Thrombospondin-4 in hMSCs in 3D 
PHBHHx/collagen hybrid scaffolds. 
PHBHHx has been found to be an effective material as an implant device in several studies 
(148), (150), (222). Further investigation into the effect of implanting a PHBHHx/collagen 
hybrid scaffold into a tendon wound site was required to gain an understanding of how the 
construct reacts in vivo, with mechanical properties, breakdown characteristics and 
immune response needed to be evaluated to gain a greater understanding of how these 
materials could be used in future therapeutic treatments. 
There are three grades of tendon injury; I, II and III, with grade III the most severe and 
most likely to not respond to treatment (31). When tendon defects are too large to heal 
naturally, constructs are required to bridge the gap and aid the regeneration process. Graft 
tissues are frequently used with varying effectiveness, with autografts providing the most 
reliable source of transplant material (40). Allografts from donor or cadaveric tissue are 
currently used, however lack of supply, greater failure rates and immunorejection problems 
prevent further development (11). Decellularised xenograft tissues are starting to be used 
more widely in the clinic, however major concerns remain regarding long term viability 
and cross species disease transmission (12). Artificial tendon grafts have been in wide 
clinical use for many years, however prolonged immune response and post-operative 
infection have been widely reported (41). Due to these problems associated with tendon 
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repair surgery, new techniques and materials are needed to meet the increasing clinical 
need. This investigation used an induced Achilles defect in the rat model to monitor an 
implanted PHBHHx and PHBHHx/collagen hybrid construct that could be used to improve 
the rate of damaged tendon tissue healing while not initiating a prolonged immune 
response.  
Mechanical testing of samples recovered from the rats 40 days post implantation found that 
the scaffold/collagen group had a comparable mechanical load capability to undamaged 
tendon, matching the performance of traditional tendon laceration treatments (218), and 
bettering the performance shown by porcine intestinal sub mucosa (219) and PLGA based 
(131), (220) treatment methods. However, the success of the implant and the healing rate 
caused was variable. This could be explained by variability in manufacturing although 
intra-group mechanical properties were within a narrow range. It has also been shown that 
small differences in components of the surgical procedure, such as suturing, can affect the 
failure rate of tendon implants (208). It was apparent that the addition of the 
PHBHHx/collagen hybrid implant at the wound site increased the mechanical strength 
significantly when compared to the no scaffold control group. This highlights the 
importance of collagen in the remodelling of tendon, concurring with previous studies 
suggesting collagen is a beneficial inclusion in tendon graft material (37), (131). 
Regular sinusoidal cellular alignment is a key marker in the histological analysis of tendon 
tissue, signifying the presence of crimp angles between collagen fibrils (224). Evidence of 
cellular alignment was seen in samples of damaged tissue from all three experimental 
groups; however it was most apparent in those with the scaffold/collagen implant, 
potentially suggesting a faster healing rate. It was also most evident when cells were in 
direct contact with the scaffold. This was observed with scaffold-collagen implants, 
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indicating that force transmission through the fibre to the cells promoted tendon cell 
proliferation and alignment. 
C-Reactive Protein (CRP) acts as an early marker for inflammatory response caused by an 
foreign object material or to tissue damage (221). As expected, CRP levels in blood serum 
rose dramatically after surgery in all experimental groups to a maximum value after 48 
hours, returning to pre surgery levels after 5 days (181). Further stability of CRP was seen 
after day 5, however small peaks were seen after 20days in animals where constructs were 
placed. Long term (40 days post-surgery) low CRP levels demonstrate that no chronic 
inflammatory response was occurring, demonstrating immunological compatibility in the 
rat model. These findings indicate a possible advantage over the available synthetic tendon 
graft materials which have been found to present long term immunological risk (40), 
however longer term assessment of constructs would be required before more conclusive 
statements can be made.  
β-Hydroxybutyrate is a constituent monomer of PHBHHx (143). Measurement of HB 
concentration in blood over time demonstrated that scaffold breakdown was erratic, with 
large error bars showing the discrepancies between the individual samples. Trends in the 
data show that constructs without collagen breakdown at an earlier stage than those 
containing collagen, where this trend was reversed, however wide variations seen in the 
groups hinder the conclusions that can be made from this. Further refinement of the 
production method should improve the variation, with more close control of both porosity 
and polymer volume aiding to make the process more consistent. When β-hydroxybutyrate 
and CRP concentrations were compared it became apparent that there is no link between 
the factors, further suggesting the immunological inertness of PHBHHx and its in vivo 
breakdown products (179). 
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8.1. Conclusion. 
This study has demonstrated the effectiveness of PHBHHx and combinations of PHBHHx 
and collagen for tendon tissue engineering applications. Early work found cellular viability 
and migration capacity to be high on PHBHHx films, providing evidence that the polymer 
was nontoxic to both human and rodent derived cells. It was also found that hMSCs adhere 
better to stiffer films, providing further evidence to the body of knowledge on cellular 
adherence being influenced by material properties.  
Polymer and collagen constructs were designed that closely resembled the mechanical 
properties of native rat Achilles tendon. Cell viability and phenotype were maintained 
throughout 20 days static culture. It was also established that a cell concentration of under 
1 x 10
5
 cells/mL in 3mg/mL collagen gels would not lead to collagen contraction, 
potentially increasing the probability of an in vivo construct integrating with native tissue 
and thus creating an overall more successful implant.  
Mechanical stimulation of cells in constructs was found to increase mechanical properties 
and tendon like matrix morphologies of PHBHHx/collagen scaffolds. It was also found 
that mechanical stimulation was essential for continued expression of tendon specific 
cellular markers. Supplementation of tenogenic growth factors was found to increase the 
mechanical properties of cell seeded scaffolds, although these increases were largely 
observational rather than statistically significant. 
Implantation of PHBHHx/collagen hybrid scaffolds in an induced rat Achilles tendon 
defect model found that scaffolds did not initiate a prolonged immune response over a 40 
day experimental period, despite increased levels of scaffold breakdown products being 
found in blood serum. Evidence of cellular migration and matrix remodelling was also 
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apparent, providing strong evidence that scaffolds were being incorporated into the wound 
site and starting to aid in the healing process. 
This thesis has proven through a series of in vitro and in vivo experiments that PHBHHx 
and collagen can be seeded with human stem cells or rat tenocytes to form constructs 
suitable for tendon tissue engineering applications.  
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8.2. Future Perspectives and Avenues of Research. 
This thesis has demonstrated that PHBHHx can be used to culture human stem cells and 
animal tenocytes, and that combination of PHBHHx and collagen can be formed into 
scaffolds suitable for tissue engineering of tendon. This research acts as a foundation for 
further work in the field, with several potential avenues of research remaining to be 
explored.  
The integration of musculotendon and osteotendon tissue boundaries provides the next 
logical step for further research. Integration of these tissues would provide a working 
model of a complete tendon system, allowing for future drug and treatment testing to be 
carried out and effect seen over the differing tissues found in and around tendons. A 
proposal to integrate graphine into the tube structure to encourage osteoblastic 
differentiation has been generated, as has a proposed collaboration with groups working in 
muscle tissue engineering areas.  
Different variants of PHBHHx can also be investigated. This research has focussed on 
using PHHBBx with an HHx mass percentage of 12.1%, due to its availability and 
compatibility with other musculoskeletal cell types. Mass percentage can vary according to 
initial culture conditions present when the polymer is produced from 8% to 20%, with 
varying properties associated with this change.  
Growth factors have been added as a media supplement as part of this investigation. 
Further research into the controlling of cellular exposure to growth factors could result in 
much stronger effects being seen. One way in which growth factors could be introduced to 
the system could be via the use of nanoparticles. These particles would breakdown at a 
controlled rate, allowing release to be temporally and spatially controlled. Another option 
would be to introduce angiogenic growth factors into the outer PHBHHx tube, adding to 
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the properties held by the polymer and better replicating the highly vascularised tissues 
surrounding large tendons. 
Further in vivo analysis of the construct would also be required before any potential use in 
humans can be made. This investigation has already determined that PHBHHx/collagen 
scaffolds do not initiate any prolonged immune response. Further experimentation using 
more advanced versions of the scaffold should provide greater insight into how this type of 
construct could be utilised in humans, with higher mechanical strengths and more accurate 
tissue architecture allowing for greater integration of tissue and thus a lower chance of 
implant failure. 
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